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Many studies carried out in man and in animals in the last three decades 
have convincingly demonstrated that immune mechanisms play a keyrole in 
the pathogenesis of most forms of human nephritis (1-5). Humoral immunity 
is an important immunologic mechanism in the induction of these renal 
diseases as evidenced by the occurrence of deposits of antibodies, 
complement components, and coagulation factors in the affected kidneys. 
These deposits are assumed to be immune complexes previously formed in 
the circulation and trapped in the kidney or resulting from an in situ 
interaction between antibodies and antigens. The antigens may be 
structural components or they may have been planted in the kidney. 
Besides the humoral immune mechanisms cellular immunity has also been 
demonstrated to play a role in a number of nephritides, particularly in 
certain tubulo-interstitial diseases or in some forms of immune complex 
induced glomerulonephritis (4,5). 
In addition to morphologic, immunologic, and serologic studies in man, we 
have to lean heavily on experimental models in order to extend our 
knowledge of the formation of immune complexes in the kidney and to 
define whether circulating immune complexes or an in situ formation are 
operating in the various forms of renal disease. We will not give a 
detailed description of all forms of experimental nephritis, but will 
confine ourselves to some introductory remarks of four models that are 
pertinent to the current study (table I). 
Table Î. Active experimental nephritis 
Model Human counterpart 
Acute serum sickness (6,7) Acute postinfectious glomerulonephritis 
Chronic serum sickness (Θ) Various forms of chronic glomerulonephritis 
Heymann nephritis (9) Membranous glomerulonephritis 
Anti-GBM nephritis (ID) Anti-GBM nephritis/Goodpasture syndrome 
These four active models were supposed to represent the experimental 
counterparts of immunologically induced glomerulonephritis in man. It was 
generally accepted that the first three forms covered the socalled immune 
complex glomerulonephritis initiated by the trapping of circulating 
immune reactants. All these diseases showed a characteristic granular 
pattern of immune deposits in the glomerular compartments. The fourth 
model closely resembled the characteristic picture of a rare form of 
human glomerulonephritis, known as the anti-GBM nephritis. The linear 
binding of circulating antibody to the glomerular basement membrane 
provided convincing evidence for an in situ mechanism. On the basis of 
the elegant and extensive studies of Dixon and Germuth in the acute and 
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chronic serum sickness models in rabbits after single or multiple 
injections of BSA respectively, it was postulated that the presence of 
renal immune deposits was a consequence of the trapping of small soluble 
circulating immune complexes formed in the blood stream (6-8). The 
clinical and pathologic features of the acute serum sickness, the 
experimental counterpart of the human postinfectious glomerulonephritis, 
were regarded as the prototype of an acute, transient inflammation of the 
glomerulus induced by one single immunologic stimulus. On the other hand 
chronic serum sickness, in which various morphologic forms of inflamma-
tion could be observed, was thought to be equivalent to many kinds of 
chronic renal diseases in humans. In both models the renal lesion was not 
related to the absolute amounts of antibody and antigen but to their 
ratio in the circulation. Particularly the size of these soluble circula-
ting immune complexes defined the glomerular localization: large 
complexes were lodged in the mesangial or endothelial areas, while the 
smaller ones settled in the subepithelial subepithelial space (7,8). It 
was suggested by Edgington et al in 196B that a similar mechanism could 
explain the formation of subepithelial deposits in Heymann nephritis (11, 
12). Although a number of experimental and clinical features could not be 
explained by this mechanism, the theory of circulating immune complexes 
has been regarded for many years as the only correct interpretation of 
immune complex formation and has thereby retarded for a long period the 
search for other mechanisms of immunologic injury. However, by the obser-
vations of Hoedemaeker and Couser and their collaborators in the passive 
Heymann nephritis (13, 14), as well as by the elucidation of electros-
tatic interaction between extrarenal antigens or antibodies with charged 
groups in the glomerulus(reviewed in 15), it has now become clear that in 
situ formation of immune deposits is an important mechanism of immuno-
logic injury. The relative contribution of either mechanism in the 
various forms of human glomerulonephritis is still unclear. It is assumed 
that subepithelial deposits are largely formed by in situ formation while 
both mechanisms can operate in the formation of mesangial and subendo-
thelial deposits. 
Aim of the study 
Experimental studies on immunologically mediated renal disease have been 
carried out in a restricted number of species, mostly the rabbit and the 
rat, because these species are highly susceptible and the nephritis 
induced is very reproducible. Apart from the "lupus-prone" mouse strains 
(16,17), which develop spontaneous autoimmune disease with many features 
of human systemic lupus erythematosus, and of the chronic allogeneic 
disease in mice (18,19), associated with the formation of autoantibodies 
and pathologic lesions resembling lupus erythematosus, this animal 
species has not been used on a large scale in experimental nephritis 
because of the variability of the lesions induced by the different 
procedures. However, the mouse is an attractive animal for immunologic 
studies because much is known about its immunogenetic background and the 
functions of the various immunoglobulin(sub)classes. Furthermore, the 
mouse with its inbred strains and complement deficient strains provides a 
good model for the more detailed examination of the role of secondary 
mediator systems in tissue destruction. 
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In this thesis we describe the successful induction of two different 
forms of glomerulonephritis in the mouse. Firstly, analogous to the 
passive Heymann nephritis in the rat we have tried to evoke a glomerulo-
nephritis in C57B1/10 mice by a single injection of an antiserum against 
homologous, pronase-digested renal tubular antigens. Although this model 
has some features in common with the passive Heymann nephritis, some 
essential differences have been found such as the putative target antigen 
and the binding kinetics of the administered antibodies. To obtain a 
glomerulonephritis with reproducible proteinuria, enabling us to study 
the mediator systems involved, we developed a passive anti-GBM nephritis 
in the mouse. This experimental disease can easily be induced in rats and 
rabbits, but in mice it was difficult to obtain reproducible lesions. As 
a starting point for further study we have evoked a highly reproducible 
heterologous phase of an anti-GBM nephritis in the mouse after injection 
of homologous anti-GBM antibodies. The disease is characterized by a 
dose-dependent proteinuria and typical dose-dependent morphologic 
lesions. In this introduction we will now first place these two new 
experimental models against the background of their known counterparts in 
other species. 
Passive models in experimental nephritis 
Three passive variants of the abovementioned active forms of experimental 
immune complex nephritis have been described (table II). They can be 
induced by a single injection of preformed immune complexes or antibodies 
and have been developed to circumvent the variations of the lesions 
imposed by the variable endogenous immune response to the administered 
proteins in the active forms. 
Table II. Passive experimental nephritis 
Model Animal species 
Passive serum sickness Mouse, rat, rabbit 
Passive Heymann nephritis Rat 
Passive anti-GBM nephritis Kat, rabbit, monkey, mouse, sheep, dog 
Because the mechanism of deposition of immune complexes and their 
composition were difficult to define in active serum sickness, 
experiments with preformed immune complexes of known antigen-antibody 
ratio and size were carried out (reviewed in 3 and 20). The aim was to 
demonstrate the importance of particularly this ratio or lattice 
structure for the final localization in glomeruli and the ensuing form of 
glomerulonephritis. However, only mesangial and subendothelial trapping 
of immune complexes was observed. 
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Passive Heymarm nephritis 
In 1959, Heymann and his collaborators described a nephrotic syndrome in 
rats after intraperitoneal injection of kidney homogenates in Freund's 
adjuvant, strongly resembling membranous glomerulonephritis in man (9). 
The glomerulonefritis, morphologically characterized by subepithelial 
deposits of immune reactants without cellular proliferation, was assumed 
to be an example of an autoimmune disease. In 1967, Edgington et al 
suggested that the Heymann nephritis was due to glomerular deposition of 
circulating immune complexes, composed of antibodies and antigens 
associated with the brush border of the renal proximal tubular epithelial 
cells and designated FxlA (11,12). The rapid variant of this nephritis, 
introduced by Barabas and Lannigan, and by Hoedemaeker and his 
collaborators in the early 1970s, is induced by a single injection of 
heterologous antibodies directed against rat brush border antigens 
(22,23). Recent studies by Van Damme et al (13), using ex vivo perfusion, 
and by Couser et al (14), in an isolated perfusion system, have 
demonstrated that there is a direct binding of the injected anti-brush 
border antibodies to a structural component of the glomerular basement 
membrane, which is identical to or corssreactive with a brush border 
protein. Recently, the putative nephritogenic antigen has been isolated 
and characterized by Kerjaschki and Farquhar (24,25). In the sodium 
dodecyl sulfate Polyacrylamide gel electrophoresis (SDS-PAGE) a molecular 
weight of 330,000 daltons was found and by immunocytochemistry the 
antigen could be localized at discrete sites on the cell surfaces of the 
glomerular cells and also intracytoplasmically. The antigen was 
concentrated in invaginations of the cell membrane, known as coated pits, 
whereas inside the cell the antigen was found in solitary or 
multivesicular bodies, the endoplasmic reticulum, and the Golgi apparatus 
(25). In the brush borders of the renal proximal tubules it was situated 
predominantly at the base of the microvilli in connection with large 
amounts of clathrin, a molecule that plays an important role in 
receptor-mediated endocytosis (26). Two phases, the first or heterologous 
phase following the injection of the antibodies and the second or 
autologous phase marked by the immune response of the rat to the 
administered protein, are distinguished analogous to the passive anti-GBM 
nephritis. However, as distinct from the rapid binding of nearly all 
antibodies to their targets in the glomerular basement membrane in the 
latter model, unique binding kinetics are seen in the passive Heymann 
nephritis (27,28). Glomerular antibody deposition occurs much slower over 
a period of several days, resulting in proteinuria as soon as sufficient 
amounts of deposited antibodies are present to activate the complement 
system. Concomitantly, a gradual decrease of circulating anti-FxlA 
antibodies can be observed. Proteinuria is not mediated by cells such as 
neutrophils, but by the activation of the complete complement sequence, 
as shown by Couser and his collaborators (29-32). However, cell 
destruction has never been observed in this model and therefore it is not 
clear how the formation of the so-called membrane attack complex (MAC) in 
the subepithelial area can disturb the normal permeability 
characteristics of the glomerular basement membrane. It is speculated 
that the MAC complex blocks the negative charges in and around the lamina 
densa and cell membranes of the glomerular epithelia. In the autologous 
phase the proteinuria is in all likelihood maintained by the antibody 
response of the rat to the planted heterologous protein. 
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Passive anti-GBM nephritis 
This prototype of specific immune reaction in the kidney can be induced 
by the administration of heterologous antibodies directed against 
antigens of the glomerular basement membrane (GBM). The term "nephrotoxic 
nephritis" originates from the publication of Lindemann (1900), who 
described the nephrotoxic effects of heterologous anti-kidney serum 
without knowing the nature and the site of the antigen (33). The disease 
is also known as the "Masugi nephritis", named after the investigator who 
provided detailed morphologic descriptions in several animal species in 
the early 1930s (34,33). In 19!>2, Krakower and Greenspon demonstrated 
that the antigen responsible for the production of nephrotoxic antisera 
was a constituent of the GBM (36). The passive anti-GBM nephritis is 
characterized by two phases each with different pathogenetic mechanisms: 
the first is the heterologous phase characterized by immediate linear 
binding of the administered antibodies to the glomerular basement 
membrane and the second is the autologous phase initiated by the immune 
response to the injected protein now planted in the GBM (reviewed in 1 
and 37, 38). Most studies of immunologic mediation systems in 
experimental nephritis have been done in the first acute phase. In this 
phase complement factors and neutrophils were demonstrated to play a 
prédominent role in glomerular injury (reviewed in 1,38,39). Unlike the 
passive Heymann nephritis, a maximal binding of the injected antibodies 
is seen within 1 hour. Eighty percent of the antibodies become fixed in 
the first 10 minutes with a concomitant, rapid decrease of the titers of 
circulating antibodies (40). Glomerular lesions are dependent on the 
amounts of antibodies deposited and the susceptibility of the various 
animal species (40). Using complement-fixing antibodies an immediate 
activation of complement occurs as evidenced by a linear 
immunofluorescence along the GBM and this activation is followed by an 
influx of neutrophils reaching a maximum at 2-4 hours and diminishing 
rapidly thereafter (37,41). Some investigators have mentioned an influx 
of mononuclear cells immediately after the transient influx of 
neutrophils (42). The first phase is morphologically characterized by 
exsudative lesions in most species with swelling and necrosis of 
endothelia, aggregation of platelets, and deposition of fibrin. The 
glomerular changes vary and are dependent on many factors such as animal 
species, amount, avidity, and charge of the injected antibodies, the 
source of the antibodies and the intensity of the immune response. In 
rabbits, for instance, the anti-GBM nephritis is characterized by a 
strong, inflammatory reaction, which seldom enters a chronic phase unless 
several injections are given, whereas in the rat a chronic phase 
frequently follows a rather mild, often exsudative heterologous phase. 
Although anti-GBM nephritis has also been induced in dogs, mice, monkeys, 
and sheep, most studies have been done in the rabbit and the rat. 
Proteinuria develops several hours after injection of the antiserum and 
appears to occur in two phases. The initial proteinuria, which is 
selective and in which the urine contains only albumin (43,44), is 
followed by an increase in permeability at 4-6 hours leading to 
nonselective proteinuria that is clearly complement- and 
neutrophil-dependent, and dose related (41,45). It is assumed that a 
defect in the charge barrier is responsible for the initial proteinuria 
while activated complement and neutrophils cause alterations in the size 
barrier of the glomerular basement membrane. 
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From in vivo and in vitro studies it was concluded that intraglomerular 
complement activation initiates a neutrophil-mediated injury of the 
capillary wall. Complement activation by tissue bound antibodies leads to 
the release of chemotactic factors such as C5a, and causes immune 
adherence of neutrophils and monocytes via their C3b receptors, analogous 
to the Arthus reaction (46-48). Several observations from different 
groups of reseachers, however, have pointed to other mediator pathways in 
this model. It was already known from the original studies of Cochrane et 
al, who induced depletion of complement by Cobra Venom Factor, that also 
a complement independent mechanism must exist. Furthermore, earlier 
studies employing non complement-fixing avian or mammalian antibodies, 
divalent ГЫЬ')2 fragments, or high doses in complement depleted or 
deficient animals have demonstrated that nephrotoxic antibodies could 
induce immediate proteinuria without the involvement of complement 
factors or neutrophils (49). In most cases a transient, selective 
proteinuria was seen without inflammatory reaction. The same results were 
observed when anti-GBM nephritis was induced in the isolated perfused rat 
kidney, where systemic mediators are absent, suggesting that binding of 
the antibodies to a structural component of the GBM caused the enhanced 
permeability (50). Recent observations of Pilia et al (51) and of Adler 
et al (3J) in rats provide also evidence for a complement-independent 
induction of proteinuria. On the other hand proteinuria was reported 
after injection of sheep anti-rabbit GBM serum in rabbits (52) not 
mediated by neutrophils, but by the activation of the whole complement 
sequence. The reasons for the discrepancies are unknown, but they may be 
related to factors in the host animal species or to the variability in 
the composition of the polyclonal antiserum (53). In addition to avidity 
and charge of the antibodies, the relative proportion of the antibody 
populations in the antiserum may play a crucial role. The development of 
monoclonal antibodies against the separate constituents of the GBM will 
probably provide the answers to at least some of these questions. Wu et 
al have described proteinuria induced by monoclonal antibodies, which was 
complement and neutrophil independent (54). In the autologous phase of 
this model proteinuria generally increases and appears then to be 
mediated by Fc-induced immune adherence of neutrophils and monocytes. 
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Membranous glomerulonephnlis m the mouse Glumerulonephntts 
was induced in Ci? Bill) mice bv a single injtttion of rabbit IgG against 
homologous pronase digested renal tubular antigens Fht htttrolo 
gous phase was characterized by a transient increase ot glomerular 
permeability with fixation of rabbit IgG to the capillary walls in a linear 
or fme-granular pattern and to the brush borders of the proximal tubuli 
The autologous phase was marked by the immune response to the 
injected protein during which subepithelial immune deposits consist 
ing of mouse IgG I rabbit IgG and mouse С 4 de\(.loped Small 
amounts were still present at I year after the injection of antiserum I he 
antibody response of the mice correlated with the development and 
resolution of the deposits None of the mice developed a nephrotic 
syndrome Control mice treated with normal rabbit IgG did not show 
immune deposits m their kidneys at any stage despite a comparable 
antibody response to rabbit IgG Immunoelectronmitroscopy showed 
that the rabbit antibodies fixed directly to an antigen in the cell 
membrane of the glomerular visceral epilhelium It seems therefore 
likely that in situ formation of subepithelial immune complexes oc 
curred in the autologous phase by fixation ol moubC immunoglobulins to 
rabbit IgG already present in the glomerular wall 
Glomérulonéphrlte extra membraneuse chez la souris Une glomeru 
loncphrite a etc induite chez des souris CS7 BIIO par une injection 
unique d IgG de lapin contre des antigènes tubulaires rénaux homo 
logues digérés par de la piondse La phase hcterologue était caractén 
sée par une augmentation transitoire de la perméabilité glomerulaire 
avec fixation d IgG de lapin aux parois capillaires d une Гас,on 1іт.аігс 
ou finement granuleuse et aux bordures en brosse des tubules proxi-
maux La phase autologue était marquée par la réponse immune a In 
protéine injectée pendant laquelle des dépots immuns sous épithéliaux 
consistant en de I IgG 1 de souris de 1 IgG de lapin et du C3 de souris se 
sont développés II en restau encore de faibles quantités 1 an après 
I injection de 1 antisérum La réponse anticorps des souris était eorrclee 
avec le développement et la disparition des dépots Aucune des souris 
π a développe de syndrome nephrolique Les souris controles traitées 
avec de 1 IgG de lapin normal η ont pas eu de dé pot s immuns dans le 
rein il aucun stade malgré une réponse anticorps aux IgG de lapin 
comparable La microscopie immuno électronique a montre que les 
anticorps de lapin se fixaient directement Λ un antigene situe sur U 
membrane des cellules de I epithelium viscéral glomérulaire 11 semble 
donc probable que la foimation in situ de complexes immuns sous 
épithéliaux est survenue a la phase autologue par fixation d immunoglo 
bulines de souris à de I IgG de lapin deja presente dans la paroi 
glomé rul dire 
Most forms of glomerulonephntis in humans and animals arc 
the result of the formation of glomerular immune deposits [ I ) 
Two mechanisms are known in the pathogenesis of the deposi 
tion ol these immune complexes trapping of soluble circulating 
immune complexes in the glomerular filter or an in situ forma-
tion of immune deposits by hxalion of antibody to planted 
fixed or stniLtuidl antigens m the glomerular basement mem-
brane (GBM) [2] 
Three basic models have been described in which renal 
lesions are induced by the administration of antibody or im-
mune complexes I he hrst is the passive serum sickness model 
in which in vitro preformed immune complexes consisting oí a 
heterologous ptotein (mostly bovine serum albumin USA) and 
an antibody against it ¿re administered Ί he second model is the 
nephrotoxic nephritis ( Viasugi nephritis) evoked in ma η ν animal 
>pecies by the intravenous or mlrapentoncal injection of a 
neterologous anti GBM serum [1 | This model was regarded as 
the only prototype of an in situ formation of immune complexes 
in the glomerulus until another model, the socallcd passive 
Heymann nephritis (PHN or heterologous immune complex 
glomerulonephritis) was developed It is induced in rats by an 
intravenous or intraperitoneal injection ot an antiserum against 
heterologous or homologous renal brushborder antigens [4 i] 
Although the glomerular subepithelial deposits were assumed 
initially to result from the trapping of small soluble circulating 
immune complexes there are now strong arguments for an in 
situ binding of the antibody to an antigen already present in the 
GBM [2 6-81 
Apart ftom the lupus prone тоиье strains and the chronic 
allogeneic disease in mice [9] this species has not been used on 
a large scale lor the study ol glomerulonephritis because of the 
variability of the lesions induced by the different procedures 
I he mouse is an attractive model tor immunologic studies 
because much is known about its immunogcnctic backgiound 
and the function of its different immunoglobulin (sub)classes 
Analogous to the passive Hey mann nephritis in rats we there­
fore, have tried to induce a glomerulonephritis in inbred 
CS7 BIIO mice with a single injection of an antiserum against 
homologous pronase digested renal tubular antigens In the 
autologous phase subepithelial deposits were observed which 
remained present for at least I year With immunoiluorescence 
and immunoelectronmicroscopv an antibodv population could 
be detected in the antiserum directed to an antigen located on 
the membrane of the visceral epithelial cells 
Methods 
Animals Inbred C57B110ScSn mice were originally ob 
tamed from the Jackson Laboratory Bar Harbor Maine In our 
animal laboratory these mouse strains were kept by continuous 
Received for publication September 30 1982 
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brother sister matings Swiss/Cpb SF mice and Wistar ( pBWU 
rats both bred randomly were bought from the Central Inst) 
tute for the Breeding of t aboratory Animals I NO Zcist The 
Netherlands New Zealand white rabbits and a goat were 
bought from a local breeder 
Antigen*; A mouse renal tubular brush border associated 
antigen Fx l A was prepared according to the method of 
bdgmgton Glassock and Dixon [10] From 330 normal male 
and female Swiss mice aged 10 to 20 weeks and weighing 20 to 
25 g the nonperfused kidneys were removed after exsanguma 
lion Lnless otherwise specified all procedures were earned 
out at 4°C After Lulling away the capsule and the medulla the 
cortices were minced with a razor blade and subsequently 
gently pushed through a 90 μ stainless steel sieve with a flexible 
spatula The sieved homogenate was suspended in phosphate 
buffered saline (PBS) pH 7 2 vigorously stirred and cenln 
fuged at x400£ for 10 mm to sediment glomeruli tubular 
segments and other coarse materia] The turbid supernatant 
(Fxl) was then centnfuged at X78 00G# for 45 mm to obtain the 
subcellular fraction designated F x l A The scdimented F x l A 
was washed three limes in distilled water centnfugmg each 
time al x78 OOOj; for 45 mm lyophilized and slored al - W C 
The crude and saline insoluble F x l A fraction was subsequently 
treated b> the enzyme pronase (sireptomyces gnscus protease 
grade В Calbiochem Behring Corp La Jolla California) ac 
cording (o Naruse Fukasawa and Miyakawa ( l l j F-xlA 
prepared from 100 g of mouse kidneys was suspended in 60 ml 
of 0 02 M Tns HCl buffer pH 7 8 containing 0 8% NaCI 
Thirty milligrams of pronase (0 5 mg en/yme/ml buffer) were 
added and the suspension was incubated under constant stir 
ring at 370C for 2 hr I he mixture was then centnfuged at 
x 100 OOOjf for 60 mm and the clear yellow colored supernatant 
was concentrated to 3 ml by ultrafiltration in a stirred apparatus 
(Amicon Corporation Scientific Systems Division Lexington 
Massachusells) with a PM 10 Diadow membrane and stored at 
-30"C Afier ihe pronase digestion the soluble fraclion of ihe 
tubular epithelial antigens was designated TAPron 
Antiura Adult male rabbils weighing 2 S to 3 kg were 
initially immunized with 20 mg of TAPron emulsified in com 
plctc Freund s adjuvant (CFA Difco Laboratory Deiroit 
Michigan) at multiple subcutaneous sues Four weeks later a 
subcutaneous booster injection of 10 mg was given and the 
animals were bled 10 days later Antisera were pooled and 
healed at 560C lor 45 mm to destroy complement activity The 
IgG fraction of the antiserum was prepared from a 509Í- ammo 
niumsulfale precipitate and after dialysis against PBS pH 7 2 
punfied by affinity chromatography on a Scpharose 4B coupled 
protein A column (Pharmacia Uppsala Sweden) The duly 
sate was placed on the column in small portions and alter 
extensive washing with PBS pH 7 2 the immunoglobulins 
were eluted from the column with a 0 05 ч cilratc buffer pH 
2 6 containing 1 м NaCI The eluate was immediately neutral 
ized with a 2 M Tns solution and dialyzed overnight against 0 02 
M PBS pH 7 2 Punfied IgG antibodies were concentrated to 10 
mg/ml by ultrafiltration with a x M 50 Diaflow membrane (Ami 
con Corporation) sterilized by passage through a stenle 0 2 μ 
filter and stored at -30oC Rabbit IgG from nonimmumzed 
animals was obtained with the same procedure conceniraied to 
10 mg/ml and used foi the control studies Analysis of puniy 
and specificity was carried out by micro Ouchtcrlony and 
Immunoelectrophoresis in 1 39? agarose f l2| Protein concen 
trations were measured spectrophotometrically at OD 280 or by 
the method of Lowry et al [ Π ] Ihe antibody specificity was 
tested by indirect immunolluoresccncc on sections of normal 
mouse and rat kidneys Subsequently the specificity was 
determined by absorption of the antiserum with TAPron 3 
mg/ml IgG antiserum 
Antiserum directed against albumin was prepared as follows 
Albumin of pooled nonimmune mouse serum was obtained by 
electrophoresis m V/f agar The albumin bands were cui with a 
razor blade pooled and washed in PBS pH 7 2 After centnfu 
galion at хЗООО^ for 15 mm the supernatant was concentrated 
to 5 2 mg/ml by ultrafiltration using a PM 10 Diaflow membrane 
(Amicon Corporation) On Immunoelectrophoresis the prepara 
tion showed a single precipitation line against normal mouse 
serum An antiserum was prepared by three monthly immuniza 
lions of a goat with 2(XVg of albumin emulsified m CFA (Difco 
Laboratory) A 509Í- ammomumsulphate precipitate of this 
antiserum was used in the radial immunodiffusion technique for 
the determination of urinary albumin concentrations [14| 
Preparation of mouse basement membranes Mouse glomer 
uh were isolated by a differential sie\e technique adapted for 
mouse kidneys [15 16] After ceninfugadon at x400# the 
sediment of the kidney homogenates was passed through a 
series of sieves of decreasing pore sizes (150 106 and 4* μ) 
with 3 liters ol 0 15 M NaCI Ihe resulting glomerular su spe η 
Sion appeared to bc contaminated with tubular segments on 
examination by light microscopy To obtain basement mem 
branes absolutely free from cellular remnants that could 
influence the absorptions we slightly modified the method of 
Meczan et al [17] by adding somcation to the detergent treat 
ment After disruption of the cell membranes by suspension ina 
large volume of distilled water the pelleted material was 
subsequently sonicated for I min in two individual 30-scc bursts 
in a Branson somfier (Branson Some Power Company Dan 
berry Connecticut) at an output of 40 W The pellet was 
subsequently treated with We Triton χ 100 for 2 hr with 2 mg 
deoxynbonuclease I (2000 Kumi/ Boe h ringer Mannheim 
Germany) for 2 hr and with 4 ^ sodium dcoxycholaie for 18 hr 
The resulting preparation of basement membranes designated 
GBM T B M was washed extensively in distilled water lyophi 
lized and stored at -30 e C 
Absorptions Antiserum used for in vitro incubations was 
first absorbed with an equal volume of freshly pooled mouse 
blood cells and subsequently with lyophilized pooled nonim 
mune mouse scrum (50 mg/0 I ml antiserum) both for 2 hr at 
room temperature by gentle shaking For absorption of and 
GBM I B M antibodies from the sera freeze dried GBM I B M 
was suspended in a small volume of PBS pH 7 2 by somcation 
in a Branson somfier for I mm m two individual 30 sec bursts 
To this suspension antiserum was added (5 mg GBM TBM ml 
antiserum) and gently shaken for 2 hr at room temperature 
Experimental protoiol Thirty male C57 BIIÖ mice aged 2 
months received an intravenous injection of 7 5 mg rabbit anti 
mouse TAPron At selected intervals three mice were sacn 
ficcd parts of their kidneys liver spleen and lung were 
processed for light microscopy and immunofluorescence and 
serum was stored for serological studies All kidneys were 
examined in the electronmicroscope Before exsanguination 
urine samples were collected for the determination of albumin 
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Fig. 1. Immunoßtwresi eni staining of a 
section of a normal mouse kidne\ tvíth 
rabbit anti-mouse TAPron and fluoré seem-
labelled snine antirabbtr Ig Staining of 
the glomerular capillary wall and of Ihe 
brush borders of proximal lubules is seen. 
The brush border of the glomerular parietal 
epithelium is also positive {arrow). No 
staining is present in the distal tubules. 
collecting ducts, or in the interstitium 
(X640) 
*ЯЬ ' 
una. Twenty male C57 BI10 mice, which had received 7,5 mg 
norma! rabbit IgG, served as controls At each interval two 
mice were sacrificed and examined according to the same 
procedures. 
light microscopy. Tissue fragments were fixed in Bourn's 
solution (kidney) or 10^ neutral buffered formalin (lung, liver. 
and spleen), dehydrated and embedded in paraplast (Amstel-
stad. Amsterdam. The Netherlands) Sections of 2 μ were 
stained with hematoxylin and eosin. Periodic Schiff, and Silver 
methenamme according to Jones [18]. 
Immunofluonsdtm 1 issue fragments were snap-frozen in 
liquid nitrogen and cut in a cryostat (2-^ sections), A direct 
immunoñuorescence technique was applied using monospecif-
ic. fluorescein-labelled rabbit anti-mouse IgG (heavy and light 
chains). C3 (Cappell Laboratories. Duwningtown. Pennsylva-
nia). and swine anti-rabbit Ig (Dakopatt. Copenhagen. Den-
mark). To exclude cross-reactivity with mouse Ig this latter 
antiserum was absorbed with 50 mg/0 I ml lyophili/ed nonim-
mune mouse serum. After absorption a single precipitation line 
developed against normal rabbit IgG in immunodiffusion where-
as no crossreaction was observed with normal mouse serum 
No staining was seen by indirect immunofluorescence on frozen 
sections of normal mouse kidney and spleen Furthermore. 
there was no crossreactive staining of kidneys from a (BALB/c 
x A/J) Fl hybrid mouse wherein a chronic graft versus host 
disease with proven deposits of mouse IgG in the glomeruli had 
been induced Binding with rabbit IgG was not impaired by the 
absorption Kidneys that exhibited granular fluorescence in the 
GBM were examined with monospecific fluorescem-Iabelled 
goat anti-mouse IgGI. IgG2. IgM. and IgA (Meloy Labora-
tories. Inc.. Springfield. Virginia) to determine the (sub)classes 
of deposited immunoglobulins. Deposits of mouse lgG3 were 
detected by indirect immunofluorescence, using a monospecific 
goat anli-IgG^ (Meloy Laboratories. I ne ) , and a monospecific. 
fluorescein-labelled rabbit anti-goat IgG as a second layer 
(Cappell Laboratories) The presence of TAPron in the kidneys 
was demonstrated by rabbit anti-mouse TAPron IgG, conjugat-
ed to fluorescein isothiocyanate according to The and Feltkamp 
[19] The conjugated antiserum had a protein content of 6.5 
mg/ml. an F/P ratio of 1.1, and was used in a 1:8 dilution. Both 
ІП the direct and indirect techniques the air-dried and acetone-
fixed sections were washed in PBS. pH 7,2. for Í0 mm, 
incubated with the antiscra for 30 mm at room temperature, and 
mounted in UVAC (GURR. Hopkin Williams. Essex. England) 
Staining of TAPron in the glomeruli was detected both m 
uneluted and partially eluted sections hlution was carried out 
by incubating washed, unfixed sections, with a 0 05 м citrate 
buffer. pH 3,2. at room temperature for 30 mm The staining 
intensity and quantity of the immune reactants were recorded 
semiquantitativcly (0 - negative or trace. I + moderate. 2 + 
- relatively strong. 3+ • strong. 4+ = maximum intensity) and 
the staining patterns classified as mesangial, GBM-TEM, and 
granular or linear. All sections were examined in a LeitZ 
fluorescence microscope with a Ploemopak epi illumination 
Electronmìcroscopy. Small pieces of cortex (2 mm') were 
fixed in 2 59? giutaraldehyde dissolved in 0 1 м sodium cacody-
late buffer. pH 7-2. for 2 to 4 hr at 4 0 C. and washed in the same 
buffer The tissue blocks were postfixed m phosphate buffered 
1% OsO-i for 2 hr. dehydrated, and embedded in Epon 812 
Ultra-thin sections were cut in a LKB ultratome and stained 
with S9c uranyl acetate for 45 mm and with lead citrate for 2 mm 
at room temperature- Ihe sections were examined in a Siemens 
ELMISKOP 101 electronmicroscope. 
¡mmiinoelei!ronmicros(op} HEXil Because the immersion 
fixation led to a poor architecture, perfusion was used to obtain 
fixed normal mouse kidney specimens as substrate for the in 
vitro incubations The left kidney was perfused via the aorta for 
2 mm with PBS. pH 7 2, containing 49Í1 BSA. and subsequently 
for 2 mm with a mixture of [% paraformaldehyde and 0.059? 
giutaraldehyde m PBS. pH 7 2. after which excess fixative was 
flushed away by perfusing the kidney with the buffer for another 
5 mm. Small blocks of renal cortex (2 mm') were snap-frozen in 
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Flg. 2. Immunofluorescence studies. A Fluorescein UihcUed swine anti-rabbit Ig at day I Staining of the brush borders of the proximal tubular and 
glomerular paneta! epithelium, along with a staining of the glomerular capillary wall in a linear or fine granular pattern Basal parts and basement 
membranes of the proximal tubules are also positive Distal tubules, collecting ducts, and interstitium are negative ( x 500) В FUtoreu ein-labelled 
swine anthruhhil Ig at äa\ 8 Staining of the glomerular capillary wall has clearly diminished, while a few deposits m the mesangium are present 
(X250) 
liquid nitrogen. Fro/en sections (20 μ} were incubated with a 
rabbit anti-mouse ГАРгоп. or with normal rabbit IgG for 
controls, during 1 hr and alter rinsing with PBS. pH 7.2. fixed 
rabbit IgG was detected by a peroxydase-labelied swine anti 
rabbit lg (Dakopatt). Horseradish Peroxydase was reacted by 
incubation for 10 mm at room temperature m a 75 mg/dl solution 
of З.З'-diaminobenzidine tetrahydrochlonde (DAB) to which 
0.0019Í hydrogen peroxide was added After several washes in 
PBS. pH 7.2. the sections were postfixed in 0.1 м phosphate-
buffered 2% OsCb for 45 mm at room temperature, dehydrated. 
and embedded in Epon 812. Thin sections, cul on a 
LKB ultratome, were examined unstained in the electron 
microscope. 
Serology. Antibodies present in the mouse sera were demon­
strated by different indirect immunofluorescence techniques 
By serial dilutions the titer was defined as the reciprocal value 
of the highest positive dilution Rabbit IgG against renal brush-
border antigens was demonstrated by incubation of the serum 
with normal mouse kidney and subsequent staining with a 
fluorescemlabelled swine anti-rabbit lg (Dakopatt) Mouse 
antibodies to the administered rabbit IgG were shown by 
incubation with rat liver that contained aggregated rabbit IgG in 
Kupffer cells and subsequent staining with a fluorescein-la-
belled rabbit anti-mouse IgG (heavy and light chains. Cappelli 
The aggregated rabbit IgG was prepared according to the 
method of Mauer et al [20]; 40 mg were injected intravenously 
in a Wistar rat. bled 30 mm later Small blocks of hver tissue 
samples were snap-frozen in liquid nitrogen Incubation with a 
fluorescemlabelled swine anti-rabbit Ig (Dakopatt) produced a 
4+ staining intensity consisting of fine and coarse granules in 
the Kupffer cells, while normal mouse serum did not fix to the 
liver. The presence of autoantibodies to brushborder antigens. 
GBM-TBM. and DNA. was detected by incubation on normal 
mouse kidney, liver, and spleen 
Urinary albumin excretion. Although mice have a physiologi­
cal proteinuria, albumin is only present in small amounts in 
normal unne [21. 22] Therefore, albuminuria measured by 
radial immunodiffusion was taken as an index for glomerular 
protein leakage. Of 47 normal male С57.ВП0 mice, the mean 
albumin concentration in the urine collected over a period of 18 
hr. was 28 ¿tg -i SD 1 l/ml. Increased albuminuria was defined as 
a value greater than the normal mean plus 2 so. 
Results 
Characteristics of the antiserum to mouse TAPron. Anti-
mouse TAPron. tested in micro-Ouchterlony and Immunoelec-
trophoresis. contained only IgG. did not react with pooled 
mouse serum, and revealed seven precipitation lines against 
mouse TAPron located in the alpha-2. beta, and gamma regions 
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Flf. 2. Continued. С Fluorescetnlahelled swine anti-rabbtt ¡g at day IS Fine granular staining along the GBM is seen. Only a few granules of rabbit 
IgG are present in the basement membranes of the proximal tubules (x500) D Fluorescetnlahelled goat anti-mouse IgGl at day 28. Fine granules 
of mouse IgGl are seen in the capillary walls of the glomerulus No clear staining of the mesangium is present (x500) 
In the indirect immunofluorescence technique on frozen sec-
tions of normal mouse kidneys, the antiserum reacted very 
strongly with the luminal brush borders of the proximal tubular 
epithelia. very weakly with the descending segments of Henle. 
and strongly with the capillary loops in a linear or fine granular 
pattern (Fig 1) Previous absorption of the antiserum with 
mouse TAPron abolished these staining patterns, whereas 
absorption with pooled mouse serum, blood cells, and GBM-
TBM had no influence The quantity of lyophilized GBM IBM. 
used for the absorption of the antiserum, was sufficient because 
it could neutralize a rabbit anti-mouse GMB-1BM serum, that 
after intravenous administration gave a 4 -^ linear staining of the 
glomerular basement membrane The anti-mouse TAPron 
showed cross reactions with rat antigens On sections of normal 
rat kidneys the antiserum fixed strongly lo the brush borders ot 
proximal tubular epithelia. the descending segments of Henle's 
loops, and to the glomerular capillary in a more coarse granular 
fashion than in the mouse glomerulus, especially at low 
dilutions. 
¡n vivo studies. Ten minutes after administration of 7 5 mg 
anti-mouse TAPron. serious anaphylactic symptoms developed 
that lasted for 2 to 3 hr. but all mice survived and could be 
followed during I year. 
The results of the immunofluorescence studies are given in 
Figure 2 and Table 1 At day 1 all three mice showed strong 
staining of rabbit IgG in the brush borders of the proximal 
tubular epithelia and the cylindrical parietal epithelia of the 
glomeruli, reflecting an enhanced glomerular permeability. The 
basement membranes of the tubular cells stained less heavily in 
a continuous, hue granular pattern, while the luminal borders of 
the descending segments of Henle were faintly stained Rabbit 
IgG had also fixed m relatively large amounts to the glomerular 
basement membrane in a pattern of such fine granularity, that it 
was sometimes difficult to differentiate from a linear pattern 
Distal tubuli and collecting ducts were negative (Fig 2A) 
Although the amount of rabbit IgG had decreased on day 8. it 
was still visible in the glomerular capillary loops (Fig 2B) and 
focally in the brush borders of the glomerular parietal and 
proximal tubular cells. Especially at this time, it was very 
dilficull to distinguish linear from fine granular staining in the 
glomerular capillaries Rabbit IgG was also present in the 
mesangium of some glomeruli Deposits of mouse Ig and C3 
were present m small quantities in the mesangium. but this 
staining was not different from that in normal and control mice. 
1 he experimental group, however, showed additional segmen-
tal linear staining of the cortical tubular basement membranes 
and Bowman's capsule by mouse C3. At day 15 rabbit IgG was 
detected in fine granules along the glomerular basement mem-
branes in a typical epimembranous pattern There were a few 
scattered granules in the mesangium and the basement mem-
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Abbreviation MES. mesangial localization 
" Mice received 7 5 mg of anti-mouse ТЛРгоп 
b
 Linear or fine granular staining of the capillary wall All other 
staining was clearly granular. 
e
 Mouse C3 is normally detectable m small amounts m the 
mesangium 
Fig. 3. Light microscopy at da\ 62 A few drop-like extensions are seen 
along the subepithelial side of (he GBM (arrow ι Spikes or vacuoles in 
the GBM. characteristic fora membranous glomerulonephritis were not 
present There is a slight increase of mesangial cells The cuboidal 
aspect of the parietal epithelium is a normal finding in mouse kidneys 
(X690I 
Fig. 4. Electronmicroscopy of a mouse kidney at day 62 Small electron 
dense deposits are located in the slit pores between the epithelial foot 
processes (arrows)- No endothelial deposits are seen (x62,OÜOI 
branes of the proximal tubules. The brush borders of the 
glomerular and tubular cpithelia. the distal tubuli. Hen les 
loops, and the collecting duels were negative 
In addition to the above-mentioned mesangial localization. 
mouse Ig and to a lesser extent mouse О were now demonstra­
ble along with rabbit IgG in the capillary loops m a pattern 
characteristic for subepithelial localization At day 29 and 62 
{Fig 2C and D) the epimembranous pattern became more 
pronounced Granules, consisting of rabbit IgG. mouse Ig. and 
small quantities of mouse О were clearly visible along the 
capillar} basement membrane. The mesangial staining with Ig 
and О remained unchanged Rabbit IgG appeared to be best 
visible at 1 month, while later on mouse Ig was easier to detect 
The number of granules in the proximal tubular basement 
membranes decreased steadily From day 109 on. the epimem­
branous pattern diminished gradually. but it remained ν isible as 
very small granules with more intensive staining for mouse Ig 
until the end of the experiment Using antisera directed against 
subclasses of mouse IgG and against mouse IgM and IgA. we 
could demonstrate that the epimembranous deposits contained 
predominantly IgGl with only small amounts of IgG2 and IgG.V 
The mesangial deposits, on the other hand, consisted mainl> of 
IgM and IgA We sought for the presence of TAPron with a 
fluorescem-labelled antiserum in a direct immunotiuorestence 
technique, with or without partial elution by a 0.05 м sodium 
citrate buffer. pH 3.2. At no stage could the antigen be detected 
in the glomerular capillary loops. 
Mice from the control group that had received normal rabbit 
IgG exhibited minor focal deposits m the mesangium only at 
day I. probably because of a few aggregates in the serum. 
Thereafter, deposits of rabbit IgG were not seen in the glomeru­
li. As in normal mice, mouse Ig and C3 were detectable in small 
quantities in the mesangium. while C3 was also present segmen-
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Fig. 5. Luiulization υ/ the antigen in immunoeleawn microscopy 
Normal mouse kidney incubated with a rabbit anti-mouse TAPron 
and a peroxidase-labelled swine anii-rabbit lg A Segment of the 
glomerular capillan наІІ The epithelial foot processes are covered 
by a dense granular reaction product The lamina densa is negative. 
but occasional granules are seen on endothelial cell membranes 
( x И.600) В Proximal tubular epithelial cell nit h a dense granular 
reaction product on the hrushhorder extensions The basement 
membrane and the organelles in the cytoplasm are negative A few 
dense granules are seen on the endothelial cell membranes (хбООО) С 
Kidney specimen incubated with normal rabbit IgG and peroxidase-
labelled antiserum No reaction product is seen on the epithelial and 
endothelial cell membranes or m the basement membrane ( χ 14.400) 
tally and linearly m the basement membranes of tubules and 
Bowman's capsule. 
Histologic findings in the light microscopy differed very little 
from those in control mice There was a slight and gradual 
increase of mesangial cells and or matrix, especially in the 
juxtamedullary glomeruli (Fig. 3). The glomerular basement 
membranes showed scattered drop-like extensions at the epi­
thelial site, which were somewhat more frequent in the anti­
body-treated mice. However, spike formation or vacuolization. 
characteristic for Heymann nephritis or membranous glomeru­
lonephritis in humans was never seen. 
Electron microscopic studies showed that only from day 15 to 
62 small electron dense deposits were located in the slit pores 
and sometimes spaced widely apart (Fig. 4) Later, the lamina 
densa became thicker and showed irregularly shaped exten­
sions on its subepithelial side. Fusion of the epithelial foot 
processes was not seen at any stage There were no deposits in 
the mesangium Control mice injected with normal rabbit IgG 
did not show any deposits in either the slit pores or elsewhere. 
Extrarenal deposits. At day 1 only a few granules of rabbit 
IgG were located along the hepatic sinuses: these had almost 
completely disappeared at day 8. Mouse Ig and C3 were never 
detected m the liver. Also in the lung very fine granular 
depositions of rabbit IgG were seen along the alveolar walls at 
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0 1 2 3 4 θ 16 24 32 40 4β 
Time weeks 
FIR 6 Titers of rahhil anti mouse TAPron (Ü A) and of 
mouse anli rabbit IgG fO •^•) in animtil\ tnatid with unti mouse 
TAPron Control animal·, thai hdd reicived normal rdbhit IgG showed a 
comparable although lower response of mouse anti rabbit antibodies 
( · · ) All liters were determined by indirect immunoñuores 
cencc 
day 1 without the presence of mouse Ig and CI On the other 
hand rabbit IgG was demonstrable in the spleen during approx 
imately Τ months and located on follicular dendritic celli At 
day 1 a marked reticular pattern of rabbit IgG was shown on 
these cells it increased during the first 2 weeks but faded 
afterwards At days I and 8 mouse Ig could not or at (he most 
in trace amounts be demonstrated on dendritic cells but after 
this period increasing amounts were piesenl in the same posi 
tion as the rabbit IgG Moreover mouse Ig could be seen in the 
walls of some arterioles together with small quantities of rabbit 
IgG Mouse C3 was never detectable in the spleen С ontrol 
mice that had received normal rabbit IgG had trace amounts of 
the injected immunoglobulin in their livers along the sinuses at 
day 1, although less than in the antibody-treated group The 
lungs were always negative As in the immtmi/cd group rabbit 
IgG was present for ì months on follicular dendritic cells in the 
spleen From day 15 on mouse lg could also be demonstrated 
in the follicles but mouse C3 was пел er seen 
1 ocahzatton of the untigen b\ ¡mmunoeli'dronmurosiopx 
lo define more precisely the antigenic sites in the glomerular 
capillary wall normal mouse kidney specimens previously 
fixed by perfusion were incubated with the antiserum where 
after bound rabbit IgG was visualized by a Peroxydase labelled 
anti rabbit Ig in the elcctronmicroscopc A dense reaction 
product was present on the cell membranes of the glomerular 
visceral epithelia, both on the part facing the urinar) space and 
on that part bordering the basement membrane (fig 5А) The 
cell membranes of the endothelial cells and the glomemlar 
basement membrane itself showed only a few granules Ihe 
proximal tubular epithelial cells demonstrated coarse granules 
of reaction product in the cell membranes of the microvilli 
while the cytoplasm and the basement membrane were negative 
(Ftg 'iB) No reaction product was seen in the glomeruli or 
tubuli of control specimens treated with normal rabbit IgG and 
the pcroxydasc-labellcd antiserum (Fig 4') The negative 
staining of the glomerular basement membrane was not due to 
poor penetration of the antibody after the fixation because a 
rabbit and mouse GBM antiserum gave positive staining of the 
lamina гага interna and externa 
Serohf>\ í/íjtí 6) Anli mouse ГАРгоп measured by ihe 
indirect immunofluorescence technique was present in de 
creasing titers until day И At day 8 high titers of mouse anti 
rabbit IgG were present in the serum of both the immum/cd 
mice and the control mice I hese tilers increased until day IS 
and showed a gradual decrease thereafter At all stages values 
were slightly lower in the control mice After 1 year the 
immuni/cd group showed a low titer while tilers in the control 
group had become negative There was a good correlation 
between ihe titers ofanti rabbit IgG and the intensity of stammg 
m the kidneys of ihe experimental group Autoantibodies to 
renal brush borders DNA or GBM ГВМ could never be 
demonstrated 
Albuminuria Mice that had received rabbit anti mouse ΓΑΡ 
ron exhibited a short bout of albuminuria during the first 2 or 3 
days after injection ol the antiserum with a mean concentration 
of 297 ± su IS /igyml None of the antibody treated mice 
showed an increased excretion of albumin at later stages In 
control mice that had received normal rabbit IgG (here was no 
rise of albumin excretion above ihe upper normal level of 50 
μβ/ml 
Discussion 
Most attempts to induce evpenmental immune complex 
glomerulonephritis m mice resulted m rather mild lesions with 
mainly mesangial deposition ol immune complexes (reviewed in 
|2J) Recently a passive scrum sickness model has been de 
scribed in which mice were injected with preformed immune 
complexes consisting of a variety ol antigens and antibodies of 
low avidity In this model subepithelial deposits and a prolifera 
Uve glomerulonephritis were observed [23 24] In a recent 
study in mice in which cationic preformed immune complexes 
were used small subendoihclial and subepithelial deposits were 
observed the localization of which correlated with structural 
anionic sues [2*4 
The model that we have described here differs from previous 
ones We could induce subepithelial deposits without any 
proliferative lesions after a single injection of antiserum against 
homologous pronasc-digesled renal brushbordcr antigens Hel 
erologous and autologous phases were observed Ihe former 
was characten/ed by enhanced glomerular permeability as 
evidenced by a transient albuminuria and fixation of the inject 
ed antibody to the brush borders of the glomerular ami tubular 
epithelial cells Moreover the antibody fixed to (he glomerular 
visceral epilhelium in a very fine granular pattern The autolo­
gous phase marked by the immune response of the mice to the 
injected rabbit IgG was dominated by subepithelial deposits 
lhal initially increased bui gradually decreased after 2 or 1 
months Only m Ihe early stages a small amount ol rabbit IgG 
most likely bound to mouse Ig was present in the mcsangium 
The subepithelial deposits were composed of rabbit IgG mouse 
IgGl and lo a lesser extent, mouse C3 A correlation was found 
between ihe serologically determined antibody response of ihe 
mouse and the development or resolution of the subepithelial 
complexes Outside the kidney rabbit IgG complexcd to 
mouse immunoglobulins was seen during a prolonged period 
only in the spleen on follicular dendritic cells but sometimes m 
the arteriolar walls None of the mice developed a nephrotic 
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syndrome or enhanced albumin excretion in the course of the 
experiment Mice of the control group injected with equal 
amounts of normal rabbit IgG did not develop deposits in the 
glomeruli despite a comparable immune response to rabbit IgG 
and similar fixation to follicular dendritic cells in the spleen 
The development of the immune deposits in the autologous 
phase could be consistent with a mechanism in which small 
circulating immune complexes are trapped in the kidneys 
which probably occurs in the acute scrum sickness model [26-
28] However the negative results in the control group that 
showed a comparable antibody response to the rabbit IgCj and 
the fact that the subepithelial immune rcactants were present 
for a prolonged period do not favor such a mechanism although 
the mcsangial deposits early in the autologous phase could very 
well be explained by it Involvement of the classic GBM 
antigens that arc responsible for the nephrotoxic nephritis is 
unlikely because absorption of the antiserum with mouse GBM 
TBM did not alter the fluorescence pattern in normal mouse 
kidneys after in vitro incubation Moreover the gradual dc 
crease of rabbit IgG fixed lo the glomerular capillary wall in the 
heterologous phase is unusual for anti GUM antibodies be 
cause generally fixation to GBM antigens remains visible during 
much longer periods The most convincing argument against 
involvement of GBM antigens came from our finding that 
antibodies from the antiserum were capable to fix directly to an 
antigen in the cell membranes ol the glomerular visceral epithe 
ha Since the antiserum detects several determinants in the 
pronase digested tubular antigen clution studies will be neces­
sary to prove definitively that the glomerular epithelial cell 
surlace antigen is involved in the immune complexes formed 
I he available data strongly point to an in situ formation of the 
immune complexes on the subepithelial site ol the glomerular 
basement membrane The inicctcd rabbit antibodies fix with 
antigen on the glomerular visceral epithelial cell membranes 
During the heterologous phase the amount of fixed rabbit IgG 
decreases substantially probably by dissociation of the anti 
body-aniigcn complex or by shedding and endocytosis of the 
immune complexes It seems likely that the subepithelial ι m 
muñe complexes grow larger in the autologous phase b> fixa 
lion of mouse immunoglobulins to the rabbit IgG already 
present in the glomerular capillary wall It can however not 
definitely be ruled out that in the early stage of the autologous 
phase small circulating immune complexes comprising low 
affinity antibodies are formed and localize on the basement 
membrane acting as a nidus for the subsequent deposition of the 
mouse antibodies It is remarkable that initially in the autolo-
gous phase the amount of rabbit IgG increased while at that 
time no rabbit IgG could be detected in the serum We could 
exclude that this was caused by crossrcadivc binding to mouse 
Ig by the fluoresceine labelled anti rabbit scrum The only place 
outside the kidney that contained rabbit IgG for a long penod 
was the spleen It seems however unlikely that this organ 
acted as an additional source of antigens Ihe most likely 
explanation seems to us that the binding of mouse anti rabbit 
antibodies demonstrable at day И caused aggregation of the 
rabbit IgG with belter exposure of its antigenic sites 
The model described here has many features like Ihe PHN m 
rats which itself is a variant of the autologous immune complex 
glomerulonephritis or active Heymann nephritis [29-11] In 
either system the glomerulonephritis takes a biphasic course 
with heterologous and autologous phases We also found a 
correlation between the amounts of deposited immune reac 
lants and the antibody response to the injected immunoglob 
ulins [32] As in the PHN in rats we used an antibrushborder 
antiserum most probably composed of a mixture of antibody 
specificities Some of these must be directed against common 
antigens because we found clearcul cross reactions on incuba­
tion of the antiserum with normal rat kidnevs However the 
immunofluorescence staining in the rat glomeruli had a more 
coarse aspect suggesting the scrum contained additional speci­
ficities against mouse antigens absent in the rat which is 
corroborated by our preliminary findings that antibody eluted 
from rat kidneys alter injection ol anti mouse ТЛРгоп did not 
stain mouse glomeruli in the immunofluorescence technique 
whereas rat glomeruli and both rat and mouse brush borders 
were positive This suggests that ihe glomerular antigenic 
determinants that act as targets in the PHN of rats arc absent in 
the mouse glomerulus (to be published) Further study of these 
differences between the ral and mouse models may lead to a 
beller insight in Ihe nature of the antigens involved 
Proteinuria in the PHN occurs as a rule after 4 to 5 days [11, 
34] Despite a transient leakage in the first days after the 
antiserum injection evidenced by a strong fixation to the brush 
borders of the glomerular and tubular epithcha and an albumin­
uria of short duration none of the mice developed an enhanced 
proteinuria or a nephrotic syndrome in (he further course of the 
disease It was recently shown in the PHN that complement-
fixing antibodies were necessary for the development of pro­
teinuria [13] This might explain the absence of proteinuria in 
our model because we found lhat almost all mouse IgG deposit­
ed was of the noncomplement fixing IgGl subclass The role of 
these factors can be studied very well m our model because so 
much is known about the characteristics of murine immuno­
globulin (sub)classcs If the membranous glomcruloncphnlis 
described here, can also be induced in other mouse strains the 
presence of many inbred lines and complement deficient strains 
also offers the opportunity to gam more insight in the role of 
genetic factors and complement m the development of the 
glomerular lesions 
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Comparison of Antigenic Targets Involved in 
Antibody-Mediated Membranous Glomerulonephritis 
in the Mouse and Rat 
KAREL J M ASSMANN, MD, PIERRE RONCO, MD, 
MARTINA M TANGELDER, WILL Ρ Η LANGE, 
PIERRE VERROUST, MD, and 
ROBERT Α Ρ KOENE, MD 
Membranous glomerulonephritis in the mouse can be in­
duced by a single injection of an antiserum against ho­
mologous, pronase-digested, renal tubular antigens 
(TAPron). In indirect immunoBuorescence studies on nor­
mal mouse and rat kidneys it bas now been found that 
the antiserum reacts strongly with the visceral epithelia 
of the mouse in a homogeneous pattern, while a faint 
granular staining is seen in the rat glomerulus against 
a homogeneous background After injection in rats, a clas­
sic passive Heymann nephritis could be induced By im-
munoprecipitation of radiolabeled rat renal brush 
borders (BB) it could be shown that anti-TAPron antisera 
contain antibodies to 330-kd and 90-kd BB proteins ex­
pressed by rat glomeruli. With the use of two monoclonal 
antibodies specific for the 330- and 90-kd proteins the 
homogeneous binding observed in rat and mouse 
THE MOST EXTENSIVELY studied experimental 
counterpart of human membranous glomerulonephri­
tis is active Heymann nephritis or autologous immune 
complex glomerulonephritis (AICN) in rats, induced 
by immunization with homologous or heterologous re­
nal tubular antigens emulsified in complete Freund's 
adjuvant (CFA) ^ 3 A variant of this model is the pas­
sive Heymann nephritis (PHN) induced in rats by a sin­
gle intravenous or intraperitoneal administration of an­
tiserum against homologous or heterologous renal 
tubular antigens 4~° After injection of the antibodies 
a rapid fixation takes place to a structural antigen lo­
cated in the cell membranes of the glomerular visceral 
epithelia, identical to or cross-reacting with one of these 
renal tubular antigens. This antigen has been called the 
Heymann antigen and was recently identified as a 330-
kd protein , 0 A similar mechanism is probably operat­
ing in the formation of subepithelial deposits m a glo­
merulonephritis that spontaneously develops in a small 
From the Department of Palholoj¡y and the Department of Medicine 
Division of Nephrology, Stnl Rjsdhoud Hospital University of 
Nijmegen, The Netherlands, and INSERM U 64, Hôpital Tenon, 
Pans France 
glomeruli could be related to the 90-kd antigen, whereas 
the coane irregular staining observed in rat glomeruli 
was only related to the 330-kd antigen. Immunoglobu-
lins eluted from glomeruli of rats bound to rat glomeruli 
and reacted only with the 330-kd protein They did not 
bind to mouse glomeruli. Discrete localization in coated 
pits, multivesicular bodies, and endoplasmic reticulum 
of the visceral epithelia was seen in immunoelectron-
microscopy. The results presented thus demonstrate that 
immune deposits induced in the rat by anti-TAPron anti-
bodies are related to antibodies specific for the 330-kd an-
tigen, ie, the classic Heymann antigen. By contrast, im-
mune deposits observed in the mouse are related to 
antibodies specific for a 90-kd protein. (Am J Pathol 1985, 
121:112-122) 
number of New Zealand white rabbits." Analysis of 
the antigens involved in the formation of immune 
deposits in the glomeruli can extend our knowledge of 
the pathogenesis of human membranous glomerulo-
nephritis. 
Recently we described a glomerulonephritis in a 
mouse strain after a single intravenous injection of an 
antiserum against homologous, pronase-digested, re-
nal tubular antigens that was characterized by subepi-
thelial deposits in the autologous phase and that, in 
this phase, closely resembled the PHN of the rat. '2 The 
antiserum was directed against an antigen located in 
the cell membrane of the glomerular visceral epithe-
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hum of the mouse In vitro studies with rat kidneys 
showed that although there was cross reactivity with 
rat glomeruli, the immunofluorescent patterns were not 
identical, which suggested that different antigens were 
involved To obtain more information on these antigens, 
we have now compared in detail the antigens detected 
by this antiserum in the mouse and the rat We report 
here that despite the great similarity of the rat and 
mouse glomerulonephritis in the autologous phase, the 
lleymann antigen which is thought to be the antigenic 
target in the initiation of the membranous glomerulo 
nephritis in the rat is not demonstrable in the glomeru-
lar visceral epithelium of the mouse 
Materials and Methods 
Animals 
The inbred strain of C57B1/10 mice was original^ ob-
tained from the lackson Laboratory, Bar Harbor, 
Maine Inbred PVG/c rats were introduced in our ani-
mal laboratory via the Institute of Psychiatry, Bethlem 
Royal Hospital, Monks Orchard, Beckenham, Kent, 
Great Britain These inbred strains were kept by con 
tmuous brother-sister matmgs Swiss mice and Wistar 
rats, all random bred, were bought from the Central 
Institute for the breeding of laboratory animals, THO, 
Zeist, The Netherlands New Zealand white rabbits were 
bought from a local breeder 
Antigens 
Mouse FxlA was prepared from Swiss mouse kid-
neys and subsequently incubated with the enzyme 
pronase according to our previously described 
method l2 The pronase digested fraction was designated 
M TAPron According to the same method, a pronase-
digested, soluble fraction of rat tubular antigens (desig-
nated R-TAPron) was prepared from kidneys of Wistar 
rats 
Antisera 
Adult male rabbits, weighing 2 5-3 kg, were im-
munized with rat or mouse TAPron, emulsified in CFA 
(üifco Laboratories, Detroit, Mich) at multiple subcu-
taneous sites as described earlier " After an initial dose 
of 20 mg of TAPron, a booster of 10 mg was given 4 
weeks afterwards, and the animals were bled 10 days 
later The pooled antiscra (designated RaRTAPron and 
RaM-TAPron) were heated at 56 С for 45 minutes The 
IgG fraction was prepared from a 50% ammonium sul­
fate precipitate and, after dialysis against phosphate-
buffered saline (PBS), pH 7 2, purified by affinity chro­
matography on a Sepharose-4B coupled protein A 
column (Pharmacia, Uppsala, Sweden) One of the rab­
bits was immunized with mouse FxlA, and the purified 
IgG fraction was obtained according to the same 
method (designated RaM-FxlA) Furthermore, a goat 
was immunized with 9 mg of M-TAPron, emulsified in 
CFA at multiple subcutaneous sites At 4,6, and 8 weeks 
subcutaneous booster injections of 3 mg were given, 
and the animal was bled 10 days later After decom-
plcmentation at 56 С for 45 minutes the IgG fraction 
of the antiserum (designated GaM-TAPron) was pre­
pared from a SOVo ammonium sulfate precipitate. All 
antisera were concentrated to 10 mg/ml by ultrafiltra­
tion with a XM 50 Diadow membrane (Amicon Corp, 
Lexington, Mass), sterilized by passage through a ster­
ile 0 2-μ filter, and stored at - 30 С Rabbit and goat 
IgG from nommmunized animals were obtained by the 
same procedure and used for the control studies 
Analysis of purity and specificity was carried out by 
micro Ouchterlony and Immunoelectrophoresis in 1 3% 
agarose '3 Protein concentrations were measured by the 
method of Lowry et al or by the radial immunodiffusion 
technique " IS The antibody specificity was tested by 
indirect immunofluorescence on normal mouse and rat 
kidneys and subsequently by absorptions of the antise­
rum with TAPron or FxlA, 3 mg/ml antiserum An-
tisera used for m vitro incubations were absorbed with 
equal volumes of freshly pooled blood cells, with 
lyophilized pooled nonimmune mouse scrum (50 
mg/0 1 ml antiserum), and with purified GBM-TBM 
(5 mg/ml antiserum) as described previously l 2 
In order to identify the specificities present in the 
polyclonal RaM-TAPron, we compared its binding 
properties with those of two previously described 
monoclonal antibodies (Mab) specific for rat brush bor­
der (BB) antigens expressed on glomeruli Mab 12 is 
specific for a 330-kd antigen identical to gp 330 ,0 " Mab 
8 is specific for a 90-kd antigen " 
In Vitro Incubations on Normal Mouse 
and Rat Kidneys 
Small pieces of freshly obtained kidneys were snap-
frozen in liquid nitrogen The distribution of antigens 
in mouse and rat kidneys was examined on frozen sec­
tions in the indirect immunofluorescence technique with 
the rabbit antisera against mouse TAPron, rat TAPron, 
and mouse FxlA, or the eluate from glomeruli of rats 
previously given injections of the GaM-TAPron serum 
Bound rabbit and goat antibodies were detected by a 
fluorescem-labeled swine anti-rabbit Ig (Dakopatt, 
Copenhagen, Denmark) or a rabbit anti-goat Ig (Bio-
nctics, Kensington, Md) 
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Passive Immunizations 
Vf/o groups of 6 PVG/c rats, weighing 130-170 g, were 
given intravenous injections of 7 mg of RaR-TAPron 
or RaM-TAPron serum Three control rats received 7 
mg of normal rabbit IgG Two groups of 6 mice, weigh­
ing 25-30 g, were given intravenous injections of 7 mg 
of RaR-TAPron or RaM-TAPron serum, and a control 
group of 6 mice received an equal amount of normal 
rabbit IgG The animals were killed, 2 at a time, at 4 
hours and at Days 1 and 7 after immunization Kid­
neys were removed and processed for light microscopy, 
immunofluorescence, and electron microscopy 
Elution of Goal and Rabbit IgG 
From Rat Kidneys 
One hundred male or female Wislar rats were given 
intraperitoneal injections of 2 ml of goat anti-mouse 
TAPron serum Five days later the rats were killed un 
der ether narcosis, and the kidneys were perfused for 
5 minutes with PBS via the aorta. Subsequently, the 
kidneys were minced with a razor blade and pushed 
through a 150-μ sieve Rat glomeruli were isolated from 
this homogenate by a differential sieve technique using 
a series of sieves of decreasing pore sizes (212, 106, and 
53 μ) The resulting glomerular suspension was exam­
ined for purity by light microscopy After six washes 
with PBS, the pellet was divided into plastic tubes of 
50 ml, to which 5 ml of 0 1 M glycine HCl buffer, pH 
2 8, was added The pellet was then sonicated for 1 min­
ute in two individual 30-second bursts in a Branson 
somfier (Branson Sonic Power Corp, Danberry, Conn) 
at an output of 40 watts After the sonication the tubes 
were filled with the buffer and elution took place for 
1 hour at room temperature under constant stirring 
After centrifugation of the suspension at 30,000g for 
45 minutes at 4 C, the clear supernatant was neutral­
ized with a 2 M Tris solution and dialyzed overnight 
against 0 02 M PBS, pH 7 2 The elution was repeated 
once, after which both supernatants were pooled, con­
centrated by ultrafiltration with a XM-50 Diaflow mem­
brane (Amicon Corp ), and stored at - 30 С The con­
centration of goat IgG was measured by radial im­
munodiffusion (200 fjg/ml) The eluted goat antibodies 
were tested on normal mouse and rat kidneys with in­
direct immunofluorescence and immunoelectron mi­
croscopy In vivo binding was determined in a C57B1/10 
mouse and a Wistar rat after intravenous injection of 
1 and 1 5 ml of eluate, respectively, with immunofluores­
cence and electron microscopy Control experiments 
were carried out with equal amounts of normal goat 
IgG By the same method we prepared an eluate from 
kidneys of rats given a rabbit anti-mouse TAPron se­
rum by injection This eluate, which had a final con­
centration of rabbit IgG of 5 mg/ml, was used in the 
immunoprecipitation analysis 
Immunoprecipitation 
Brush border membrane vesicles were prepared ac 
cording to Malathi and radiolabeled with 1 ! , I with the 
use of lactoperoxidase " '* Immunoprecipitations were 
performed by incubating 1 μg of antibody with 300,000 
cpm radiolabeled antigen for 30 minutes at room tem­
perature At this stage, when polyclonal rabbit antibod­
ies were used, antibody and immune complexes were 
subtracted from the reaction mixture by addition of 200 
μΐ of protein A containing staphylococci When mouse 
antibodies were studied, 5 (jg of rabbit anti-mouse IgG 
were added before addition of the staphylococci After 
a further incubation of 30 minutes at 4 С the bacteria 
were pelleted and washed extensively Radiolabeled an­
tigen was eluted with sample buffer, used to perform 
PAGE-SDS electrophoresis according to Laemmli " 
Light and Electron Microscopy 
The fixation and staining techniques have been pre­
viously described " 
Immunofluorescence 
Two-micron sections from tissue fragments, snap-
frozen in liquid nitrogen, were cut in a cryostat Both 
the direct and indirect techniques were carried out as 
described previously We used monospecific, fluorescein 
labeled rabbit anti-mouse IgG (heavy and light chains) 
and anti-C3, rabbit anti-rat IgG, and anti-C3 (Cappcll 
Laboratories), rabbit anti goat Ig (Bionetics), and swine 
anti-rabbit Ig (Dakopatt) directly or as a second layer 
in the indirect technique The two latter antisera were 
absorbed with 50 mg/ml lyophilized nonimmune mouse 
serum The presence of TAPron in the mouse or rat 
glomeruli was detected both in uneluted and in partially 
eluted sections with the use of rabbit anti-mouse or rat 
TAPron IgG, conjugated to fluorescein isothiocyanate 
according to The and Feltkamp I 0 Elution was done by 
incubating washed, unfixed sections, with a 0 05 M ci­
trate buffer, pH 3 2, at room temperature for 30 minutes 
The staining intensity of the immune reactants was 
recorded semiquantitatively (0, negative, 1 +, modcr 
ate, 2 + , relatively strong, 3 + , strong, 4 + , maximum 
intensity). 
Immunoelectron Microscopy 
As substrates for in vilro incubations normal mouse 
and rat kidneys were employed, fixed by perfusion with 
a mixture of 1% paraformaldehyde and 0 05% glu-
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Table 1 -In Vitro incubations on Normal Mouse and Rat Kidneys 
Glomerular staining 
Mouse nat 




taraldehyde in PBS, pH 7.2, as described earlier.12 ^ 
Small blocks of fixed renal cortex (2 cu mm) were snap-
frozen in liquid nitrogen, and 20-^-thick frozen sections 
were incubated in 200 μΐ of a rabbit anti-mouse TAPron 
serum, a goat IgG eluate from kidneys of rats previ­
ously given injections of GaM-TAPron serum, or with 
normal rabbit or goat IgG for controls. Bound rabbit 
or goat IgG was detected by incubation with a 
peroxidase-labeled swine anti-rabbit Ig or a rabbit anti-
goat Ig (Dakopatt) for 6 hours. After reaction of 3,3'-
diaminobenzidine tetrahydrochloride (DAB) with 
horseradish peroxidase and postñxing in lio OsC, thin 







Figure 1 -Indirect immunofluorescence and immunoelectron microscopic studies ot normal mouse and rat kidney incubated with a rabbit anti-mouse 
TAPron IgG A—Homogeneous slaimng on the visceral epithelia of the mouse glomerulus along with a strong staining of proximal tubules 
( χ 640) В-Fine and coarse granules on the rat visceral epithelia set on a weak homogeneous background The brush borders of proximal tubules 
are heavily stained (χ 640) С - M o u s e glomerular capillary wall with a strong reaction product on the cell membranes of the visceral epithelia and 
weak staining of the cell membranes of the endothelia ( χ 34,000) О—Granular reaction product on the cell membranes of the rat visceral epithelia 
and m coated pits (arrow) Cell membranes of the endothelia also show weak staining ( χ 30,000) Ер. epithelial cell, US, urinary space 
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Figure 2 indirect immunofluorescence ot normal mouse and rat kidney incubated with rabbit anti-mouse F χ 1A IgG A - M o u s e kidney No staining 
of capillary wails, while brush borders of proximal tubules and glomerular parietal eptthelia are heavily stained Faint staining of the cytoplasm of proximal 
tubules (x512) B—Rat kidney Fine and more coarse granules in glomerular capillary wail without a homogeneous background (x512) 
Results 
In Vitro Incubations on Normal Mouse 
and Rat Kidneys (Table 1) 
The heterologous antisera against mouse TAPron, 
rat TAPron, and mouse FxlA, all stained the BB of the 
proximal tubular epithelia of both the rat and the mouse 
kidney. Intense staining was seen with RaM-TAPron and 
RaM-FxlA, while the staining in mouse kidneys with 
RaR-TAPron was weaker than in the rat. On the other 
hand, the staining patterns in the glomeruli were com­
pletely different in the two species. RaM-TAPron serum 
caused a strong and homogeneous immunofluorescence 
in the mouse (Figure IA), while in the rat a granular 
staining was seen, with fine and more coarse granules 
against a weak and homogeneous background (Figure 
IB). These differences were confirmed by immunoelec-
tron microscopy. In the mouse glomerulus a homogene­
ously distributed reaction product was seen predomi­
nantly in the cell membranes of the visceral epithelia 
and, to a lesser extent, of endothelial cells. The glo­
merular basement membrane was negative (Figure 1С). 
In the rat glomeruli there was additional reaction prod­
uct in invaginations of the cell membranes (coated pits), 
mostly in the parts that faced the urinary spaces (Fig­
ure ID). Furthermore, some coated vesicles and mul­
tivesicular bodies in the cytoplasm were stained, but 
other cellular structures were negative. The immuno­
fluorescence patterns in rat and mouse kidneys seen with 
the RaR-TAPron serum were essentially the same as 
those shown in Figures 1A and В for the RaM-TAPron 
serum. RaM-FxlA serum showed no reaction with the 
mouse glomerulus (Figure 2A). In the rat glomerulus 
a weak granular staining was seen with fine and more 
coarse granules, but there was no homogeneous back­
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Passive Immunizations in the Rat and the 
Mouse (Table 2) 
In PVG/c rats a classic PHN could be evoked by a 
single intravenous injection of the anti-rat TAPron se­
rum. A rapid fixation of the injected protein to the glo­
merular capillary wall in a weak granular pattern was 
observed. In some glomeruli there was also a faint and 
transient homogeneous fluorescence in addition to the 
granular pattern. The number of granules had increased 
at Day 7. On light microscopy no abnormalities were 
seen at this time, but, ultrastructurally, small deposits 
were found located predominantly in the slit pores be­
tween intact epithelial foot processes. The results ob­
tained with anti-mouse TAPron serum were essentially 
the same (Table 2 and Figure ЗА). No fixation of rab­
bit IgG to the glomeruli was seen in the control group. 
On the other hand, the in vivo binding characteristics 
after intravenous administration of these two antisera 
to C57BI/10 mice were quite different. Injection of 
RaR-TAPron serum resulted in a faint to moderate, 
homogeneous immunofluorescence of the glomerular 
capillary wall, along with a faint staining of some BB 
of the proximal tubular epithelia. The glomerular stain­
ing was already maximal at 4 hours and decreased there­
after. At Day 7, all renal structures were negative apart 
from small mesangial deposits. Light microscopy 
showed no abnormalities at that time, and electron-
dense deposits could not be observed on electron mi­
croscopy. After intravenous administration of the anti-
mouse TAPron serum to C57BI/10 mice, the immedi­
ate and homogeneous binding of the antibodies to the 
glomerular capillary wall was much stronger (Figure 
3B). Also, strong staining was observed on the BB of 
the proximal tubular epithelia and of the basal parts 
of the cytoplasm. At Day 7, the glomerular deposits, 
still seen as very fine granules, were substantially re­
duced. Light microscopy did not show any abnormal­
ity, and no deposits were seen by electron microscopy. 
Characteristics of Eluted Immunoglobulins 
From Rat Kidneys 
Passive immunization with an anti-mouse TAPron 
serum could thus induce a classic PHN in rats. In or­
der to purify the antibody population directed against 
the Heymann antigen, we used a rat as a living immu-
noabsorbent. Because large volumes of antiserum were 
needed for this experiment we used a goat anti-M 
TAPron serum. This serum caused a granular im-
munofluorescent pattern in the glomerular capillary 
walls at Day 5 after intraperitoneal injection into Wistar 
rats. The goat immunoglobulins eluted from the 
glomeruli of rats that had been previously given this 
antiserum were tested both in vitro and in vivo. 
With the indirect immunofluorescence technique, in 
normal mouse and rat kidneys, the BB of the proximal 
tubular epithelia were heavily stained by the eluted IgG 
(Figure 4). The mouse glomerulus was negative (Fig­
ure 4A), whereas the rat glomerulus demonstrated fine 
or more coarse granules on the epithelial side of the 
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Figur· 3—Direct immunofluorescence of kidney specimens from a rat and mouse 1 day after intravenous administration of rabbit anti-mouse TAPron 
IgG A - l n the rat glomerulus granules are present along the capillary wall ( χ 512) В—Strong homogeneous fluorescence along the capillary 
wall of the mouse glomerulus Furthermore, the brush borders of the proximal tubules are heavily stained (x512) 
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Figure 4 - Indirect immunofluorescence of normal mouse and rat kidney incubated wrth IgG eluted from kidneys of rats treated with GaM-TAPron A -
Only strongly positive brush border staining is present in the mouse kidney (x512) B-A long with a strong brush border staining fine and more 
coarse granular deposits are present in the rat glomerular capillary wall {x512) 
capillary wall, however, without the homogeneous 
background as seen with the anti-mouse TAPron se-
rum (Figure 4B). The distal tubules, collecting ducts, 
and loops of Henle were all negative. These findings 
were confirmed by immunoelectron microscopy. No 
reaction product was observed in the mouse glomeru-
lus, but in the rat discrete localization was present both 
on the cell surface and within organelles of the glomer-
ular epithelial cells (Figure 5). At the cell membrane 
it was concentrated in coated pits, mostly facing the 
urinary space but sometimes at the bases of the foot 
processes (Figure 5A and inset). Intracytoplasmic locali-
zation was observed in coated vesicles, multivesicular 
bodies, and sometimes in cisternae of the endoplasmic 
reticulum (Figure 5B and C). We could not discover any 
reaction product in the Golgi apparatus, nor any diffuse 
epithelial membrane staining. No reaction product was 
located in the lamina densa, the cell membranes of the 
endothelium, or the mesangium. In both the mouse and 
the rat diffuse reaction product could be detected on 
the BB membranes of the proximal tubular epithelia, 
especially concentrated in invaginations at the base of 
the microvilli, and in apical vesicles (Figure 5D). All 
controls were negative. The eluate of injected rabbit 
anti-mouse TAPron serum that was used for the im-
munoprecipitation analysis gave the same results as the 
eluted goat IgG both with immunofluorescence and im-
munoelectron microscopy. 
In VÌVO binding to the rat glomerular capillary wall 
was observed by immunofluorescence 5 days after in-
travenous administration of 350 ^ g of eluted goat IgG. 
The antibody was deposited in a faint, but distinctly 
granular, pattern (Figure 6A), while by electron micros-
copy small deposits were seen in the slit pores between 
the epithelial cell foot processes (Figure 6B). After in-
travenous injection of 200 ng of eluted goat IgG in the 
mouse no deposits were found in the glomerular capil-
lary wall by immunofluorescence (Figure 6C), and this 
was confirmed by the absence of subepithelial deposits 
in sections studied by electron microscopy. Normal goat 
IgG did not fix to the glomerular capillary wall of the 
mouse or the rat. 
Immunopreclpltation of Microvilli 
The antibody specificities present in the various an-
tibody preparations were characterized by immunopre-
cipitation of radiolabeled BB. As shown in Figure 7, 
rabbit anti-mouse TAPron antisera (Lanes 2A, ЗА, 2B, 
and 3B) immunoprecipitated essentially two bands: one 
comigrated with the antigen identified by Mab 12 (Lanes 
5A and 5B) with an apparent molecular weight of 330 
kd; the other comigrated with the antigen identified by 
Mab 8 (Lane 7B) with an apparent molecular weight 
of 90 kd. Anti-mouse FxIA immunoprecipitated the 330 
kd band but only modest amounts of the 90 kd anti­
gen. Ig eluted from glomeruli of rats given injections 
5 days previously of RaM-TAPron immunoprecipitated 
only the 330 kd band. 
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Figura S—Indirect immunoelectron micrograph of normal rat kidney incubated with the eluted GaM-TAPron IgG A—Coated pits in the cell mem­
branes of the visceral epithelium and in basal part of foot process ( χ 37,000 χ 24,000) В - A multivesicular body in an epithelial foot process con­
tains reaction product ( x 40 800) C - A f a m t l y positive reaction is seen in the endoplasmic reticulum of the visceral epithelium ( χ 21 700) D - T h e 
villi of brush borders or proximal tubules show a strong reaction product on the cell membranes ( χ 24.800) Cap, capillary lumen, Ep. epithelial cell, 
US, urinary space 
Discussion 
Studies of several groups in the last few years have 
demonstrated that the antigen involved in the develop­
ment of AICN and PHN in rats is located on the 
subepithelial side of the glomerular basement mem­
brane. This so-called Heymann antigen is identical or 
cross-reactive to an antigen in the BB of the renal prox­
imal tubular epithelia.""10 2 2" ! s There is at present strong 
evidence indicating that it is a 300-kd BB protein ex­
pressed by glomerular epithelial cel ls . 1 0 "" It is as­
sumed that the presence of this antigen in the glomeruli 
explains the high susceptibility of rats to the induction 
of membranous glomerulonephritis. The glomerulone­
phritis that we could induce in the mouse by a single 
injection of an antiserum against homologous, pronase-
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Figur· β - Binding of eluted goat anti-mouse TAPron IgG to mouse and rat glomeruli at 5 days alter intravenous injection A—Rat kidney Direct 
immunofluorescence shows fine granular deposits along the glomerular capillary walls ( χ 512) В—Rat kidney Electron micrograph of subepithelial 
small deposits located in the slit pores or below a foot process (x68,000) C—Mouse kidney Direct immunofluorescence shows no staining of the 
glomerulus ( χ 640) Cap. capillary lumen. Ep. epithelial cell. US. urinary space 
digested renal tubular antigens, resembles the PHN in 
rats and is almost identical to it in its autologous 
phase." 
Despite this similarity, we provide evidence suggest­
ing that the antigens responsible for the 2 models are 
distinct and can be characterized as 330-kd and 90-kd 
proteins in rat and mouse, respectively. The antibody 
specificities contained in anti-TAPron antisera could be 
analyzed by immunoprecipitation of radiolabeled BB 
and by immunofluorescence with reference to previously 
characterized Mab raised against BB antigens expressed 
on glomeruli. Anti-mouse FxlA and anti-mouse 
TAPron contain antibodies to a 330-kd protein also 
identified by Mab 12. By contrast, only anti-TAPron 
antisera contain significant amounts of antibody to a 
90-kd protein identified by Mab 8. By indirect im­
munofluorescence using the monoclonal antibodies, the 
2 antigens can be demonstrated on rat glomeruli, but 
the patterns of binding are clearly distinct: fine punc­
tate and irregular for the 330-kd antigen, diffuse and 
homogeneous for the 90-kd antigen. When anti-TAPron 
antisera containing the 2 specificities are applied on rat 
glomeruli, a mixed pattern is observed. Nevertheless, 
the 330-kd antigen is clearly responsible for the EM 
deposits induced in the rat by anti-TAPron antibodies. 
This assertion rests upon analysis of the Ig eluted from 
the glomeruli. These antibodies are able to precipitate 
a single 330-kd protein from radiolabeled rat BB, which 
comigrates with the band immunoprecipitated by Mab 
12. The immunofluorescence pattern of the eluate is typ­
ical of anti-gp 330 antibodies. At the ultrastructural 
level, using the glomerular eluate, the antigen is exclu­
sively localized in invaginations of the cell membranes 
(coated pits) and in several intracytoplasmic structures 
of the glomerular visceral epithelial cell. This pattern 
is in complete agreement with the studies of Kerjaschki 
and Farquhar, who used affinity purified antibodies to 
a 330-kd nephritogenic protein.10 Observations made 
in the mouse indicate that the 330-kd antigen is not ex­
pressed on mouse glomeruli and thus probably not in­
volved in the nephritis. This was suggested by the purely 
homogeneous immunofluorescence pattern obtained 
with anti-TAPron antibodies and confirmed with anti­
bodies eluted from rat glomeruli which, as previously 
described, react only with gp 330: binding was observed 
on proximal tubule BB, but not on glomeruli. A role 
of the 90-kd homogeneously distributed antigen thus 
appears likely. This possibility is supported by the ki­
netics of binding of the antibodies,11 which are identi­
cal to those reported by Ronco et a l" for this anti­
gen-antibody system in the rat: binding is maximum 
in the hours following intravenous administration and 
decreases rapidly. Ideally it would be desirable to elute 
glomerular IgG to demonstrate antibody activity 
specific for the 90-kd antigen. This experiment is 
difficult to perform, because substantial deposits are 
only noted in the hours following administration of the 
antibody. Furthermore, preparation of glomerular sus­
pensions of a satisfactory degree of purity is techni­
cally difficult in the mouse. 
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Figure 7-lmfTiunoprecipitation analysis of radiolabeled rat B8 using various anti-BB antibodies A—Unreduced samples Lane 1, rabbit anti-mouse 
Fx 1A Lanes 2 and 3. two different preparations of rabbit anti-mouse TAPron Lane 4, glomerular eluate of rats previously injected with rabbit anti-
mouse TAPron Lane 5, Mab 12. Lane 6, unprecipitated BB B-Reduced samples Lane 1. Rabbit anti-mouse Fx 1A Lanes 2 and 3. two different 
preparations of rabbit anti-mouse TAPron Lane 4. glomerular eluate of rats previously given rabbit anti-mouse TAPron Lane 5. Mab 12 Lane 6, rabbit 
anti-rat BB Lane 7, Mab θ 
Because the 90-kd homogeneously distributed anti­
gen was so clearly visible in the rat glomerulus in the 
in vitro studies, it may seem somewhat surprising that 
the corresponding antibodies are not detected in the rat 
glomerular eluate. This finding is explained by the ki­
netics of binding of the antibodies to the 90-kd anti­
gen: the homogeneous background is only faintly and 
transiently observed in rat glomerulus, so that very low 
levels are observed 5 days after injection, when the du­
ales were prepared. Because the same sequence is ob­
served in rat and mouse, with the use of monoclonal 
or polyclonal antibodies, it is likely that these kinetics 
are related to some properties of the 90-kd antigen. It 
is beyond the scope of this article to discuss those in 
detail, but they may relate to the diffuse distribution 
on the epithelial cell membrane and/or rapid turnover. 
Other factors that may be of significance when one is 
comparing immune deposits in the mouse and in the 
rat include differences in antibody concentrations — 
identical amounts of antibody were used in the two spe­
cies, which differ in body weight by a factor of 5 — and 
differences in glomerular permeability. Immediately af­
ter injection of RaM-TAPron in the mouse, we always 
see a short protein leakage, as evidenced by mild pro­
teinuria and heavy staining of the brush borders of the 
proximal tubular cells by the antibody. This heavy stain­
ing of the brush borders was not seen after injection 
of the same antiserum in the rat (Figure 3). It seems, 
therefore, likely that in the rat less antibody against the 
homogeneously distributed antigen reached the visceral 
epithelial cells in Bowman's space, and this may explain 
the discrepancy between the in vivo and in vitro bind­
ing studies in the rat. 
It has been suggested that the inability to induce Hey­
mann nephritis in species other than the rat is related 
to the absence of the Heymann antigen in those spe­
cies.22 " The fact that we were able to induce a mem­
branous glomerulonephritis in the mouse which closely 
resembled PHN in the autologous phase demonstrates 
that this is not so in all cases. The antigen involved in 
membranous glomerulonephritis in the mouse is pres­
ent in the cellular membrane of the visceral epithelial 
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cells of the glomerulus Because this homogeneously 
distributed antigen seems to occur also in the rat 
glomerulus and does not show cross-reactivity with the 
Heymann antigen, it will be interesting to further study 
the pathogenetic potential of antisera containing anti­
bodies to the 90-kd antigen only Previous expenments" 
using Mab 8 induced transient glomerular deposits of 
the monoclonal antibody but were unable to trigger an 
autologous phase. Different results may be obtained 
with polyclonal goat or rabbit antibodies On the basis 
of our in vivo results, we would predict that in such 
experiments rats have to be made proteinuric by other 
means to enable sufficient amounts of antibody to reach 
its antigenic target 
In conclusion, we have demonstrated the presence of 
a new BB antigen in the visceral epithelial cells of mouse 
and rat glomeruli that is different from the Heymann 
antigen Antibodies against the pronase-digested frac­
tion of this antigen can induce a membranous glomer­
ulonephritis in the mouse, despite the absence of the 
Heymann antigen in the glomeruli of this species 
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SUMMARY 
Injection of heterologous antiserum in the mouse directed against murine 
pronase digested renal tubular antigens (TAPron) results in a membranous 
glomerulonephritis. Although the antiserum contains antibodies against 
the Heymann antigen (gp-330), this is not the target in the mouse 
because the Heymann antigen is not present in the mouse glomerulus. The 
glomerular damage in the mouse is initiated by transient binding of 
another antibody population to an antigen present in a homoaeneous 
distribution on the visceral epithelial cells. The binding pattern is 
similar to that of a monoclonal antibody directed against a 90 kd 
protein (gp-90). The latter protein is also present in mouse liver, 
whereas gp-330 is not expressed in this organ. We have now studied an 
eluate obtained from livers of mice previously injected with anti-mouse 
TAPron serum. Immunoprenpitation on radiolabelled renal proximal 
tubular brush borders demonstrated that the mouse eluate reacted with 
the gp-90, but not with the qp-330. Immunofluorescence on normal mouse 
and rat kidneys showed that the eluate bound to the glomerular capillary 
wall of both species in a homogeneous pattern and also to the brush 
borders. Injection of mouse eluate led to binding to the capillary wall 
of the mouse and to a lesser extent to that of the rat. The results 
demonstrate that an antigen with a molecular weight and a kidney 
distribution different from the Heymann antigen, can serve as target for 
antibody-mediated membranous glomerulonephritis in the mouse. 
Furthermore, they suggest that this antigen may also be involved in the 




The antigen responsible for the binding of antibodies in the active 
Heymann nephritis (HN), and its passive variant (PHN) in rats, which are 
the supposed experimental analogues of human membranous 
glomerulonephritis (Heymann et al., 1959; Barabas, Nagy and Lannigan, 
1970; Feenstra et al., 1975), has been characterized as a large 
330,000-mol.wt. glycoprotein (gp-330). It has been localized at 
discrete sites on the glomerular visceral epithelial cells and on the 
brush borders of the proximal tubular epithelia (Kerjaschki and 
Farquhar, 1982; 1983). Another antigen, homogeneously distributed in 
the cell membranes of the glomerular visceral epithelia and endothelia 
as well as the brush borders of the proximal tubuli in rats, has 
recently been defined with a monoclonal antibody as a 90,000-mol.wt. 
protein (gp-90) (Ronco et al., 1984a; 1984b). A rapid but transient 
fixation of the injected monoclonal antibodies to this antigen in the 
glomerular capillary wall takes place in vivo, in contrast to the much 
slower kinetics in the PHN in rats after administration of polyclonal or 
monoclonal antibodies to the Heymann antigen (HA). 
We have previously described a heterologous antiserum directed against 
pronase-digested mouse renal tubular antigens that can provoke a 
membranous glomerulonephritis in the mouse (Assmann et al., 1983). This 
antiserum contained antibodies against the HA, but these could not be 
held responsible for the glomerulonephritis since the HA, although 
present on mouse tubular brush borders, is absent from the visceral 
epithelial cells of the mouse glomerulus (Assmann et al., 1985). The 
polyclonal antiserum contains a second antibody population directed 
against an antigen with a more homogeneous distribution both in the 
brush borders of the proximal tubular epithelia and in the cell 
membranes of the glomerular visceral epithelia and endothelia. This 
latter antigen was also present in the rat glomerulus in addition to the 
HA. The in vivo and in vitro characteristics of this second antibody 
population closely resemble those of the earlier described monoclonal 
antibody against the gp-90 protein. 
Our attempts to obtain purified antibody against the σρ-90 protein by 
elution from kidneys of mice injected with the polyclonal antiserum 
failed, because we were unable, like others, to prepare glomerular 
suspensions in this species, that were not contaminated by proximal 
tubular cells. Furthermore, substantial deposits are only noted in the 
hours following the injection of the antibody (Assmann et al., 1985). 
We have now succeeded in separating the antibody population directed 
against gp-90 by preparing an eluate from livers of mire previously 
injected with the antiserum. The specificities of the eluted antibodies 
were defined by immunoprecipitation of radiolabelled mouse brush borders 
and by studying their binding characteristics by immunofluorescence on 
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normal mouse and rat kidneys. 
MATERIALS AND METHODS 
Animals. Inbred C57B1/10 mice were originally obtained from the Jackson 
Laboratory, Bar Harbor, Maine, USA. Swiss mice and Wistar rats, all 
random bred, were bought from the Central Institute for the breeding of 
laboratory animals, TNO, Zeist, The Netherlands. New Zealand white 
rabbits were bought from a local breeder. 
Preparation of antigens and antisera. The crude fraction of the brush 
borders of the renal proximal tubular epithelia, FxlA, p'repared from 
Swiss mouse kidneys, and the pronase-digested fraction thereof, 
designated M.TAPron, were obtained as previously described (Assmann et 
al. 1983). Rabbits were immunized with mouse TAPron, emulsified in 
complete Freund's adjuvant (Difco Laboratories, Detroit, Michigan, USA). 
The IgG fraction was harvested from the serum and subseguently tested 
for purity and specificity as described previously (Assmann et al., 
1983). 
Elution of rabbit antibodies from mouse livers. Thirty five C57B1/10 
mice that had been injected with J ml of rabbit anti-mouse TAPron serum, 
were killed 15-30 min later under ether narcosis and perfused for 15 min 
with PBS, pH 7.2, via the abdominal aorta until the livers bleached. 
Forty g of liver tissue were suspended in 150 ml of PBS, pH 7.2, + 0.1 M 
ethylene diaminotetraacetic acid (EDTA), and homogenized at maximum 
speed for 1 min. in a homogenizer (Ystral). 
Subsequently the suspension was centrifuged at 27,000 g for 15 min at 
40C. After 5 washes with PBS+0.1 M EDTA, pH 7.2, the resulting pellet 
was resuspended in 225 ml of a 0.12 M glycine HCl buffer, pH 2.8, and 
elution took place for 30 min at room temperature under constant 
stirring. After centrifugation of the suspension at 30,000 g for 45 min 
at 4 C, the clear supernatant was neutralized with a 2 M Tris solution 
and dialysed overnight against PBS+ 0.1 M EDTA, pH 7.2 at 40C. The 
IgG fraction from the dialysate was obtained from a 50% ammonium 
sulphate precipitate and again dialysed against PBS+ 0.1 M EDTA, pH 7.2, 
at 4 C. The dialysate was concentrated over an YM-10 Diaflow membrane 
(Amicon Corp., Lexington, Mass., USA), and stored at -30 C. The 
protein content was determined at 2 mg/ml according to the method of 
Lowry et al (1951). Eluates from livers of mice injected with equal 
amounts of normal rabbit IgG and prepared in the same manner, were used 
in the control experiments. 
Immunoprecipitation. Mouse renal brush border membrane vesicles were 
prepared from 80 g of frozen mouse kidney according to the method of 
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Malathi et al. (1979), and radiolabelled with 125 I usino 
lactoperoxydase (Ronco et al., 1984a). Polyclonal rabbit antisera to 
mouse FxlA, mouse TAPron, rat gp-330, mouse liver eluate, a rat kidney 
eluate directed to the gp-330 (Assmann et al., 1985), and monoclonal 
antibodies to the qp-330 were used in the immunoprecipitation procedure 
as described (Ronco et al., 19 4 ). The characterization of the 
immunoprecipitated proteins was subsequently performed on PAGF-SOS 
electrophoresis according to Laemmli (1970). 
In vitro incubations on normal mouse and rat kidneys. The distribution 
of the antigen identified by the eluate from mouse livers was examined 
in the indirect immunofluorescence technique on frozen sections of 
normal mouse and rat kidneys. The fixation and staining techniques have 
been described earlier (Assmann et al., 1983). Two pm sections from the 
kidneys were incubated with the eluate (diluted 1:20) for 30 m m at room 
temperature. Bound rabbit antibodies were detected by a 
fluorescein-labelled swine anti-rabbit Ig (Dakopatt, Copenhaoen, 
Denmark), absorbed with 500 mq/ml lyophilized non-immune mouse and rat 
serum. Fluorescein-labelled anti-rabbit Ig alone and normal rabbit Ig 
were used in the control incubations. The staininq intensity was 
recorded semiquantitively (0=negative, l+=moderate, 2+=relative strong, 
3+= strong, 4+=maximum intensity). 
Passive immunizations. The eluate from the mouse livers was injected 
intravenously into a rat and a mouse in doses of 1 and 0,5 mg protein 
respectively. The animals were killed 4 hours later and their kidneys 
and livers were removed and processed for immunofluorescence and 
electronmicroscopy. The procedure for the processing of the specimens 
of the electronmicroscopy was previously reported (Assmann et al., 
1983). Bound rabbit Ig in the kidney was detected with the 
fluorescein-labelled swine anti-rabbit Ig (Dakopatt) in the indirect 
immunofluorescence. 
RESULTS 
Analogous to the method of purifying antibodies directed to the Heymann 
antigen (gp-330) from an anti-mouse TAPron serum employing rat glomeruli 
as immunoabsorbants (Assmann et al., 1985), we tried to separate the 
antibodies directed against the homoneneously distributed antigen 
(gp-90) in mice. However, in this species this method proved to be 
unsuitable since all attempts failed to provide a highly enriched 
suspension of mouse glomeruli, uncontaminated by tubular cells and 
devoid of Bowman's capsule in which the parietal cells carry a brush 
border. Also attempts to elute the immunoglobulins from whole kidney 
homoqenates of mice 10-15 min after administration of the antiserum and 
supposedly before the antibodies had leaked into Bowman's space, did not 
yield a monospecific antibody population as evidenced in the indirect 
immunofluorescence technique on normal mouse and rat kidneys. During 
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these experiments we noticed a rapid binding of the antibodies to the 
endothelia of the liver sinuses, after injection of anti-mouse TAPron 
serum intravenously or directly into the portal vein. Furthermore, we 
could not detect the Heymann antioen in normal mouse and rat livers by 
immunofluorescence using a rat kidney eluate against the qp-330 
described earlier (Assmann et al., 1985). Therefore we chose the mouse 
liver as immunoabsorbant for preparing the specific antibodies to the 
gp-90 protein. 
Immunoprecipitation of mouse microvilli. A comparison of the IP pattern 
obtained with anti FxlA and anti TAPron serum is shown in figure 1. The 
results indicate that the 2 antisera bind similar antigens in the high 
molecular weight area (330 kD). By contrast, the patterns are distinct 
in the lower MW area: anti TAPron antibodies bind two distinct 
antigens: one of 90 kD and another of slightly lower MW; anti FxlA 
antibodies do not bind the 90 kD antioen but only the lower MW band. 
These patterns were compared to those obtained with various antibodies 
of known specificity. The highest MW antigen comigrates with the 
antigen immunoprecipitated by rat glomerular eluate, monoclonal and 
polyclonal anti gp-330. The 90 kD band identified by anti TAPron 
antisera is not immunoprecipitated by any of these antisera but 
comigrates with the antigen bound by mouse liver eluates. 
1 2 3 4 5 6 7 8 9 
t f 
Figure 1. Immunoprecipitation of mouse renal brush borders. 1. Whole brush borders. 
2. Control with normal mouse serum. 3. Anti-mouse TAPron serum. A, Eluate of rat 
glomeruli five days previously injected with anti-mouse TAPron serum. 5. Anti-mouse 
FxlA serum, 6. Eluate from mouse glomeruli 10-15 min. previously injected with 
anti-mouse TAPron serum. 7. Mouse liver eluate. 8. Mab 12 (anti-pp 330). 9. 
Polyclonal anti-gp 330. 
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In vitro incubations of the eluate on normal mouse and rat kidneys 
(Table I). The eluted antibodiesfrom the mouse livers stained the 
brush borders of the proximal tubuli of the rat and the mouse in an 
intense and diffuse pattern. In the mouse glomerulus a homogeneous 
fluorescence was seen along the capillary wall, even stronger than the 
staining of the brush borders (figure 2 A). Rat glomeruli also showed a 
homogeneous pattern but this was less intense (figure 3 A). The 
granular component seen in the rat glomeruli with the unseparated 
anti-TAPron serum and with the rat glomerular eluate was lacking. The 
endothelia of the peritubular capillaries, particularly of the medulla 
in mice were clearly stained (figure 2 B ) , while they were hardly 
visible in the rat. The long loops of Henle stained very strongly in 
the rat (figure 3 B), but only weakly in the mouse (figure 2 C). Some 
fine granules were furthermore seen in the apical parts of the distal 
convoluted tubules, especially in the rat (figure 3 A). Along the 
smooth muscle cells of the large arteries in the mouse a fine granular 
staining was seen, while furthermore many cells in the interstitium of 
the papilla showed a weak and granular staining (figure 2 D ) . Control 
incubations, including an eluate from livers of mine injected with 
normal rabbit Ig, were negative. 
Table I. Indirect immunofluorescence usino mouse liver eluate on normal mouse and rat 
kidneys. 
Renal structure Immunofluorescence 
Mouse Rat 
Glomerulus ++++ ++ 
duxta glomerular cells + 
Brush border of proximal tubules +++ +++ 
Apical parts of distal convoluted tubules + + 
toops of Henle + +++ 
Capillary endothelium ++ -/+ 
Interstitial cells of papilla + + 
Cells of arterial media + 
Homogeneous staining along the glomerular capillary wall 
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f i g u r e 2. Immunofluorescence of mouse l i v e r eluate on normal mouse kidneys. A. 
Homogeneous s t a i n i n g along the glomerular c a p i l l a r y w a l l wi th a s l i g h t l y lesser s t a i n i n g 
of the brush borders. x512. B. The endothelium of the p e r i t u b u l a r c a p i l l a r i e s i s 
p o s i t i v e . x512. С f i n e granular s t a i n i n g in the loops of Nenie in the medulla. x512. 
D. Cel ls i n the i n t e r s t i t i u m of the p a p i l l a are c l e a r l y p o s i t i v e . x403. 
Passive immunizations. Four hours after intravenous i n j e c t i o n of the 
mouse l i v e r eluate we found the t y p i c a l homogeneous or f ine granular 
sta in ing in the glomerular wal l of the mouse kidney ( f i g u r e 4 A). The 
sta in ing pattern in the rat glomerulus was much less intense, but 
otherwise similar to that in the mouse. The injected antibody also 
f ixed to the endothelia of the peritubular c a p i l l a r i e s , p a r t i c u l a r l y in 
the mouse medulla. Concomitantly, there was a strong binding to the 
endothelia of the l i v e r sinuses in the mouse along with a f a i n t binding 
to the c a n a l i c u l i ( f igure 4 B), whereas in the rat only a moderate 
f i x a t i o n to the sinuses was observed. No deposits were seen in the 
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Figure 3. Immunofluorescence of mouse l i v e r eluate on normal rat kidneys. A. 
Homogeneous s ta in ing of the glomerular cap i l l a r y wal l w i th a b r igh t s ta in ing of the brush 
borders and f a i n t s ta in ing of the apical par ts of the d i s t a l convoluted tubules (arrow). 
x512. B. Strong s ta in ing of the loops of Henle i n the medulla around the vasa recta. 
x256. 
DISCUSSION 
In e a r l i e r r e p o r t s we have shown t h a t the anti-mouse TAPron serum used 
f o r the i n d u c t i o n of a membranous g l o m e r u l o n e p h r i t i s i n the mouse 
conta ins at l eas t two s p e c i f i c i t i e s . The r e s u l t s of the 
immunoprec ip i ta t ion ana l ys i s of t h i s serum us ing r a t brush borders have 
demonstrated t h a t one o f the an t i bod ies I s d i r e c t e d aga ins t the Heymann 
ant igen (gp-33U), whereas the second ant ibody popu la t i on de tec ts the 
gp-9ü (Assmann et a l . , 1985). The l a t t e r an t igen was p rev i ous l y def ined 
using a monoclonal ant ibody prepared by immunizat ion of mice w i t h r a t 
brush border (Ronco et a l . , 1984a). To extend the comparison of the 
monoclonal and p o l y c l o n a l an t i bod ies t o t h e i r respec t i ve t i s s u e 
d i s t r i b u t i o n i n the k idney we needed to separate the two an t i bod ies i n 
the ant i -TAPron serum. With regard to a n t i - g p 330 t h i s was r e l a t i v e l y 
easy because we cou ld take advantage of the d i f f e r e n t b ind ing k i n e t i c s 
of both an t i bod ies (Assmann et a l . , 1985). A n t i - g p 90 b inds only 
t r a n s i e n t l y to the g lomeru lar c a p i l l a r y w a l l o f mice and r a t s . At day 5 
a f t e r i n j e c t i o n o f the ant iserum the ant ibody has almost completely 
disappeared wh i l e a n t i - g p 330 i s near ly at i t s maximum of b i n d i n g . 
Thus, the a n t i - g p 330 could be e l u ted at t h i s day from i s o l a t e d ra t 
g lomeru l i w i t hou t de tec tab le contaminat ion by a n t i - g p 90 . Prepara t ion 
of p u r i f i e d a n t i - g p 90 by e l u t i o n cou ld t h e o r e t i c a l l y be achieved by 
using i s o l a t e d mouse g l o m e r u l i , because i n con t ras t to i t s presence i n 
the r a t g lomeru lus , gp-330 i s absent from the g lomeru lar c a p i l l a r y w a l l 
J 
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Figure 4. Four hours after injection of the mouse liver eluate in a mouse a homogeneous 
binding along the glomerular capillary wall can be observed. x512. B. Strong binding 
along the liver sinuses and in canaliculi (arrow). XÛ03. 
in the mouse (Assmann et al., 1985). However, it was impossible to 
prepare isolated mouse glomeruli. Fortunately, mouse liver proved to be 
a useful alternative immunoabsorbant, because we found in in-vitro 
incubations that this organ lacks gp-350 and contains gp-90 on its 
endothelial cells. 
The polyclonal antlsera directed against mouse FxlA and TAPron bound to 
several proteins in the immunoprecipitation analysis on radiolabelled 
mouse brush borders, including gp-330. In contrast, gp-90 was only 
minimally precipitated by the anti-mouse FxlA compared to the amounts of 
gp-90 bound by anti-mouse TAPron serum. This was reflected in the 
in-vitro incubations on normal mouse and rat kidneys where the most 
prominent difference was the homogeneous staining along the glomerular 
loops with anti-mouse TAPron sera, not seen with anti-mouse FxlA sera 
(Assmann et al., 1985). It is conceivable that the enzymatic treatment 
of the mouse renal brush border suspension may have uncovered a hidden 
antigen or have rendered the antigen more immunoaenic. The 
immunoprecipitation studies confirmed that rat glomeruli are an 
excellent immunoabsorbant for the purification of the antibodies to the 
Heymann antigen. With the mouse liver eluate we could considerably 
enrich the antibodies to the qp-90, but a few traces of other proteins 
were also precipitated. This is most likely caused by elution of 
antibodies against additional antigens shared by renal brush borders and 
liver (Lojda and Gossrau, 1980; Fukasawa et al., 1981; Spater et al., 
1982, 1983). 
With these two eluates, containing the desired specificities, we could 
compare the binding characteristics in normal kidneys. The in-vitro and 
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in-vivo localization studies of the rat eluate containina anti-gp 330 
have previously been described by us and are in accordance with the 
results obtained by others with antibodies aqainst the Heymann antigen 
(Kerjaschki and Farquhar, 1983; Assmann et al., 1985). The liver 
eluate enabled us to study in detail the distribution of the ap-90. The 
staining patterns closely resembled those of the earlier described Mab 
8, a monoclonal antibody that binds to gp-90 (Ronco et al., 1984a). The 
results confirm our earlier assumption that this antigenic system occurs 
both in the rat and mouse glomerulus. The distribution of the antigen 
in the kidney is more widespread than that of the Heymann antigen. The 
gp-90 is a brush border associated antigen that is also present in the 
capillary endothelium, distal convoluted tubules, loops of Henle, media 
of the larger arteries, and interstitial cells of the papilla. The 
nature and function of this cell membrane bound antigen are as yet 
unknown. 
Our successful attempts to induce a membranous nlomerulonephritis in the 
mouse combined with the demonstration that the Heymann antigen is not 
present in the glomerular capillary wall in this species proves that 
another antigenic system must be involved. The results of the in vitro 
and in vivo studies suggest that this is the gp-90 antigen. Final proof 
must come from experiments in which membranous glomerulonephritis is 
induced by injection of polyclonal antibodies against gp-90. The 
amounts of polyclonal Ig's eluted from mouse livers were not sufficient 
to extend our in vivo experiments at this moment. Work is now in 
progress in our laboratory to prove this hypothesis. 
The guestion arises as to whether this system is also involved in the 
Heymann nephritis in the rat, because gp-90 is present in the rat 
glomerulus in addition to gp-330. Our previous studies have shown that 
polyclonal antisera against pronase digested rat FxlA contain antibodies 
to gp-90. Recently Jeraj et al. (1984) described an antibody 
population in an anti-rat FxlA serum with similar kinetics, i.e. 
immediate bindino to the endothelium of the glomerular capillary wall 
followed by the development of subepithelial complexes later in the 
disease. The earlier demonstration of the binding of anti-op 90 
monoclonal antibody (Mab 8) to the rat glomerulus shows that gp-90 can 
in principle act as an antigenic target. The fact that injection of Mab 
8 into rats caused only a transient binding to the glomerular capillary 
wall and failed to induce a membranous glomerulonephritis (Ronco et al., 
1984a) does not exclude the possibility that, also in the rat, gp-90 is 
involved in this disease. Indeed, studies with monoclonal antibodies in 
vivo have several disadvantages. First, they hardly provoke an immune 
response in the injected animal, so that an autologous phase does not 
develop. Second, for the formation of immune complexes in the 
glomerular capillary wall a precipitating antigen-antibody system will 
be the most effective. This is easily achieved with polyclonal 
antibodies, but not with monoclonal antibodies (Agodoa et al., 1984). 
Therefore, further studies are needed to establish the capacity of 
anti-gp 90 antibodies to induce subepithelial deposits in the autologous 
phase in the rat analogous to the events in the membranous 
glomerulonephritis in the mouse. 
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SUMMARY 
The Heymann antigen (gp-ЗЭО) and an antigen with lower molecular weight 
(gp-9U) are major constituents of the brush border of the renal proximal 
tubuli in the rat and the mouse. The Heymann antigen can also be found at 
discrete sites in the glomerular visceral epithelium of the rat, but not 
of the mouse. Gp-90 is diffusely present along the glomerular capillary 
wall of rat and mouse. The Heymann antigen is probably the target antigen 
for membranous glomerulonephritis in the rat, while in the mouse, where 
this form of glomerulonephritis can also be induced, gp-90 seems to be 
the antigen involved. We have separated the antibody populations against 
these two antigens by preparing eluates from kidneys of rats and livers 
of mice that had been injected with an antiserum against pronase-digested 
mouse renal tubular antigens. Using these purified antibodies we have 
examined by indirect immunofluorescence the distribution of the two anti­
gens on normal mouse and rat tissues. The expression of the Heymann anti­
gen is limited to the epithelia of several organs, while gp-90 has a more 
widespread distribution in many cells of different origin and function in 
both the mouse and the rat. 
60 
INTRODUCTION 
Antisera directed against pronase-digested mouse renal tubular antigens 
contain antibodies against the Heymann antigen (gp-330) and against an 
antigen with a lower molecular weight (gp-9U) (Assmann et al. 1984, 
198b). Both antigens are abundantly present in the brush borders of the 
renal proximal tubules. The Heymann antigen can be found at discrete 
sites in the glomerular visceral epithelium of the rat but not of the 
mouse, while the gp-9û protein has a more homogeneous distribution in the 
cell membranes of the glomerular visceral epithelia and endothelia of 
both the mouse and the rat (Assmann et al. 1983, 1984, Kerjaschki and 
Farquhar, 1983, Ronco et al. 1984a, 1984b). It is assumed that the 
Heymann antigen plays a key role in the formation of subepithelial 
deposits in the active and passive Heymann nephritis in rats. On the 
other hand, gp-90 is the target for antibodies that can induce a 
membranous glomerulonephritis in the mouse (Assmann et al. 1985). 
Purified antibodies against gp-330 can be obtained by preparing eluates 
from kidneys of rats previously injected with antiserum against pronase 
digested mouse renal tubular antigens. Antibodies against gp-9U can be 
similarly purified using livers of mice previously injected with the 
antiserum (Assmann et al. 1984, 1985). In this report we describe in 
detail the localization of these two antigens in normal mouse and rat 
tissues as detected by immunofluorescence studies with the two eluates. 
MATERIALS AND METHODS 
Animals. The inbred mouse strain C57B1/10 was originally obtained from 
the Jackson Laboratory, Bar Harbor, Maine, USA. Swiss mice and Wistar 
rats, all random bred, were bought from the Central Institute for the 
breeding of laboratory animals, TNO, Zeist, The Netherlands. New Zealand 
white rabbits were bought from a local breeder. 
Preparation of antigens and antisera. Mouse FxlA prepared from Swiss 
mouse kidneys, and the pronase-digested fraction thereof, designated 
M.TAPron, were prepared as previously described (Assmann et al. 1983). 
Rabbits were immunized with mouse FxlA or TAPron, emulsified in complete 
Freund's adjuvant (Difco Laboratories, Detroit, Michigan, USA). The IgG 
fraction was obtained from a 50% ammonium sulphate precipitate, purified 
by affinity chromatography on a Sepharose-4B coupled protein-Α column 
(Pharmacia, Uppsala, Sweden), and concentrated to approximately 10 mg/ml 
by ultrafiltration with a XM-5Ü Diaflow membrane (Amicon Corporation, 
Scientific System Division, Lexington, Massachusetts, USA) as described 
earlier (Assmann et al. 1983). 
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Preparation oF eluates From rat kidneys and mouse livers. As described 
earlier, antibodies against the Heymann antigen (gp-330) were puriFied by 
acid elution oF a glomerular suspension oF Wistar rats that had previous­
ly been injected with 2 ml oF anti-mouse TAPron serum (Assmann et al. 
1984). The glomeruli were isolated From a homogenate by a diFFerential 
sieve technique and aFter a short sonication oF the suspension bound 
antibodies were eluted with a 0.1 M Glycine-HCl buFFer, pH 2.B, For 1 h 
at room temperature. AFter concentration oF the eluate by ultraFiltration 
with a XM-i>0 DiaFlow membrane (Arnicon Corp.), the protein content was 
adjusted to 5 mg/ml. Protein concentrations were measured with the method 
oF Lowry et al. (1951). Antibodies to the gp-90 were obtained From livers 
oF similarly injected C67B1/10 mice killed 15-30 min aFter injection. We 
have previously shown that mouse liver expresses the gp-90, while lacking 
the gp-330. Bound antibodies were eluted with the same acid buFFer From a 
homogenate as reported in an earlier study (submitted For publication). 
The Ig Fraction From the eluate was obtained From а 50л ammonium sulphate 
precipitate. The protein content oF the Final preparation was 1.7 mg/ml. 
In vitro incubations on normal mouse and rat organs. The distribution oF 
the antigens by the eluates was examined in the indirect immunoFluores-
cence technique on Frozen sections oF normal mouse and rat tissues. The 
Fixation and staining techniques have been described earlier (Assmann et 
al. 1983). Bound rabbit antibodies were visualized by a Fluorescein-
labelled swine anti-rabbit Ig (Dakopatt, Copenhagen, Denmark), absorbed 
with 500 mg/ml lyophilized non-immune mouse and rat serum. The staining 
intensities and the quantities oF the immune reactants were recorded 
semiquantitatively (0+ = negative, 1+ = moderate, 2+ = relatively strong, 
3+ = strong, 4+ = maximum intensity). 
In vitro incubations oF cell suspensions oF mouse and rat thymus, spleen, 
and peripheral blood lymphocytes (PBLs). Single cell suspensions oF 
thymocytes and spleen cells oF C57B1/10 mice and Wistar rats were 
obtained in petri dishes by teasing apart the organs with a needle. Mono­
nuclear cells were isolated From 8 ml oF citrated blood by Ficoll-
Isopaque density gradient centriFugation. The cells were washed twice in 
PBS, pH 7.2, containing b% bovine serum albumin and O.OlSí Na «zide (PBS/ 
B5A/NaN3). Subsequently 5-lOxlU6 cells were incubated with 200 μΐ 
PBS/BSA/NaN3 containing anti-mouse FxlA (100 jjg/ml), anti-mouse TAPron 
(100 jjg/ml), the eluate From rat kidneys (50 jjg/ml), or the eluate From 
mouse livers (50 jjg/ml) For 30 min at 4°C. AFter washing, the cells were 
incubated with 100 μΐ oF Fluorescein-labelled swine anti-rabbit Ig (dil. 
1:40) For 30 min at 4°C. The number oF positive cells was expressed as 
the percentage oF the total number oF cells analysed. Normal rabbit Igs 
replacing the antisera and eluates in the First step oF the incubations 
and the swine anti-rabbit Ig alone were included as controls. 
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TABLE I ORGAN DISTRIBUTION OF THE HEYMANN ANTIGENS 

















Brain + + 
fine granules along capillary wall 
basis of villi of BB 
AP 
AP 
fine granules in alveolar cells, type II 
fine granules in basal cells of ciliary body 
AP 
AP 
fine granules in endocrine cells 
AP of ductules; acini negative 
AP of ductules; acini negative 
fine granules in outer cells of lobules 
fine granules in outer cells of lobules 
AP; on some coelomic epithelia 
AP, focal 
AP, focal 
AP, on some ependym cells; choroid negative 
a
 Detected in the indirect immunofluorescence technique with a kidney eluete of rats 
previously injected with rabbit anti-mouse TAPron serum 
b All other organs examined are negative 
c
 BB= brush border of the proximal tubules; AP= apical parts of the epithelium 
RESULTS 
The two eluates have been used in previous studies and have been charac-
terized by immunoprecipitation analysis on radiolabelled brush borders. 
The eluate from rat kidneys precipitated a single protein that comiqrated 
with a protein bound by a monoclonal antibody to the gp-330. The mouse 
liver eluate predominantly bound to the gp-9Û comigrating with a protein 
immunoprecipitated by a monoclonal antibody to the gp-90 protein (Assmann 
et al. 1985, and submitted for publication). 
In vitro incubations of eluted antibodies from rat kidneys. The antigen 
against the rat eluate was abundantly present in the brush borders of the 
proximal tubular epithelia of both the mouse and the rat kidney and 
furthermore at discrete sites along the glomerular capillary wall of the 
rat, but not of the mouse (Figures 1A and 2A). Outside the kidney the 
antigen was present in several organs as summarized in table I. In both 
animals the type II alveolar cells in the corners of the alveolar septa 
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Fig. 1. Indirect immunofluorescence on cryostat sections of normal mouse tissues 
incubated with rat kidney eluate. A. Kidney; only binding is seen to the brush borders of 
proximal tubules and glomerular parietal cells. Glomerulus is negative. x512. B. 
Placenta; strong binding to the yolk sac epithelium. x256. C. Binding to apical parts of 
epithelia of Harderian gland. x512. D. Fine granules in epithelia of preputial gland. 
x4Q3. 
Fig. 2. Binding of rat kidney eluate to normal rat tissues. A. Kidney; fine granules 
along the capillary wall and strong staining of the brush borders of proximal tubules. 
x312. B. Thyroid; apical part of endocrine epithelium. x512. С Parathyroid; slight 
granular staining of the endocrine cells, x512. D. Lung; only binding to the type II 
alveolar cells. x512. E. Epididymis; apical part of epithelium is stained. x512. F. 
Oviduct; apical part of epithelium. xî>12. G. Uterine epithelium is positive- x512. H. 
Coelomic epithelium. X512. I. Epithelium of the ciliary body in the eye. x512. 3. 
Epithelium of ductules of the parotid gland; apical part is stained. x512. K. Epithelium 
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homogeneous along capillary wall 
BB diffusely stained 
AP of convoluted part 
superficial epithella 
E pos. 
AP and BP 
AP and BP; faint staining of contents 
AP and BP 
around epithella 
E of CC in rat strongly pos. 
theca cells of nping follicles 
AP 
AP 
superficial layer of epithelia 
superficial layer of epithella 
some glandular cells 
decreasing intensity toward distal end 
AP 
AP of lumen and crypts in mouse; 
Gall bladder + 
Liver sinusoidal lining cells ++ 
hepatocytes + 
biliary epithelium ++++ 
Peritoneum ++-M-
in rat only crypts 
AP 
only part of cell facing sinus 
Cardiovascular and pulmonary systea 




Trachea surface epithelium 
gland 
Lung bronchial epithelium 
alveolar epithelium 
pleura 
in almost all organs; 




diffuse along with E 
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TABLE II ORGAN DISTRIBUTION OF THE gp-90 PROTEINS (CONTINUED) 
Organh Mouse Rat Commentsc 























+/++ -/* АР 
* - fine staining endocrine cells 
+ + AP 
++ +++ AP 
± * diffuse staining of some endocrine cells 
++ ++ AP 
+++ +++ AP 
++ ++ AP ductal epithelia; faint staining acini 
+ + AP ductal epithelia; faint staining acini 
in mice prominent staining E 
membrane bound staining of thymocytes 
some cells with fine granular staining 
membrane bound staining 
sinus endothelium; faint staining of 
stroma cells 
membrane bound staining of follicle cells 
media of some arteries (in mouse) 









+/- outer cells 
+ in connective tissue of many organs; 
organ capsules 
+/- outer squamous epithelium; Descemet's 
membrane; F 
Hardenen gland AP irregularly 
a
 detected by mouse liver eluate in the indirect immunofluorescence technique 
Ь BB = brush border; AP = apical parts of epithelium; BP = basal parts of epithelium; CC 
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Fig. 3. Indirect immunofluorescence on frozen sections of normal mouse tissues incubated 
with mouse liver eluate, A. Glomerulus and brush borders of proximal tubules are 
stained. x5i2, B. Liver with positive canalicoli and sinuses. хЫ2. С. Brush border of 
the small intestine. x2b6. D. Homogeneous staining of the alveolar septa of the lung. 
xbl2. E. Heavy staining of the apical part of the epididymal epithelium; also granules in 
the basal parts of the cell. x312. F. York sac epithelium with strong apical staining. 
x256. G. Heart; Endocardium (arrow) and capillary endothelium. x256. H. Strong positivity 
of the capillary endothelium in the brain. x512. 1. Harderian gland; apical part of the 
epithelium and capillary endothelium (arrow) are positive. x512. J. Cell membrane 
staining of cortical thymocytes. x512. K. Cornea; stroma cells and superficial epithelia 
show fluorescence. хЫ2. L. Thyroid; apical part of epithelium and capillary endothelium 
are positive. x312. M. Parotid gland; acinar and ductular epithelia show apical 
staining. хЯ2. N. Prostate; predominant apical staining of epithelium, faint basal 
fluorescence. x2i6. 0. Ovary; theca cells (arrow) and some stroma cells. хЯ2. P. 
Uviduct; strong apical staining of epithelia. Also some stroma cells. x256. Q. Apical 
staining of uterine epithelium. Some stroma cells are also positive. x256. 
of the lung, the apical parts of the epithelia of the epididymis, 
thyroid, ductules of the lacrimal gland, visceral yolk sac, and some 
ependym cells of the ventricles of the brain contained the antigen in 
varying degrees (Figures 1 and 2). Fine granules could also be observed 
in the endocrine cells of the parathyroid and especially in the basal 
epithelia of the ciliary body in the eye (Figure 2). Some organs showed 
however a species specific localization. In the mouse the epithelia of 
the Harderian gland, a sebaceous-like gland situated behind the eye, and 
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the outer c e l l s in the lobules of the preput ia l and c l i t o r i c glands 
revealed the antigen (Figures 1С and D). On the other hand, only in the 
rat the antigen was present in the ductules of the parotid gland and, 
i r r e g u l a r l y , in the coelomic, oviduct, and on the uterine epithelium 
(Figures 2F,G,H, and J ) . A l l other organs of both animals were negative, 
p a r t i c u l a r l y the spleen, thymus, lymph nodes, heart, l i v e r , small intes­
t i n e , pancreas, and acinar c e l l s of the lacrimal and sal ivary glands. 
Although in single c e l l suspensions the majority of thymocytes, spleen 
c e l l s , and PBLs showed posi t ive staining with the unseparated ant isera, 
the results of incubations with the rat eluate were completely negative 
(Table I I I ) . A l l control incubations were negative. 
In v i t r o incubations of eluted antibodies from mouse l i v e r s . As shown in 
table I I we found a widespread organ d i s t r i b u t i o n of the antigen in both 
F i g . 4 . I n d i r e c t immunofluorescence on normal rat t issues w i t h mouse l i v e r e l u a t e . A. 
Kidney; glomerulus, brush borders of proximal tubules, and apical parts of d i s t a l 
convoluted tubules (arrow) are p o s i t i v e . x236. B. Sinus endothelium of the adrenal 
gland. х Я 2 . С. Capi l lary endothelium of the heart . x512. 0. Spleen; sinus endothelium 
and some stroma c e l l s are p o s i t i v e . Also the peritoneum (arrow) i s s ta ined. x256. 
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the mouse and the rat. Differences between the two animals were generally 
quantitative, the mouse showing a more prominent expression of the 
antigen in most tissues. The most common binding site was the endothelium 
of the capillary bed of almost all organs examined. Occasionally 
endothelial cells of arterioles also showed a faint staining (Figures 
3B,D,H, and I; Figures 4B,C, and D). Differences in staining intensities 
in individual organs of the same species and interspecies variations were 
observed. In the mouse, the most intense staining was found in the 
endothelial cells of brain, liver, muscle, and thyroid, whereas m the 
rat the endothelial cells of liver, adrenal, thyroid, heart, spleen, 
muscle, and corpora cavernosa of the penis were highly positive. Several 
parts of the kidney contain the antigen as previously described (Assmann 
et al. 1985). A homogeneous staining along the glomerular capillary wall 
of the mouse, and to a lesser degree of the rat was seen, while the brush 
borders of the proximal tubules were heavily stained in both animals 
(Figures ЗА and 4A). The loops of Henle and to a lesser extent the apical 
parts of the convoluted distal tubules showed the presence of the antigen 
particularly in the rat. In the lung a more diffuse fluorescence was 
visible along the alveolar septa (Figure 3D). A prominent staining was 
seen in the cells lining the cavities and in cells in the capsule of 
several organs (Figure 3G). Furthermore, as is listed in table II, many 
epithelia in different organs contained the antigen in varying densities 
where it was located mostly in the apical part of the cells (Figures ЗА, 
В,С,E,F,I,L,Μ,Ν,Ρ, and Q). In connective tissues, for instance the stroma 
of ovary, oviduct, and uterus, there was a faint to moderate staining of 
fibroblasts and some other unidentified cells (Figures 30 and Q). Thymo­
cytes in the cortex of the thymus (Figure 33) and lymphocytes in the 
TABLE III INCUBATIONS OF SUSPENSIONS OF THYMUS, SPLEEN, AND PBLa OF MOUSE AND RAT WITH 
ANTISERA AND ELUATES 
Percentage of positive cellsa 
Antiserumb 
Thymus Spleen PBLsc 
Mouse Rat Mouse Rat Mouse Rat 
RaM.FxlA 62 d 80 d 66 74 Bb 85 
RaM.TAPron BO BO B6 84 91 B7 
R.eluate - - - - -
M.eluate 70 85 83 39 90 72 
a
 Expressed as the percentage of 300-400 cells analysed. 
Ь RaM.FxlA = rabbit anti-mouse FxlA; RaM.TAPron = rabbit anti-mouse TAPronj R.eluate and 
M.eluate = eluates from kidneys of rats and livers of mice previously injected with 
RaM.TAPron 
c
 PBLs = peripheral blood lymphocytes 
d Intensity of staining of RaM.FxlA was weak on thymocytes. 
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follicles of the spleen and lymph nodes demonstrated a cell membrane 
bound fluorescence. Examination of suspensions of the thymus, spleen, and 
PBLs of the mouse and the rat revealed that the majority of cells was 
positive as listed in table III. All control incubations were negative. 
DISCUSSION 
The microvillous fraction of the brush borders of the renal proximal 
tubules, the starting material for the preparation of our antisera, 
contains numerous proteins, many of which are cell membrane-bound (Kenny 
and Maroux 1982). Two proteins, gp-330 and gp-90 are reported to play a 
crucial role in evoking a membranous glomerulonephritis in the rat 
(Heymann et al. 19Ь9; Barabas et al. 1970; Feenstra et al. IST?; 
Kerjaschki and Farquhar 19Θ2, 19B3), and in the mouse respectively 
(Assmann et al. 1983, 1984). By preparing eluates from kidneys of rats 
and livers of mice injected with anti-mouse TAPron antiserum we have 
demonstrated that this antiserum actually contains antibodies against 
both specificities (Assmann et al. 1984, 1985, and submitted for publica­
tion). With these eluates, previously characterized by immunoprecipita-
tion analysis and used for studying the distribution of the antigens in 
the kidney, we could now examine the extrarenal distribution by indirect 
immunofluorescence in both the mouse and the rat. 
Earlier studies on the extrarenal distribution of brush border antigens 
in rats by means of indirect immunofluorescence were done with less well-
defined antisere against the crude FxlA fraction (Linder 1969; Miettinen 
and Linder 1976; Chant and Silverman 1978; Bakker et al. 1979; Naruse 
1981; Makker and Singh 1983). In later studies with eluates from kidneys 
of rats with active or passive Heymann nephritis only a restricted number 
of organs were examined and the results were conflicting (Chant et el. 
1980; Miettinen et al. 1984). In recent studies in which the extrarenal 
localization of the Heymann antigen was examined by monoclonal antibodies 
directed to the gp-330 protein, only four organs were found to contain 
the antigen. It was concentrated in coated pits in the epithelium of the 
epididymis, visceral yolk sac, hepatocytes, and brush border of the small 
intestine (Doxsey et al, 1983; Kerjaschki and Farquhar 1985). Ronco et al 
(1984b) who also used monoclonal antibodies described additional locali­
zations in cells of the elveolar septa of the lung. The results suggest 
that the Heymenn antigen is not very widely expressed outside the kidney. 
On the basis of our study with the rat eluate we can now add some organs 
of both mouse and rat in which the Heymann antigen is present. Besides 
the kidney, epididymis, lung and visceral yolk sac, we could locate the 
antigen in several glandular epithelia and some cells with known reab-
sorptive capacities. Although the antigen showed in general a similar 
localization in both species, a few disparities were observed as 
indicated in table I. 
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Studies of Bakker et al (1979) have suggested that the Heymann antigen is 
also present on thymocytes and other lymphoid cells. Our studies with the 
rat eluate did not confirm this. However, since we found positive reac-
tions with both the unseparated sera and the mouse liver eluate, it seems 
most likely that the positive findings of the abovementioned authors were 
caused by the presence of anti gp-90 antibodies in their sera. Contamina-
tion with gp-90 antibodies is probably also the explanation for the 
apparently widespread distribution of the Heymann antigen recently 
described by Singh and Makker (1985) who used a "monospecific" antiserum 
against gp-600. Actually these authors also identified antibodies against 
gp-9ü in their serum, but they considered this protein to be a breakdown 
product of gp-600. Our results suggest that this conclusion is not 
justified and that gp-90 is an antigen completely different from the 
Heymann antigen. Our inability to detect the antigen in the liver and the 
small intestine is more difficult to explain in the light of the positive 
findings with monoclonal antibodies. Comparison of the eluate with mono-
clonal antibodies under otherwise similar test conditions will be neces-
sary to resolve these discrepancies. 
The eluate from the mouse liver revealed a much more widespread distribu-
tion of the corresponding antigen than the gp-330 protein. One of the 
most common and prominent sites was the endothelium of the capillaries, 
although quantitative differences between the two species and between 
various organs within the same animal were observed. Apart from the 
reported occurrence of the antigen in normal kidneys, many epithelia in 
glands,, liver canaliculi, brush borders of the small intestine, and 
crypts of the small and large intestine, cells covering or lining the 
organs and cavities, as well as thymocytes, lymphocytes, and stroma cells 
were positive. The expression corresponds with the localization of the 
gp-90 protein as detected with a monoclonal antibody for some organs by 
Ronco et al. (1984e, 1984b). At this moment the nature and function of 
this antigen is unknown. The widespread distribution of the antigen in 
the cell membranes of many cells with apparently different functions 
closely resembles that of several hydrolytic enzymes, e.g. aminopeptidase 
A or angiotensinase A, and dipeptidyl peptidase IV. These enzymes form a 
major group of cell membrane bound proteins in the renal tubular brush 
borders (Gossrau 1979; Lojda and Gossrau 1980; Fukasawa et al. 1981). 
Future studies will hopefully reveal whether this protein is a cell 
membrane bound proteinase or a molecule with completely different 
function. 
The differences in kinetics of the anti gp-90 and anti gp-330 specifici-
ties after administration of the anti-mouse TAPron antibodies, can be 
explained to a large extent by the different localization of the respec-
tive target proteins (Assmann et al. 1983, 1985). The widespread occur-
rence and the easy accessibility of the gp-90, notably on the endothelial 
cells of the capillary bed, account for the prompt binding of the 
specific antibodies and its rapid disappearance from the circulation 
after injection into the mouse. We have actually observed a rapid fixa-
tion to the capillary endothelium of particularly the liver and the lung 
with a quick disappearance of the antibodies from the blood stream. In 
rats the same was seen by Ronco et al (1984a) after intravenous adminis-
tration of monoclonal antibodies directed against gp-90. Paired label 
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studies showed that most of the injected antibodies fixed to the lung and 
the liver, and only small amounts to the kidney. On the other hand, a 
slow and gradual binding takes place to gp-330 in the rat glomerulus 
during several days after injection of anti-mouse TAPron antibodies, 
while circulating antibodies to gp-330 remain detectable for almost a 
week (unpublished observation). These results are in agreement with the 
more elaborate studies of Salant et al. (19B0). The specific localization 
of gp-330 along with factors determining the permeability of the 
glomerular capillary wall may account for the characteristic kinetics in 
the PHN of rats. 
In spite of the fact that many organs contain the Heymann antigen, active 
Heymann nephritis in rats can only be induced with rat kidney prepara-
tions. Therefore it is assumed that only this organ possesses the nephri-
togenic antigen (Naruse, 1980; Miettinen et al. 1984; Heymann et al 1971, 
19^9; Fleuren et al. 1980; Klassen et al. 1971; Sugisaki et al. 1973). A 
report by Naruse (1981) of the successful induction of active Heymann 
nephritis with liver and lung tissues has not been confirmed by others 
(Miettinen et al. 1984; Fleuren et al. 1980; Sugisaki et al. 1973). Immu-
nization of rats with suspensions of epididymis containing the Heymann 
antigen, was also not successful (Miettinen et al. 1984). It is yet 
unknown why renal tissue is such a superior material for the induction of 
active Heymann nephritis. The antigen concentration and epitope densities 
of the gp-330 might be important factors. 
The induction of a passive Heymann nephritis with heterologous antisera 
against non-renal tissues has been examined far less extensively. 
Antisera directed to liver and small intestine gave negative results 
(Miettinen et al. 1984). Bakker et al (1979, 1980) found that antisera 
against rat thymocytes, fixed homogeneously to the glomerular wall after 
injection in rats. However, as discussed above their binding is probably 
related to the presence of gp-90, both on thymocytes and in rat 
glomeruli, and not to the Heymann antigen. Also the homogeneous 
glomerular pattern which they described fits in better with the diffuse 
distribution of gp-90 than with the discrete pattern that is always found 
for gp-330. 
In conclusion, the antigen that we have identified and that is involved 
in the membranous glomerulonephritis of the mouse is different from the 
Heymann antigen and has a much more widespread tissue distribution. Like 
the Heymann antigen, its normal physiologic function is unknown. It is 
also not clear whether its involvement in membranous glomerulonephritis 
is limited to the mouse or extends to the rat or even other species. 
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Summary. Highly reproducible anti glomerular basement membrane 
(GBM) nephritis has been induced in the mouse after a single injection 
of rabbit or goat antibody against purified homologous GBM. The sever-
ity of albuminuria was closely related to the amount of antibody given. 
With doses of 4 mg or more, low serum albumin concentrations, some-
times accompanied by ascites and oedema, were observed after 1 week. 
Glomerular injury was characterized by an initial accumulation of poly-
morphonuclear granulocytes followed by thrombosis and necrosis, the 
extent of which defined the outcome of the glomerulonephritis. With 
high doses of antibody the exudative lesions entered a chronic phase, 
while at doses lower than 2 mg remission of the lesions occurred. Immun-
ofluorescence studies showed prompt linear fixation of the injected anti-
bodies to the glomerular capillary wall, accompanied by immediate bind-
ing of C3 in a fine granular pattern. Fibrin deposits appeared at 2 h 
in some glomeruli, increased thereafter, and were present after one day 
in more than 90% of the glomeruli in mice that had received 4 mg 
of antibody. This new reproducible model in the mouse is suited for 
the study of the relationship between activation of mediator systems, 
histological lesions, and proteinuria 
Key words: Anti-GBM nephritis - Complement - Polymorphonuclear 
granulocytes - Mouse 
Introduction 
One of the first experimental models in which immunological pathways 
of glomerular injury were studied was the anti-glomerular basement mem-
brane (GBM) nephritis or nephrotoxic nephritis, originally described by 
Masugi et al. (1932), and induced by the injection of antibodies against 
antigens from the GBM. The disease has been most extensively studied 
in the rabbit and the rat, because the lesions induced in these species proved 
Offprint requests to K.J.M. Assmann at the above address 
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to be highly reproducible Two distinct phases can be identified The first 
socallcd heterologous phase is the result of a rapid fixation of the injected 
antibodies to the glomerular wall Concomitantly with morphological chan-
ges an immediate proteinuria can occur, the severity of which depends on 
the amount of antibody given The second or autologous phase is character-
ized by the immune response of the host to the heterologous antibodies. 
Binding of these antibodies to the heterologous proteins already present 
in the glomerulus leads to an exacerbation of the disease. The glomerular 
changes in both phases arc variable and depend on the animal species, 
source and amount of administered antibodies, and the intensity of the 
immune response of the host The anti-GBM nephritis of the rabbit, for 
instance, is usually characterized by transient proliferative alterations, but 
seldom enters a chronic phase However, a chronic glomerulonephritis fre-
quently develops in the rat, despite mild, predominantly exudative lesions 
during the heterologous phase (Kondo and Shigematsu 1980, Unanue and 
Dixon 1967) 
The mouse would be an attractive model to study this disease, because 
so much is known of its immunogenetic background Unfortunately, only 
a few detailed studies have been carried out in this species, mainly because 
it is difficult to induce lesions in the heterologous phase in the absence 
of reproducible changes in the autologous phase (Douglas et al 1969, Nagai 
et al 1982, Nishihara étal 1981, Okada étal 1982, Russell étal 1969; 
Unanue étal. 1967) Proteinuria and morphological lesions usually devel-
oped only several days after injection of the nephrotoxic antibodies, in 
most cases probably as part of the autologous phase Unanue et al. in one 
of the most extensive reports of this model in mice, did not observe a 
correlation between the amount of antibodies injected and the severity and 
time of appearance of the proteinuria (Unanue et al 1967) A chronic glo-
merulonephritis characterized by thrombotic lesions slowly developed in 
the autologous phase and was sometimes accompanied by proteinuria, as-
cites, and renal insufficiency The severity of the nephritis was strain-depen-
dent which was most probably caused by difference in the immune response 
of the host 
Only a few studies have been published in which brief mention is made 
of the induction of significant morphological lesions and immediate protein-
uria in mice in the heterologous phase after injection of anti-GBM anti-
bodies (Arana et al 1964, Blair et al 1965, Okada et al 1982, Russell et al 
1969) In this study we describe the heterologous phase of a highly reproduc-
ible anti-GBM nephritis in a mouse strain, evoked by intravenous injection 
of antibodies against homologous GBM The seventy of the immediate 
proteinuria and of the morphological changes depended on the amount 
of antibody injected. 
Materials and methods 
Animals Swiss mice, randomly bred, were bought from the Central Institute for the breeding 
of Idboralory animals, TNO, Zeist, The Netherlands The inbred strain of C57BI 10 mice 
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was originally obtained from the Jackson Laboratory, Bar Harbor, Maine, USA. and was 
kept by continuous brother-sister matings New Zealand white rabbits and goats were bought 
from a local breeder 
Antigens. Mouse basement membranes were prepared from Swiss mouse kidneys by a differen­
tial sieve technique, followed by somcation and detergent treatment as previously described 
(Assmannet al 1983). The resulting preparation of basement membranes was designated GBM 
TBM, because the glomerular basement membranes were contaminated with tubular segments 
GBM/TBM was washed extensively in distilled water, lyophili^ed, and stored at —30° С 
Antisera Two adult male rabbits were initially immunized with 1 mg GBM IBM. emulsified 
in complete Freund's adjuvant (CFA. Difco Laboratory. Detroit, Ml, USA) at multiple subcu­
taneous sites Four and six weeks later subcutaneous booster injections ofO 2 and I mg respec­
tively were given, and the animals were bled 10 days later A goat was immunized by the 
same procedure The pooled antisera were heated at 56° С for 45 mm and IgG fractions 
were prepared from a 50% ammonium sulphate precipitate After dialysis against PBS. (pH 7 2) 
the rabbit antibody was further purified by affinity chromatography on a Sepharose-4B coupled 
protem-A column (Pharmacia, Uppsala, Sweden). The purified IgG antibodies were concen­
trated to 20 mg ml by ullrafillralion with a XM-50 Diaflow membrane (Amicon Corporation, 
Scientific System Division, Lexington, Massachusetts), sterilized by passage through a sterile 
0.2-цт filler and stored at — 30° C. Rabbit and goat IgG from non-immuni/ed animals were 
obtained by the same procedure and used for the control studies. Analysis of purity and 
specificity was carried out by micro-Ouchtcrlony and Immunoelectrophoresis in 1 3% agarose 
(Ouchlerlony and Nilsson 1978) Protein concentrations were measured by the method of 
Lowry or by the radial immunodiffusion technique (Lowry et al 1951, Mancini et al 1965). 
The antibody specificity was tested by indirect immunofluorescence on normal mouse kidneys 
and by absorptions of the antiserum with mouse GBM TBM (5 mg GBM TBM per ml of 
antiserum). 
An antiserum against mouse albumin raised in a goat was prepared according to our 
previously described method (Assmann et al 1983) Λ 50% ammonium sulphate precipitate 
of this antiserum was used in the radial immunodiffusion technique for the determination 
of urinary albumin concentration. 
Experimental protocol 
Experiment A Two groups of 7 female C57BI 10 mice received 8 mg of rabbit or goat antibody 
Albuminuria was measured at days 0, 1,. 2. 3, 4, and 8 Thereafter a dose response study 
was done in other groups of 7 mice that received increasing amounts of goat antibody Albumin­
uria was dclermmcd at days 0, 1, and 8 Kidneys were processed for light microscopy and 
immunofluorescence at the lime of killing. 
Experiment В Two groups of 21 female C57BI,'10 mice were injected with 1 and 4 mg of 
goat anti-mouse GBM antibodies and 3 mice were sacrificed at selected intervals 15 mm, 
1, 2, and 6 hours, days 1, 4, and 8 Parts of their kidneys were processed for light microscopy. 
immunofluorescence, and electronmicroscopy, and scrum was stored for determination of albu­
min and urea concentrations. At days 0, 1, 4, and 8, urine was collected during 18 h for 
the determination of albuminuria, while during the first day albumin concentration was mea­
sured in samples obtained by bladder puncture. Two other groups of 21 female C57B1,10 
mice, that received 1 or 4 mg of non-immune goat Ig. served as controls. At each interval 
3 mice were sacrificed and examined according to the same procedures. 
Tissue processing 
Light- and electronmicroscopy. The fixation and staining techniques have been previously de­
scribed (Assmann et al. 1983). The number of polymorphonuclear granulocytes (PMNs) were 
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counted in 40 glomeruli of each mouse. The average counts per glomerulus of 3 mice are 
reported. 
Immunofluorescence For the direct immunofluorescence techniques, tissue fragments were snap 
frozen in liquid nitrogen and in 2 μτη sections cut in a cryostat We used monospecific, fluorcsce-
m-labelled goat anti-mouse IgG (heavy and light chains) and C3 (Cappell Laboratories, Down-
ingtown, Pennsylvania, USA) rabbit anti-human fibrinogen that cross-reacted strongly with 
mouse fibrinogen, swine anti-rabbit lg (Dakopatt, Copenhagen, Denmark) and rabbit anti-goal 
Ig (Nordic, Tilburg, The Netherlands) The antisera against rabbit and goat Ig were also 
used as a second layer in the indirect immunofluorescence technique, and absorbed with 
500 mg'ml lyophili7ed non-immune mouse serum. The staining intensity and quantity of the 
immune reaclants were recorded semiquanlitatively (0 = negative, 1 + = moderate, 2+ = rela­
tively strong, 3+ = strong, 4 + = maximum intensity) and the patterns classified as mesangial, 
GBM'TBM, and granular or linear Sections were examined in a Leilz fluorescence microscope 
with a Ploemopac epi-illumination 
Other procedures 
Albuminuria, as an index of glomerular protein leakage, was measured by radial immunodiffu­
sion on 18-h urine samples obtained in metabolic cages (Hoffstcn et al. 1975). During the 
urine collections only tap water was provided ad libitum. Of 46 normal female С57ВГ10 
mice, the mean albuminuria determined over this period was 22 μg + SD 33 Pathological albu­
minuria was defined as a value greater than the normal mean plus two standard deviations 
Albumin concentration in the serum was assayed by the bromecresol-green method (Doumas 
et al. 1971). Blood urea was measured by use of the CoBasBio Autoanalyzer (Roche, Basel, 
Switzerland) 
Results 
Clinical and laboratory findings 
The mice showed no untoward systemic reactions immediately after the 
intravenous injection of 8 mg of rabbit or goat antibody. However, albumin­
uria developed after injection with peak values at day i (Fig. 1). All animals 
became seriously ill during the subsequent days and some mice died of 
renal failure. The surviving mice were sacrificed at day 8. At that time 
they had low concentrations of serum albumin (18 + 4 g/L, η = 5, normal 
value 33.3+ 1.6 g/L), sometimes accompanied by ascites and foot pad swell­
ing. None of the mice that received lower doses of antibody died of renal 
insufficiency. The results of the dose response study with goat-anti GBM 
antibody are depicted in Fig. 2. They show a correlation between the quan­
tity of goat Ig injected and the degree of albuminuria both at day 1 and 
day 8. A transient albuminuria was found after administration of 0.4 mg, 
while a plateau was reached with 4 mg or more. Albuminuria did not de­
crease to normal values after 8 days if more than 0.5 mg of antibody had 
been administered. Measurements in two urine samples, obtained by bladder 
puncture at the time of killing, 6 h after antibody injection, yielded albumin 
concentrations as high as 5.8 + 3.9 mg/ml (1 mg group) and 25 + 20.2 mg/ml 
(4 mg group), while in the first 2 h the albumin concentrations remained 
normal, not exceeding the amount of 45 μg/ml. Mice injected with 4 mg 
of normal goat Ig demonstrated amounts of albumin excretion just above 
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Fig. I. Albuminuria (mg albumin 
excreted during 18 hours) after 
administration of 8 mg of rabbit-
(o - —o) , or goat anti-mouse GBM 
antibodies ( · — · ) Each point 
represents the mean -(-SEM of 7 
animals 
7 8 
T I M E ( D A Y S ! 
Fig. 2. Dose dependency of 
albuminuria (mg albumin excreted 
during 18 hours) Albuminuria is 
measured on day 1 (o o), 
and day 8 ( · · ) Shaded area 
represents the physiological range 
of albuminuria in this mouse 
strain Each point represents the 
mean +SD of 7 animals 
DOSE OF GaMGBMImfl GOAT Ig) 
the upper limit of physiological albuminuria, while no pathological albumin-
uria was seen after administration of 1 mg of goat Ig. 
The albumin concentration in serum slightly decreased in all mice imme-
diately after injection of antibody as well as control Ig, but it rose to normal 
values at the end of the experiment in all groups, except in the one injected 
with 4 mg of antibody. This group showed a gradual reduction of the albu-
min concentration to one third of the normal range (Table 1). These mice 
also had raised concentrations of urea from the first day on. 
Morphological changes 
Light microscopy. The extent of the morphological changes were also related 
to the amount of the antibody administered. No distinct changes were pres-
sa 
Tabic I. Albumin and urea conccnlrjlions in scrum dfler injection of 1 and 4 mg of goat 




















Albumin (g 1) 
Experiment 
280 + 2 0 
28 7 + 1 5 
283 + 2 1 
28 7 + 1 2 
30 3 + 2 1 
320 + 0 0 
340 + 0 0 
233 + 0 6 
245 + 0 7 
2 5 0 + 1 0 
24 3 + 0 6 
197 + 3 5 
177 + 2 5 
Π 3 + 2 5 
Control 
26 3 + 0 6 
2 7 0 + 1 0 
24 7 + 1 5 
27 3 + 1 5 
34 3 + 1 5 
2 8 7 + 0 6 
3 2 0 + - b 
24 0 + 1 0 
235 + 0 7 
245 + 2 1 
2 7 0 + 1 0 
287 + 0 6 
30 3 + 3 0 
31 7 + 0 6 
Urea (mmol 1) 
[ xpenment 
6 4 + 0 1 
7 9 + 2 2 
5 7 + 1 2 
108 + 0 5 
144 + 2 2 
139 + 2 3 
125 + 0 6 
8 2 + 10 
7 9 + 1 8 
7 9 + 0 6 
1 2 0 + 1 2 
328 + 108 
43 6 + 2 5 8 
43 2 + 3 9 
Control 
8 7 + 2 0 
6 5 + 1 4 
5 4 + 1 2 
11 1 + 0 4 
125 + 1 0 
150 + 4 5 
1 0 7 + - " 
1 0 4 + 1 0 
11 0 + 2 0 
6 0 + 1 1 
9 3 + 10 
128 + 2 1 
11 8 + 1 8 
9 7 + 0 2 
" Means + S D of 3 observations each Normal albumin concentration 33 3 + 1 6 g liter 
normal una concentration 110 + 14 mmol 1 
b
 Single observation 
TIME HOURS^vOAYS 
Fig. 3. Number of polymorphonuclear granulocytes (PMNs) per glomerulus after administra­
tion of 1 mg {open barf) and 4 mg (shaded bars) of goat anti-mouse GBM antibodies Black 
areas in the bars represent control numbers after injection of 1 and 4 mg of normal goat 
Ig Number of PMNs were counted in 40 glomeruli of each mouse The a\cragc counts per 
glomerulus of 3 mice are reported 
ent within 15 mm following the injection of 1 or 4 mg of antibody PMNs 
appeared in the glomerular lumina in small numbers at 1 h, were most 
prominent at 2 h, dropped considerably at 6 h, and remained at normal 
levels during the subsequent days (Fig 3) An increase in monocytes was 
not observed After administration of 4 mg of antiserum, focal and segmen-
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Fig. 4A, В. Histological changes after injection of 4 mg goat anti-GBM. A Extensive intravas­
cular coagulation in the glomerulus at day 1. В Progressive glomerulonephritis at day 15. 
Increase of mesangial cells and matrix in the glomerulus with swelling of the endothelia cells. 
Adhesions to the Bowman's capsule are present with an increase of epithelial cells. Tubular 
epithelia are swollen of flattened and some casts fill the lumina, χ 380 
Fig. 5 Α-C. Immunofluorescence findings 
after injection of 4 mg of goat anti-
mouse GBM antibodies. 
A The injected goat immunoglobulins 
bound immediately to the glomerular 
capillary wall in a linear pattern. 
В Mouse complement at 2 h is seen 
along the capillary wall predominantly in 
a fine granular pattern. The segmental 
staining of Bowman's capsule and the 
tubular basement membranes is a normal 
finding in mice. 
С Extensive fibrin deposits are seen at 
6 h x480 
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Table 2. Immunofluorescence findings Deposition of immune reaclanls in the glomerular capil­
lary wall after injection of 4 mg of goat anti mouse GBM antibodies 
Goat Ig" 
+ + + + L 
+ + + + 
+ + + + 
+ + + + 
+ + + + 
+ + + + 










+ + G 











+ + + 
+ + + 
+ + 
" Three mice were killed at each lime 
ь
 (L) linear and (G) granular staining of the glomerular capillary wall 
c
 Small amounts of mouse Ig and C3 in the mesangium being a normal finding in this mouse 
strain, are not listed 
л
 Predominantly fine granular deposits in the capillary wall 
tal glomerular thrombosis and swelling of endothelial cells could be seen 
coinciding with the peak value of PMNs at 2 h Thereafter, many glomeruli 
showed segmental or global thrombosis, leading to overt necrosis (Fig 4 A) 
From day 1 on, the tubules contained many homogeneous or granular 
casts, while the tubular epithelial cells were swollen, flattened or focally 
necrotic Eight days after administration of the antiserum a marked swelling 
of epithelial and endothelial cells, and a slight increase of mesangial cells 
were still present along with thrombosis and necrotic lesions The GBM 
looked fluffy, irregular or showed occasional splitting with a few adhesions 
to Bowman's capsule Mice receiving 1 mg of antiserum initially showed 
comparable, but less extensive lesions of the glomeruli At day 8 the exuda­
tive lesions were notably reduced Mice given 1 or 2 mg of antiserum and 
sacrificed at day 15, demonstrated an almost normal morphology, while 
higher doses had caused a progressive glomerulonephritis at that time 
(Fig 4B) 
Immunofluorescence ( Table 2) A rapid linear fixation of goat Ig was ob­
served along the glomerular capillary wall after injection of 4 mg of antibody 
(Fig 5 A) Immediate binding of C3 to the capillary wall could also be 
seen However the pattern was more fine granular although it was sometimes 
difficult to distinguish it from a faint linear pattern (Fig 5 B) The binding 
of C3 became weak or hardly visible at day 4 and had increased again 
to a weak linear pattern on day 8, concomitant with the appearance of 
mouse Ig Focal and segmental deposits of fibrin were seen after 2 h along 
the capillary wall, as small trombi in the lumina, and in the mesangium 
The amount of fibrin increased considerably in the subsequent hours 
(Fig 5C), and it was present in more than 90% of the glomeruli at day 
1 Although most thrombi gradually disappeared, fibrin deposits generally 
did not tend to regress The proximal tubular epithelia contained granules 
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Fig. 6A, В. Ultrastructural findings 2 h after the injection of 4 mg of goat anti-mouse GBM 
antibody. A PMN inserts its cyloplasmic processes into the subendothelial space. В Platelets 
with granular material in a glomerular capillary loop close to the denuded basement membrane 
{arrow). A χ 16,420. Β χ 9,700 
of goat and mouse Ig from 6 h on, while C3 and fibrin predominantly 
stained the tubular casts after 1 day. Mice injected with 1 mg of goat Ig 
showed comparable immunofluorescence findings with only quantitative dif­
ferences. Fibrin deposits affecting about 50% of the glomeruli at day 1, 
demonstrated an enhanced clearing on day 8. No fibrin was seen with doses 
of 0.5 mg or less, despite a linear fixation of goat Ig. Mice of the control 
groups showed only small or trace amounts of mouse Ig and C3 in the 
mesangium, which is a normal finding in this mouse strain. 
Electronmicroscopy. The earliest change following the injection of 4 mg of 
antibody and preceding the highest influx of PMNs, was a slight and patchy 
swelling of the endothelium, especially of the attenuated layer at 1 h. Many 
PMNs present at 2 h in the glomerular capillary lumina, inserted their cyto­
plasmic processes into the subendothelial space or replaced the endothelium 
(Fig. 6 A). At the same time platelets in combination with granular material 
or strands of fibrin were observed in some glomerular segments mostly 
related to a strong swelling of the endothelium or a denuded basement 
membrane (Fig. 6B). The epithelial foot processes were partly fused in these 
areas. The lesions at 6 h were characterized by a decline of the number 
of PMNs and an increase of the platelet-fibrin thrombi along with a marked 
swelling and exfoliation or necrosis of the endothelium, and deposition of 
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Fig. 7. Ultrastructural changes six hours after the injection of 4 mg of goat anti-mouse GBM 
antibodies. Two capillary loops occluded by plateled-fibrin thrombi along with swollen or 
necrotic endotheha {arrows). The epithelia foot processes are partly fused, χ 5,800 
a fluffy or dense granular material in the subendothelial space, mesangium, 
and between swollen endothelia (Fig. 7). After 1 day these changes had 
largely increased with occlusion and collapse of many glomeruli, a slight 
increase of mesangial cells, and hypertrophy of the epithelium. At day 4 
many glomeruli showed global necrosis. On the other hand repair of the 
glomerular alterations was seen in the 1 mg group, marked on day 4 by 
disappearance of the platelets, cellular debris and by more patent capillary 
lumina, although some swelling of the endothelia and a widened subendothe­
lial space filled with granular material in it were still present at day 8. 
Mice of the control groups did not show changes. 
Discussion 
In this report we describe the induction of immediate morphological and 
functional alterations in a mouse strain after the administration of both 
a rabbit antiserum and a goat antiserum directed against purified mouse 
GBM/TBM material. Determination of albumin concentrations on urine 
samples from the bladder during the first hours after injection of the antise-
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rum, showed that already at 6 h severe albuminuria occured. A close correla-
tion was observed between the amount of albumin excreted m the urine 
during 18 h on day 1 and 8 after injection and the administered dose of 
goat antibodies Although we did not use the paired isotope labeling tech-
nique to quantify more precisely the amount of glomerular fixed antibodies 
to which an enhanced glomerular permeability can be related, our results 
indicate that a certain amount of antibody bound to the glomerular base-
ment membrane is essential to produce albuminuria and that with increasing 
doses of antibody a maximum of albuminuria is reached We measured 
albuminuria instead of total proteinuria as the hallmark of enhanced glomer-
ular permeability in mice, because many mouse strains have physiological 
proteinuria, the extent of which depends on the sex and age of the mice 
(Finlayson and Bauman 1958, Hoffslen ci al 1975) Furthermore, the 
amount of excreted albumin reflects the enhanced permeability caused by 
failure of the charge selective barrier of the glomerular capillary wall more 
precisely. This occurs, most probably, in the initial phase of the nephrotoxic 
nephritis (Cochrane et al 1965, Gang et al 1970, Kreisberg et al 1979) 
The induction of the first phase of the anti-GBM nephritis in mice was 
highly reproducible and appeared not to depend on the species in which 
the antibodies were raised With both rabbit and goat anti-mouse GBM 
antibodies an identical glomerular injury could be evoked Most attempts 
to induce clinical and morphological changes in the heterologous phase 
in mice mention inconsistent results as distinct from the highly reproducible 
anti-GBM nephritis in rats and rabbits A few attempts to induce of immedi-
ate glomerular injury in the mouse have been reported in abstract form 
(Arana et al 1964, Blair étal 1965) Most studies, although sometimes 
containing a description of short-lasting enhanced glomerular permeability 
in the first days, only focus on the clinical and morphological lesions of 
the autologous phase (Douglas et al. 1969, Lindberg and Rosenberg 1968, 
Nagai et al 1982, Okada et al 1982, Russell étal 1969) Unanue étal 
did not observe glomerular changes in the heterologous phase after adminis-
tration of an anti-mouse GBM antiserum (Unanue et al 1967) In a more 
recently published study morphological alterations in the glomeruli and 
ascites were seen after injection of a rabbit anti-rat GBM antiserum, but 
not after injection of anti-mouse GBM antibodies (Nishihara et al 1981) 
In another study glomerular injury after injection of a rabbit anti-mouse 
GBM antiserum was only observed in mice in which an accelerated autolo-
gous phase was induced by pre-immunization with normal rabbit Ig (Nagai 
et al 1982). 
The causes of these inconsistent results in mice are unknown. One of 
these could be the potency of the antiserum. In most reports antibodies 
were raised by injecting rabbits with kidney homogenates or sediments, 
while sometimes GBM material obtained by somcation was used We in-
jected rabbits and goats with mouse GBM rendered free from cellular rem-
nants by detergent treatment Houscr et al have shown that antisera against 
glomerular membranes, isolated by detergent extraction, detect many differ-
ent antigens located in site-specific arrays in and along the lamina densa 
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(Houser el al. 1982) It is possible that our way of preparing the antigenic 
fraction of the GBM leads toa more potent antiserum by eliciting antibodies 
against more antigenic determinants 
Lack of activation of one of the mediator systems in the mouse, such 
as complement, might be another cause for the variable findings during 
the heterologous phase This is suggested by the observations of Unanue 
who could not evoke glomerular injury in mice, but who could induce 
a classical anti-GBM nephritis with acute proteinuria and fixation of com-
plement to the glomerular capillary wall in rats with the same antiserum 
(Unanue et al. 1967) In our studies we saw fixation of mouse C3 in a 
fine granular pattern concomitant with a prompt linear fixation of goal 
immunoglobulins along the capillary wall This fixation of C3 was transient, 
reaching its maximum in the first 2-6 h These findings are in contrast 
to the results obtained in rats in which C3 did not disappear, but fixation 
even became more intense after a few days (Unanue et al. 1964) From 
studies in a model of acute antibody mediated rejection of skin grafts in 
the mouse, it is known that mouse skin allografts can be successfully des-
troyed by alloantibody only when at the same time heterologous comple-
ment, i.e., rabbit complement is administered (Koene et al 1973). Mouse 
endogenous complement is inefficient in this model and this correlates well 
with the low efficiency of this complement species in in vitro cytolytic sys-
tems (Berden et al 1978 a) Complement activation depended upon the de-
gree of histo-incompatibihty between donor and recipient, because mouse 
complement could be activated in a xenogeneic system, in which antigenic 
targets are more abundantly available for binding with the antibody (Balda-
mus et al 1973, Berden étal 1978b, Bogman étal 1982) Thus, mouse 
complement seems to be less easily activated and this might explain why 
induction of a heterologous phase of anti-GBM nephritis has proved to 
be difficult in the mouse in contrast to rats or rabbits 
Like the albuminuria, the morphological changes were also proportional 
to the amount of antibody given Besides the dose related accumulation 
of PMNs the most prominent feature after two hours was the deposition 
of fibrin along with the aggregation of platelets that ended in varying degrees 
of necrosis depending upon the amount of antiserum given. After a low 
dose of antiserum there was a tendency to recovery in the lesions, however 
a large amount of antibody caused irreversible damage to the glomeruli, 
with progression to a chronic glomerulonephritis At the highest amounts 
of antiserum given most of the mice became seriously ill and developed 
renal insufficiency, sometimes accompanied by an overt nephrotic syn-
drome The histological pictures seen in these mice and the outcome of 
the lesions resembled the Shwartzman reaction as it can occur in the hypera-
cute rejection of human kidney grafts (Starzl et al 1968). The heterologous 
phase of the anti-GBM nephritis in rats is also characterized by exsudative 
lesions, but generally a recovery takes place within a couple of days Only 
when high doses of antibodies are given is the outcome of the glomerular 
changes determined by the extent of the thrombotic process affecting the 
glomeruli. 
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The mouse with its many inbred strains has several advantages over 
the rat or rabbit in a systematic study of the role of secondary mediator 
systems in tissue destruction in both the heterologous and autologous phase 
A complement-neutrophil dependent injury is thought to play a key role 
in the heterologous phase as shown especially from studies in the rat (Coch­
rane et al 1965, Unanue and Dixon 1967) It is assumed that lysosomal 
enzymes released from PMNs, chemotactically attracted by complement 
factors, cause the glomerular damage with resulting proteinuria Groggel 
et al however demonstrated that in the heterologous phase of rabbits a 
complement-dependent, neutrophil-independent component of injury, in 
which the terminal complement components, including the membrane attack 
complex, was essential for the full development of proteinuria (Groggel 
et al 1984) Activation of the complete lytic pathway seemed also to be 
necessary for evoking the proteinuric effect in the passive Heymann nephritis 
(Adler et al 1983, Salant et al 1980) The anli-GBM nephritis in the mouse 
provides a good model to study further these interrelationships between 
complement and PMNs The role of the terminal complement components 
can be delineated in normal and C5 deficient mice Furthermore, treatment 
of C5 deficient mice with Cobra Venom Factor, can give additional informa­
tion on the role of C3 The role of PMNs can be studied in mice depleted 
of PMNs by total body irradiation (600 rad) This method is preferable 
to treatment with anti-PMN sera which always induces concomitant deple­
tion of complement levels (Bogman et al 1984) The conspicuous Shwartz-
man-like morphological lesions occurring in the first phase of the anti-GBM 
nephritis in mice, renders this model suitable for the examination of the 
effects of anti-platelet and fibrinolytic therapy on the outcome of the glomer­
ulonephritis The reproducibility of this new model of anti-GBM nephritis 
in the mouse offers an opportunity to obtain more insight in the relationship 
between activation of mediator systems, histological lesions and proteinuria 
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The study of Heymann nephritis, the counterpart of human membranous 
glomerulonephritis, has contributed a lot to our understanding of the 
immunologic mechanisms playing a role in the formation of subepithelial 
deposits and has stimulated many researchers to look for identical 
factors in the human disease. Although the antigen responsible for the 
binding of antibodies in the Heymann nephritis has been defined end 
localized in the rat glomerulus, sofar no identical antigen system has 
been identified in human membranous glomerulonephritis. The new antigenic 
system identified by us in the mouse, which clearly differs from the 
Heymann antigen, might be important for our understanding of human 
membranous glomerulonephritis. Before discussing the possible mechanisms 
operating in murine glomerulonephritis, a summary will be given of the 
factors which determine the deposition of subepithelial immune 
reactants. Subsequently we will discuss the protein composition of the 
brush border of the renal proximal tubular epithelia and the antisera 
derived from it. This may give insight into the factors governing the 
development of the deposits in our model and may clarify many 
contradictory observations of the Heymann nephritis in the rat. 
The usefulness of the passive anti-GBM nephritis, aimed to achieve an 
experimental model characterized by proteinuria and morphologic lesions 
for studying the mediator systems of glomerular injury will be discussed 
at the end of this chapter. 
I. M E M B R A N O U S G L O M E R U L O N E P H R I T I S IN T H E M O U S E 
MECHANISMS IN THE FORMATION OF SUBEPITHELIAL IMMUNE COMPLEXES 
Several mechanisms have been described in recent years that play a role 
in the formation or localization of immune complexes in the subepithelial 
space. Some factors are related to the characteristics of the protein or 
complex itself, such as size, antibody avidity, charge and plasma 
concentration, others to the electric charge of the glomerulus itself and 
to its permselective properties. It was generally accepted that the site 
of deposition and the quantity of immune complexes in the glomeruli were 
dependent on their antigen-antibody ratio in the circulation. Small 
preformed immune complexes either immunologically or covalently bound to 
each other were thought to lodge in the subepithelial space (reviewed in 
1). Studies with preformed immune complexes and the observations in the 
passive Heymann nephritis now strongly suggest that subepithelial 
deposits are often formed by in situ binding of antibody (reviewed in 
2,3К Moreover, many recent studies have revealed that in situ formation 
not only occurs with regard to structural antigens, such as in the 
Heymann nephritis and anti-GBM nephritis, but also with many nonrenal 
exogenous and endogenous antigens that are planted in the glomerulus 
before they react with free circulating antibodies (reviewed in 4J. The 
possible mechanisms are summarized in table I. 
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Table I. Formation of subepithelial immune complexes 
I In situ foraation a. structural glomerular antigens 
b. planted nonrenal antigens or antibodies: cationic 
anionic 
Π Trapping of small circulating immine complexes 
The classical subepithelial glomerular antigen is the Heymann antigen, 
characterized as a glycoprotein of 330,000 mol wt (gp-330) and localized 
at discrete sites in the glomerular visceral epithelia in rats (5,6). 
Another antigen involved in the development of a spontaneous nephropathy 
in rabbits, as described by Neale and Wilson, has been localized along 
the epithelial foot processes, but its molecular weight has not been 
defined (7). The gp-90 antigen, described by Ronco et al in rats and 
which is the putative target antigen in our model, has a homogeneous 
distribution in the glomerular endothelial and epithelial cell membranes 
(8,9). All three antigens have in common their presence in cell membranes 
of glomerular cells. It is thought that complexes formed on the cell 
membranes are shed, move in the direction of Bowman's space under the 
influence of the water flux through the membrane, and are subsequently 
retarded under the slit pore membranes. 
Subepithelial deposits can also occur after the binding of free circula­
ting antibodies to several nonrenal antigens, that are planted in the 
subepithelial space mostly on account of electrostatic interactions (4). 
Most studies, done with cationized nonrenal antigens, have revealed that 
the persistence of planted antigens in the subepithelial area is influen­
ced by interaction with specific antibodies (10). The formation of immune 
deposits may take place directly subepithelially or immune complexes, 
initially formed at the subendothelial side, dissociate and reform in the 
subepithelial area (11). Electrostatic interactions are also involved in 
the trapping of nonrenal anionic antigens (3). Binding may occur to 
cationic antigens or antibodies already deposited prior to immune deposit 
formation. Alternatively, a reduction in the charge barrier by binding of 
cationic macromolecules may result in an enhanced glomerular permeability 
leading to trapping of immune complexes. Furthermore, the presence of 
cationic groups in the glomerular capillary wall cannot be ruled out. In 
spite of the renewed interest in studies with preformed immune complexes, 
it is at present not clear whether these complexes can localize directly 
in the subepithelial space. Because they have the tendency to dissociate 
in the circulation, in situ formation cannot be excluded with certainty. 
However, the results of studies with preformed complexes of which the 
antigen and antibody are bound covalently suggest that direct trapping of 
circulating complexes in the subepithelial area can indeed occur (12,13). 
The question of whether an in situ or circulating immune complex mecha­
nism is operating may become impossible to answer in some cases, because 
small initial deposits can serve as a nidus for binding of free circula-
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ting antigen or antibody, causing dissolution, rearrangements and 
condensation of the immune reactants dependent on the circumstances. It 
has been shown that precipitating antigen-antibody reactions are 
important for the persistence of the immune deposits and for the 
formation of electron dense deposits (10,14). Furthermore, rheumatoid 
factor activity and anti-idiotypic antibodies can influence the size of 
immune aggregates and stabilize the immune deposits (15-17). 
Table II. Enzymes in the microvillar cell membranes of the proximal 
tubules 
Name EC no 8 Subunit 
Mol wt (х10-3)Ь 
Peptidases 
Aminopeptidase N 3.4.11.2 130,ÜÜ0-160,000 
Aminopeptidase A 3.4.11.7 125,000 
Aminopeptidase Ρ 3.4.11.9 135,000 
Dipeptidylpeptidaae IV 3.4.14.- or 3.4.21.- 110,000-130,000 
Endopeptidase I 3.4.24.11 90,000 
Endopeptidase II (meprin) 3.4.24,- 81,000 
y-Glutamyltransferase 3.2.2.2 70,000 
Angiotensin I converting enzyme 3.4.15.1 150,000 
Carboxypeptidase Ρ 3.4.11.9 
Glycosidases 
Maltese 3.2.1.20 300,000 
Trehalase 3.2.1.28 
Phosphatases 
Alkaline phosphatase 3.1.3.1 78,000 
5'-nucleotidase 3.1.3.5 
Phosphodiesterase 1 3.1.4.1 
From Kenny and Maroux (19) 
a
 classification number from the Enzyme Commission 
° relative molecular weights (M
r
) of subunits as measured in the elec­
trophoresis of microvillar preparations under denaturating conditions, 
i.e. after reduction and in the presence of SDS. The molecular size is 
also dependent on the method of solubilization of the membrane protein. 
99 
PROTEIN COMPOSITION OF THE BRUSH BORDER OF THE PROXIMAL EPITHELIAL CELL 
The antisera used in the studies of membranous glomerulonephritis in the 
mouse were raised with crude or enzymatically solubilized fractions of 
the renal proximal tubules, particularly the brush border. In order to 
understand the composition of these antisera, we have to look more close-
ly at the structure of this specialized cell and at its protein consti-
tuents that may act as antigens (18,19). The renal proximal tubular cell 
shows a morphologic and biochemical asymmetry. The luminal surface is 
composed of densely packed microvilli in a uniform array, known as the 
brush border, whereas the basal side is marked by smooth infoldings. 
Adjacent cells are connected to each other at the level of tight junc-
tions. It is believed that this tight junction is the principal structure 
capable of maintaining the biochemical asymmetry in the distribution of 
plasma membrane proteins at the opposing cell surfaces. Many membrane 
bound proteins preferentially localize in the luminal cell membrane, 
while others localize in the basolateral membranes. Many of the known 
cell membrane bound proteins are transmembranous amphipathic hydrolytic 
enzymes revealing similarities of structure: 1) they have large subunits, 
mostly higher than 90,0Ü0 dalton, 2) they are mostly dimeric frequently 
with identical subunits in most of the animals examined, 3) the bulk of 
the protein is hydrophylic and glycosylated, the sugars attached to the 
proteins constituting the glycocalyx of the microvilli, and 4) a small 
domain is involved in hydrophobic interactions with the membrane lipids 
(.Table II). Several of these proteins are furthermore connected with com-
ponents of the cytoskeleton, which possibly explains their localization 
in micro-domains in the brush border cell membranes (20). In addition to 
these enzymes several other proteins have now been described (Table III). 
Table III. Other glycoproteins located in the microvillar cell membranes 
of the proximal tubular epithelia 
Namea Subunit Species 
Mol wt (xl0-3)b 
Heymann antigen (5,6,21) 330,000 rat, mouse 
Heparan sulfate proteoglycan (22,23) 7b,000 rat 
Antigen detected by Mab (В,9) 90,000 rat, mouse 
Antigen detected by Mab (29) 118,000 - 107,000 rat 
a
 References between parentheses. Mab: monoclonal antibody 
b Relative molecular weights 
The function of these proteins is as yet unknown, but the association of 
the Heymann antigens with clathrin in coated pits has stressed its 
relation with receptor-mediated endocytosis (24), while proteoglycans by 
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their highly negative charge and high sugar composition are known to bind 
nonspecifically to several substances by electrostatic or lectin-like 
interactions (23,25). 
A prominent feature of several membrane proteins of the brush border is 
their widespread distribution in many organs and on many cells with 
apparently distinct functions. This applies particularly for certain pro-
teinases and for gp-90 as described by us. Many proteinases can be found 
collectively on the same cell, where they most likely enhance each others 
function (26). Regarding their possible role in the induction of a glome-
rulonephritis, several brush border glycoproteins are also present in the 
glomerulus: the Heymann antigen or gp-330 in rats (6), the gp-90 protein 
in rats and mice (8,9), the heparan sulfate proteoglycan of the cell mem-
branes in the rat (23), a leukemia associated antigen in man possibly 
related to gp-90 in rodents (27,28), an antigen detected by a monoclonal 
antibody in rats with a molecular weight of 118 and 107 kdaltons (29), 
and the enzymes angiotensinase A (or aminopeptidase A) (30-33), as well 
as dipeptidylpeptidase IV in man and rodents (34,35). Also the sharing of 
brush border proteins with the liver, the organ that we used to purify 
antibodies against gp-90, has been mentioned in several reports in recent 
years (30,34-39). The lobules of the liver are composed of hepatocytes 
and sinusoidal lining cells. The hepatocytes also exhibit a striking 
polarity with three functionally and morphologically distinct surface 
domains: the sinusoidal, the lateral, and the canalicular domain. Many 
cell surface proteins are restricted to one of these areas and serve as a 
specific marker of this domain (39,40). The purification of the antibo-
dies to gp-90 from our polyclonal antisera was facilitated by the absence 
of the Heymann antigen in this organ while gp-90 was abundantly present 
in the bile canalicular area and along the sinus. 
The nature and the function of gp-90 is unknown. It resembles in its 
organ distribution certain cell membrane bound proteinases, receptors, or 
other yet unidentified proteins, found both on mesenchymal and epithelial 
cells, some of which have furthermore a similar or approximately identi-
cal molecular weight (Table IV). The common leukemia-associated antigen 
(Calla) is recognized on cells from many patients with acute lymphoblas-
tic leukemia (ALL) and some patients with chronic myelocytic leukemia 
(CML) in blast crisis and is also found on renal tubular and glomerular 
cells, as well as on many other extrarenal epithelia (27,28). However, 
using monoclonal antibodies we could not detect a crossreactivity with 
normal mouse and rat kidneys. The transferrin receptor subunit, another 
ubiquitous major cell surface antigen, has a similar molecular weight as 
gp-90 but unlike this protein the receptor is composed as a disulfide-
linked molecule showing a molecular weight of 180 kdaltons under nonredu-
cing conditions in the SDS-PAGE (41,42). In mouse and rat kidneys we 
could locate the transferrin receptor only in the endothelia, but not in 
the brush borders. By enzyme or immunohistochemical methods the kidney 
brush border's neutral endopeptidase has only been located in the brush 
borders of the renal proximal tubular cells of several animal species 
(35,43). Recently, a monoclonal antibody has been produced against this 
proteinase of the pig, determined as a 90 kd glycoprotein (44). Although 
the investigators described an association only with the luminal aspects 
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Table IV. Some cell membrane proteins with approximately identical 
molecular weight and tissue distribution as the gp-90 protein8 
Mr subunit (xlü-^b Author Remarks 
90,000 Ronco et al (8) 
90,000 Metzgar et al (27) Calla, human 
90,ÜÜ0 Schneider et al (42) subunit transferrin 
receptor, human 
90,000 Gee et al (44) endopeptidase, pig 
90,000 + 70,000 + 72,000C Hughes et al (45) murine 3T3 cells 
90,000 + 76,000d Hubbard et al (49) hepatocyte, sinusoidal 
lining cell, rat 
80,000 or 92,000 Hughes et al (45) murine 3T3 cells 
8
 references between parentheses c related to (48) and (49) 
b relative molecular weights d related to (54,55), (56) and (57) 
of the proximal tubular epithelia, the accompanying micrograph of the 
immunofluorescence showed a moderate homogeneous staining along the 
glomerular capillary wall. Two monoclonal antibodies prepared by August 
and his collaborators by fusion of mouse myeloma cells and spleen cells 
of rats immunized with 3T3 murine fibroblasts detect also antigens with a 
molecular weight of approximately 90 kd (45,46). The first one is direc-
ted against a 90 kd protein that is concentrated in coated pits of murine 
cells (46). It co-precipitates two other peptides of 70 and 72 kd. This 
antigen system is probably identical to a 92 kd protein in the murine 3T3 
cell membranes studies previously by Pouysségur and Yamada with polyclo-
nal goat antiserum and that was always associated with a 75 kd protein 
(48). The presence in coated pits excludes in all likelihood a connection 
with our 90 kd protein that always shows a homogeneous distribution. 
Recently similar associated proteins of 90 and 72 kd have been detected 
with monoclonal antibodies in the cell membranes of both the hepatocyte 
and sinusoidal endothelial cell of the rat liver (49). The second mono-
clonal antibody described by August et al is directed against another 
antigen diffusely present on the cell surfaces of murine 3T3 cells, as 
well as on macrophages and epithelial cells (45,46,50-53). Their monoclo-
nal antibody detects a polymorphic glycoprotein of 80 kd, designated as 
Pgp-1 or ly-24 and identical to the 92 kd glycoprotein of mouse myeloid 
cells also mentioned by them. Trowbridge et al have independently identi-
fied the same protein on mouse lymphoid tissues (54,55). However, their 
monoclonal antibodies were mostly directed against common determinants, 
while a few detect allodeterminants of this polymorphic antigenic system. 
The protein might also be identical to other myelomonocytic cell surface 
components, such as the 90 kd protein of the J774 macrophage cell line 
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(56), and β 9Ü kd polypeptide of murine macrophages and neutrophils (57). 
At this time it is not possible to determine which of these cell surface 
antigens is related to gp-90. 
It is conceivable from our knowledge about the protein composition of the 
brush borders of the renal proximal tubular epithelia, that antisera 
raised against crude or solubilized fractions must contain antibodies 
with many specificities. Previous attempts to purify the Heymann antigen, 
such as the RTEa5 of Edgington et al (58), clearly illustrate the diffi-
culties in obtaining a specific protein from renal brush border prepara-
tions of the rat by revealing the presence of many proteins other than 
the nephritogenic component in SOS-PAGE. Even the large glycoprotein 
identified by Kerjaschki and Farquhar as the Heymann antigen by gel fil-
tration and lentil lectin affinity chromatography from detergent-solubil-
ized brush border membranes, appeared to be contaminated with the enzyme 
maltase (21). Polyclonal antisera have falsely suggested a more wide-
spread extrarenal distribution of the Heymann antigen due to the concomi-
tant presence of antibodies against this disaccharidase (59). 
The question of whether only one or multiple antigen systems are contri-
buting to the formation of subepithelial deposits in the Heymann nephri-
tis has not been settled satisfactorily. Monoclonal antibodies to gp-330 
can induce a classic passive Heymann nephritis in the rat (60), whereas 
monoclonal antibodies to gp-90 evoke a transient, almost linear,binding 
to the glomerular capillary wall (Θ). A similar linear binding to the 
capillary wall is also observed in the first hours following the injec­
tion of polyclonal anti-brush border antibodies changing thereafter in a 
granular pattern with subsequent formation of subepithelial deposits (61-
63). Jeraj et al employing a polyclonal anti-rat FxlA serum speculated 
about the presence of a new glomerular antigen in the passive Heymann 
nephritis situated on the plasma membranes of the endothelia (64). 
Together with the results that we obtained with eluates from a polyclonal 
mouse antiserum these data strongly suggest that at least two antigen 
systems are important in these models. In the rat, where both the gp-330 
and the gp-90 are present in the glomerular capillary wall, the differen­
ces in binding kinetics of the two antibody populations may lead to a 
misinterpretation of the events occurring in the first hours after injec­
tion of the antiserum. We took advantage of the mouse lacking the Heymann 
antigen in the glomerulus, to demonstrate that gp-90 alone is responsible 
for the induction of subepithelial deposits. There is no reason to assume 
that this antibody cannot cause similar lesions in the rat. Therefore, we 
are now investigating the capacity of polyclonal antibodies to gp-90 to 
induce a membranous glomerulonephritis in rats analogous to the nephritis 
in mice. The earlier reported failure of monoclonal antibodies to gp-90 
to cause membranous glomerulonephritis in rats is most likely due to the 
fact that these antibodies did not evoke an immune response and that con­
sequently an autologous phase did not occur. 
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С. MECHANISMS OPERATING IN MURINE MEMBRANOUS GLOMERULONEPHRITIS 
Like the Heymann nephritis in rats and the spontaneous glomerulonephritis 
in rabbits, the membranous glomerulonephritis described in this thesis is 
an example of an experimental nephritis in which the in situ formation of 
subepithelial deposits is initiated by the binding of the injected anti­
bodies to a structural antigen (gp-90). The model has some features in 
common with the passive Heymann nephritis and the anti-GBM nephritis, 
like its biphasic course and binding kinetics. The initial or heterolo­
gous phase is characterized by transient enhanced glomerular permeability 
and a prompt binding of the injected antibodies to the glomerular capil­
lary wall reaching a maximum in the first hours but rapidly decreasing 
thereafter. The early maximal binding in our model, identical to that of 
the monoclonal anti-gp-90 in rats as described by Ronco et al (8), resem­
bles more the events in the passive anti-GBM, although the antigen system 
involved and the ultimate outcome are completely different. The binding 
pattern in the murine model remained homogeneous or fine granular during 
this stages and no electron dense deposits could be observed in the elec­
tron microscope. The binding kinetics are different from the passive 
Heymann nephritis, in which an immediate fixation of the antibodies takes 
place to the gp-330 proteins in coated pits on the cell membranes, and a 
gradual increase of subepithelial deposits shed from the cell membranes 
into the lamina гага externa occurs. The peculiar anatomy of this area 
prevents the immune complexes from diffusion and promotes their 
accumulation under the slit pores. The phenomenon of shedding of cell 
membrane proteins crosslinked by their specific antibody or ligand has 
been extensively studied in lymphocytes and is preceded in this 
particular cell by capping of the complexes on the cell surface (6b). 
Camussi et al have recently observed on rat glomerular epithelial cells 
in culture that the Heymann antigen is being capped after administration 
of antibodies and subsequently shed in the culture medium (66). This 
rapidly occurring phenomenon is driven by cytoskeletal proteins attached 
to the cell surface antigen. After shedding the antigen cannot be seen 
for a while but reappears after several hours in the plasmalemma. These 
very interesting in vitro studies can probably extend our insight in the 
binding of the antibodies and the gradual built-up of the immune 
complexes in the subepithelial space. Until now, it has been assumed that 
the specific binding kinetics in the passive Heymann nephritis could be 
related to the interposition of proximal layers of the capillary wall 
between the circulation and the site of deposit formation, but other 
factors such as a modulated or enhanced expression of the antigen on the 
cell surface after the initial binding of the antibodies can contribute 
to this phenomenon. This can easily be studied in such in vitro systems. 
A similar mechanism of capping and shedding was recently observed in vivo 
after interaction of antibodies to angiotensin converting enzyme 
expressed on the oolemma of rabbit oocytes (67). Binding of antibodies to 
the cell membranes in our murine model did not disturb the homogenenous 
distribution of the antigen in the cell membranes. We have assumed that 
the rapid decrease of fixed antibodies might be caused by dissociation of 
the antibody-antigen complex. Only after the development of antibodies 
against the injected rabbit IgG in the autologous phase and their binding 
to the planted heterologous antibody, aggregation of the IgGs occurred 
with consequent formation of shed immune complexes under the slit pores, 
a phenomenon already taking place in the heterologous stage of the 
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passive Heymann nephritis. It is well-known that some cell membrane bound 
proteins are more liable to aggregation and capping after binding with 
their ligand than others, dependent of their function and possible 
connection with cytoskeleton proteins. For instance, the migratory 
behavior of the Heymann antigen in the vitro studies of Camussi (66 ) 
contrasts with the uniform distribution of a 80 kd major cell surface 
glycoprotein on murine fibroblasts after binding with specific monoclonal 
antibodies (53). The homogeneous binding persisted during a culture 
period of more than 100 hours, but changed very quickly from uniform to 
patched upon the addition of a second antibody directed against the 
monoclonal antibody. A relationship of these patches to the underlying 
cytoskeleton was observed. The kinetics of aggregation of complexes on 
the cell surface, as described for the gp-80 on murine 3T3 fibroblasts, 
might be the same as those operating in our model during the two phases. 
This can be tested on rat glomerular epithelial cell cultures with 
monoclonal and polyclonal antibodies against the gp-90. 
I I . P A S S I V E A N T I - G B M N E P H R I T I S IN T H E M O U S E 
Unlike the membranous glomerulonephritis in the mouse, the heterologous 
phase of the anti-GBM nephritis was characterized by immediate, dose 
dependent albuminuria and morphologic lesions. The major cause for this 
difference is probably the site where the reaction takes place. In the 
case of the anti-GBM nephritis the antibody binds at the endothelial side 
of the GBM. The secondarily activated humoral and cellular mediator 
systems can easily gain access to the subendothelial space. Studies of 
the heterologous phase have clearly established a role for complement and 
neutrophils. Our interest in the role of these mediator systems in the 
mouse has been stimulated by the observations of Bogman et al (68) made 
in the hyperacute antibody mediated graft rejection in the mouse. From 
these studies it has emerged that the dose of administered antibody is an 
important determinant in the complex interplay between humoral and cellu-
lar mechanisms. Most investigators have only studied the systemic media-
tor systems such as complement, neutrophils, monocytes, platelets, and 
the coagulation factors. Ito et al, using a hyperacute renal allograft 
rejection model in the rabbit, have stressed the importance of in situ 
release of factors in renal injury (69). They observed after an immediate 
binding of antibodies and complement to the endothelial antigens of the 
graft, a local release of platelet-activating factor and massive accumu-
lation, aggregation, and degranulation of platelets and neutrophils, 
resulting in a binding of platelet and neutrophil derived cationic 
proteins to the capillary wall. It seems likely that the endothelial 
release of prostaglandins and other vasoactive compounds also contributes 
to the glomerular lesions of the anti-GBM nephritis. Although the antige-
nic targets of this model are assumed to be located in the glomerular 
basement membrane and not on the endothelial cell membranes, swelling and 
destruction of the endothelia are preceding or go along with the influx 
of neutrophils, the lysosomal release of which is believed to be the 
starting mechanism of tissue destruction. This time dependent relation-
ship between the influx of neutrophils and endothelial cell destruction 
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might conceal other destructive mechanisms. For instance, the immediate 
activation of complement on the inner side of the GBM generates a 
membrane attack complex (MAC). Trapping of this complex on the 
neighbouring endothelial cell membranes may cause cell lysis with 
subsequent release of mediators even before granulocytes will have 
arrived. Another explanation for the apparent destruction of endothelial 
cells by an anti-GBM antiserum is obviously the possible presence of 
additional specificities. Our antiserum against glomerular membranes was 
rendered free from cellular remnants by detergent treatment. Not unexpec-
tedly, it detects many different antigens located in site-specific arrays 
in and along the lamina densa, such as type IV and V collagens, fibronec-
tin, laminin, enactin, heparan sulfate proteoglycan and several unidenti-
fied antigens reactive with monoclonal antibodies. Several glycoproteins 
like fibronectin and laminin function as anchor molecules attaching endo-
thelial and epithelial cells to the GBM. These molecules are also found 
on the cell membranes and may, in this location, serve as targets for 
antibody-mediated endothelial damage. 
Our new murine model of passive anti-GBM neprhtis will probably be help-
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Experimental models of glomerulonephritis are necessary to obtain insight 
into the immunologic mechanisms that play a role in this disease. Most 
studies have been carried out in rabbits and rats. In the past the mouse 
has not been used on a large scale in experimental nephritis because of 
the variability of the lesions induced by the different procedures. It is 
however an attractive animal for immunologic studies because extensive 
information on immunogenetics and immunologic mediators is available in 
this species. In this thesis we describe the successful induction of two 
different forms of murine glomerulonephritis. The first one is a membra-
nous glomerulonephritis passively induced by a single injection of an 
antiserum against murine, pronase digested renal tubular antigens. The 
second one is a passive anti-glomerular basement membrane (GBM) nephritis 
evoked by the administration of anti-GBM antibodies. 
A decade ago, the concept of trapping of soluble circulating immune 
complexes as the only mechanism of glomerular injury in the socalled 
"immune complex induced nephritis" has been guestioned by observations in 
passive Heymann nephritis (PHN) in rats, in which in situ formation of 
immune complexes, consisting of a structural antigen in the glomerular 
capillary wall and the administered antibodies, could be demonstrated. 
Until then, this latter mechanism was only supposed to play a role in the 
anti-GBM nephritis. In our first experiments we have tried to induce in 
mice a membranous glomerulonephritis similar to the PHN in rats. To this 
end, we injected C57B1/1U mice with antibodies against enzymatically 
solubilized, murine renal tubular antigens. These antibodies had been 
prepared in rabbits or goats. The initial, socalled heterologous phase 
was characterized by a transient increase of glomerular permeability with 
immediate, homogeneous fixation of the injected antibodies to the glome-
rular capillary wall. The amount of antibody bound decreased rapidly in 
the subsequent days. In the second or autologous phase, which is marked 
by the immune response of the recipient to the injected protein, small 
subepithelial immune deposits developed in a distribution typical for 
membranous glomerulonephritis. None of the mice developed a nephrotic 
syndrome. Like in the PHN, in situ formation of the deposits seemed to be 
the most likely explanation because the injected antiserum contained 
antibodies directed against an antigen homogeneously present in the cell 
membranes of the glomerular epithelia and endothelia. Although our model 
has some features in common with the PHN, several essential differences 
have been found such as the binding kinetics of the injected antibodies, 
the absence of a prolonged enhanced glomerular permeability, and the 
relationship of the formation of the immune aggregates with the immune 
response of the mouse. This led us to the assumption that the antigen 
involved in our model differed from the Heymann antigen which is the 
target for the binding of antibodies in PHN. 
Therefore, we carried out experiments aimed to compare the antigenic 
targets involved in the induction of membranous glomerulonephritis of the 
rat and the mouse. In rats, a classic PHN could be induced after injec-
tion of our antiserum with a gradual built-up of subepithelial deposits 
in the heterologous phase. There was a striking difference with the 
binding kinetics and development of immune aggregates in the autologous 
phase in the mouse. In indirect immunofluorescence studies on normal 
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mouse and rat kidneys we observed that the antiserum reacted strongly 
with the visceral epithelia of the mouse in a homogeneous pattern, while 
a faint granular staining was seen in the rat glomerulus against a homo-
geneous background. These observations suggested that we were dealing 
with at least two different antibody populations in our antiserum, one 
against the Heymann antigen, recently defined as a 330,000-dalton protein 
(gp-330) and localized at discrete sites in the glomerular visceral 
epithelia of the rat, and the other against the homogeneously distributed 
antigen operating in the mouse model. 
Taking advantage of the differences in binding kinetics of the two anti-
bodies, we were able to purify antibodies against the Heymann antigen 
from kidneys of rats injected with the antiserum. Elutions of rat glome-
rular suspensions were performed at 5 days after injection of the anti-
serum because at that time antibodies bound to the homogeneously distri-
buted antigen had already disappeared from the glomerular capillary wall. 
The antibodies thus prepared bound to the brush borders of normal mouse 
and rat kidneys. However, staining of the glomeruli was seen only in the 
rat, where it was present in a fine granular pattern. The distribution at 
discrete sites in the cell membranes and the presence in some intracyto-
plasmic organelles of the visceral epithelia as seen in the immuno-elec-
tron microscopy were characteristic for the Heymann antigen. Subsequent-
ly, we carried out an immunoprecipitation analysis to compare the poly-
clonal antiserum and the rat eluate with monoclonal antibodies against 
brush border antigens. The results confirmed that the eluted antibodies 
detected a 330 kd molecular weight glycoprotein, earlier identified as 
the Heymann antigen. Furthermore, the immunoprecipitation results toge-
ther with those of the immunohistologic studies strongly suggested that 
the homogeneously distributed antigen involved in the murine membranous 
glomerulonephritis was a 90 kd glycoprotein, which was present both in 
the mouse and the rat glomerulus. 
Our initial attempts to separate the antibodies to gp-90, using glomeruli 
of mice injected with the antiserum, failed because in this species it is 
impossible to prepare suspensions sufficiently enriched with glomeruli. 
Mouse liver was then chosen as an immunoadsorbant for preparing the 
specific antibodies to gp-90, because we had observed in in vitro studies 
that the liver expresses gp-90, but lacks gp-330. Elution of antibodies 
from livers of mice at 15-30 min after injection of the antiserum proved 
to be successful. The eluted antibodies bound homogeneously to the glome-
rular capillary wall of the mouse, and to a lesser extent of the rat. In 
immunoprecipitation they bound predominantly to an antigen with a molecu-
lar weight of 90 kd, but not to gp-330. These results gave definite proof 
for our hypothesis that an antigen with a molecular weight different from 
the Heymann antigen can serve as the target for antibody-mediated membra-
nous glomerulonephritis in the mouse. They also raise the possibility 
that anti-gp-90 antibodies can induce subepithelial deposits and conse-
quent membranous glomerulonephritis in other species, such as the rat. 
The expression of the two antigens outside the kidney, as examined with 
the separated antibody populations on normal mouse and rat tissues in the 
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immunofluorescence, was also different. We found the Heymann antigen, 
which is thought to be poorly expressed outside the kidney, in a few 
other organs of the mouse and the rat. Gp-90 showed a much more wide-
spread distribution closely resembling that of several hydrolytic 
enzymes. The most common site was the capillary endothelium. 
The second model described in this thesis is a passive form of anti-GBM 
nephritis. This is an example of a nephritis in which in situ formation 
of the immune reactants takes place by the binding of anti-GBM antibodies 
to a structural antigen located in the glomerular basement membrane 
itself. It has been difficult to induce a reproducible anti-GBM nephritis 
in the mouse. By the intravenous injection of a goat antibody against 
purified murine GBM we were able to induce such a nephritis with a 
severe, dose dependent, and highly reproducible albuminuria in the 
heterologous phase. Morphologically, there was immediate linear deposi-
tion of goat IgG in the GBM accompanied by diffuse, fine granular depo-
sits of mouse C3. Influx of neutrophils was present after one hour. This 
was followed by thrombosis and necrosis, the extent of which determined 
the outcome of the glomerulonephritis. This reproducible model in the 
mouse is ideally suited to study the relationship between activation of 
mediator systems, histologic lesions, and proteinuria. 
Human glomerulonephritis can manifest itself with a wide spectrum of 
clinical symptoms. The disease may present as a nephritic or a nephrotic 
syndrome, renal failure may occur suddenly or the course may be protrac-
ted, histologic lesions may be extensive or almost absent. Although 
cellular immune mechanisms are probably important in some forms of 
glomerulonephritis, it is likely that humoral immunity plays a 
predominant role in most instances. The great variability in presentation 
of this disease is certainly related to differences in binding kinetics 
of the antibodies involved, in the- location and nature of the target 
antigens, and in the contributions of secondary mediator systems. The 
reproducible models described in this thesis allow for further detailed 






Experimentele modellen van glomerulonefritis zijn nodig om inzicht te 
krijgen in de immunologische mechanismen die een rol spelen bij deze 
ziekte. De meeste studies zijn uitgevoerd bij konijnen en ratten. De muis 
is in het verleden nooit op grote schaal gebruikt in de experimentele 
nefritis omdat de afwijkingen die verkregen werden in het algemeen slecht 
reproduceerbaar bleken. Voor immunologische studies is het echter een 
aantrekkelijk proefdier omdat er zo veel bekend is over de immunogenetica 
en immunologische mediatoren in deze diersoort. In dit proefschrift 
beschrijven wij de succesvolle inductie van twee verschillende vormen van 
glomerulonefritis bij de muis. De eerste vorm is een membraneuze glomeru-
lonefritis, die passief opgewekt werd door een enkelvoudige injektie van 
een antiserum gericht tegen door pronase verteerde tubulaire antigenen 
van de muizenier. üe tweede vorm is een passieve anti-glomerulaire 
basaalmembraan (GBM) nefritis, opgewekt door de toediening van anti-GBM 
antilichamen. 
Aan de opvatting, dat het neerslaan van oplosbare circulerende immuuncom-
plexen als enig mechanisme verantwoordelijk is voor de glomerulaire 
afwijkingen bij de zogenaamde "immuuncomplex geïnduceerde nefritis", is 
men tien jaar geleden gaan twijfelen op grond van waarnemingen bij de 
passieve Heymann nefritis (PHN) in de rat. Hierbij werd aangetoond dat 
immunocomplexen in situ ontstonden en dat ze samengesteld waren uit een 
struktureel antigeen in de glomerulaire liswand en de toegediende antili-
chamen. Tot dan toe werd verondersteld, dat dit laatste mechanisme alleen 
een rol speelde bij de anti-GBM nefritis. In onze eerste experimenten 
hebben we getracht in de muis een membraneuze glomerulonefritis op te 
wekken die gelijk was aan de PHN in de rat. Daartoe dienden we C57B1/1Ü 
muizen antilichamen toe gericht tegen enzymatisch oplosbaar gemaakte, 
renale tubulaire antigenen van de muis. Deze antilichamen waren opgewekt 
in konijnen of geiten. De eerste, of heterologe fase, werd gekenmerkt 
door een voorbijgaande verhoogde glomerulaire doorlaatbaarheid en een 
onmiddellijke, homogene binding van de geïnjiceerde antilichamen aan de 
glomerulaire liswanden. De hoeveelheid gebonden antilichaam verminderde 
in de daarop volgende dagen snel. In de tweede, of autologe fase, geken-
merkt door de iitvnuunresponse van de ontvanger tegen het toegediende 
eiwit, ontwikkelden zich kleine, subepitheliaal gelegen, immuunneerslagen 
in een verdeling die kenmerkend was voor een membraneuze glomerulonefri-
tis. Geen van de muizen ontwikkelden een nefrotisch syndroom. Evenals in 
de PHN leek in situ vorming van de neerslagen het meest aannemelijk, 
omdat het toegediende antiserum antilichamen bevatte gericht tegen een 
antigeen, dat homogeen aanwezig was in de celmembranen van de glomeru-
laire epitheel- en endotheelcellen. Hoewel ons model overeenkomst toonde 
met de PHN, werden ook essentiële verschillen gevonden, zoals de bin-
dingskinetiek van de geïnjiceerde antilichamen, de afwezigheid van een 
langdurige verhoogde glomerulaire doorlaatbaarheid en de samenhang van de 
vorming van de immuun-aggregaten met de immuunresponse van de muis. Dit 
leidde tot de veronderstelling, dat het verantwoordelijke antigeen in ons 
model verschilde van het Heymann antigeen, dat de antilichamen in de PHN 
bindt. 
Daarom voerden we experimenten uit, die tot doel hadden de antigenen die 
verantwoordelijk waren voor het ontstaan van de membraneuze glomerulone-
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fritis in de rat en de muis te vergelijken. In ratten kon na toediening 
van het antiserum een klassieke PHN opgewekt worden met een geleidelijke 
vorming van subepitheliale deposities in de heterologe fase. Er werd een 
opvallend verschil gezien met de bindingskinetiek en het ontstaan van 
immuun-aggregaten in de autologe fase in de muis. In de indirekte immuno-
fluorescentie studies op normale muize- en rattenieren zagen we dat het 
antiserum sterk reageerde met het viscerale epitheel van de muis in een 
homogeen patroon, terwijl een zwakke granulaire aankleuring werd waarge-
nomen in de ratteglomerulus tegen een homogene achtergrond. Deze waarne-
mingen deden vermoeden, dat we te maken hadden met ten minste twee ver-
schillende antilichaampopulaties in ons antiserum, één gericht tegen het 
Heymann antigeen, dat onlangs gekarakteriseerd is als een 330.000 dalton 
eiwit (gp-330) en dat aanwezig is op diskrete plaatsen in het glomeru-
laire viscerale epitheel van de rat, en het andere gericht tegen het 
homogeen verdeelde antigeen dat in ons model een rol speelt. Door gebruik 
te maken van de verschillen in bindingskinetiek van de twee antilichamen, 
konden we de antilichamen gericht tegen het Heymann antigeen zuiveren uit 
nieren van ratten die ingespoten waren met het antiserum. De antilichamen 
werden uit glomerulaire suspensies ge'élueerd, vijf dagen na toediening 
van het antiserum omdat op dat tijdstip de antilichamen die zich hadden 
gebonden aan het homogeen verdeelde antigeen, reeds uit de glomerulaire 
liswanden waren verdwenen. De ge'élueerde antilichamen bonden zich aan de 
tubulaire borstelzoom van normale muize- en rattenieren. Aankleuring van 
de glomeruli werd echter alleen in de rat gezien, waarbij het patroon 
fijn granulair was. De diskrete verdeling in de celmembranen en de aanwe-
zigheid in sommige intracytoplasmatische organeilen van de viscerale epi-
theelcellen, aangetoond in de immuno-elektronenmicroscopie, waren karak-
teristiek voor het Heymann antigeen. Vervolgens werd een immunoprecipita-
tie-analyse uitgevoerd om het polyclonaal antiserum en het ratte-eluaat 
te vergelijken met monoclonale antilichamen tegen tubulaire borstelzoom 
antigenen. Inderdaad bleken de ge'élueerde antilichamen een glycoproteïne 
met een molekuulgewicht van 330 kd te herkennen dat eerder als het 
Heymann antigeen was gekarakteriseerd. De resultaten van de immuunpreci-
pitatie, alsmede die van de immunohistologische studies wekten tevens het 
vermoeden dat het homogeen verdeelde antigeen in de membraneuze glomeru-
lonefritis van de muis een glycoproteïne was, met een molekuulgewicht van 
90 kd, dat zowel in de muize- als ratteglomerulus aanwezig was. 
Eerdere pogingen om de antilichamen tegen gp-90 te scheiden door ze te 
eluëren van glomeruli van muizen die tevoren ingespoten waren met het 
antiserum, mislukten omdat het in deze diersoort onmogelijk is om zuivere 
glomerulaire suspensies te bereiden. Daarom werd voor de zuivering van de 
specifieke antilichamen tegen gp-90 de muizelever gebruikt als een immu-
no-adsorbans. Uit voorafgaand onderzoek was gebleken dat de lever wel 
gp-90 bevat, doch geen gp-330. Elutie van antilichamen uit muizelevers, 
verkregen 15-30 minuten na injektie van het antiserum leidde tot het ver-
wachte resultaat. De geëlueerde antilichamen bonden homogeen aan de glo-
merulaire liswanden van de muis en in mindere mate van de rat. In de 
immunoprecipitatie-analyse bonden ze voornamelijk aan een antigeen met 
een molekuul gewicht van 90 kd, maar niet aan gp-330. Deze resultaten 
leverden het definitieve bewijs voor onze hypothese, dat een antigeen met 
een molekuulgewicht verschillend van dat aan het Heymann antigeen kan 
dienen als target voor de door antilichamen geïnduceerde membraneuze glo-
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merulonefritis in de muis. Ze suggereren tevens dat anti-gp-90 antiliche-
men in andere diersoorten, zoals de rat, subepitheliale neerslagen kunnen 
veroorzaken die kunnen leiden tot een membraneuze glomerulonefntis. 
Onderzoek met de gescheiden antilichaampopulaties op normale muize- en 
ratteweefsels in de immunofluorescentie leerde dat de expressie van de 
twee antigenen ook buiten de nier verschilde. Wij vonden het Heymann 
antigeen, waarvan men dacht dat het weinig buiten de nier voorkwam, in 
een aantal andere organen bij zowel de muis als de rat. Gp-90 toonde een 
veel grotere verspreiding die sterk leek op die van sommige hydrolytische 
enzymen. De meest op de voorgrond staande lokalisatie was het capillaire 
endotheel. 
Het tweede model dat beschreven is in dit proefschrift is een passieve 
vorm van anti-GBM nefritis. Dit is een voorbeeld van een nefritis, waarin 
een in si tu vorming van de immuuncomplexen plaats vindt door binding van 
anti-GBM antilichamen aan een struktureel antigeen, dat gelokaliseerd is 
in de glomerulaire basaalmembraan zelf. Het is zeer moeilijk gebleken om 
een reproduceerbare anti-GtìM nefritis in de muis op te wekken. Door 
intraveneuze toediening van een geite-antilichaam tegen gezuiverd GBM van 
de muis, konden we een nefritis induceren, die gekenmerkt was door een 
ernstige, dosis afhankelijke, en reproduceerbare albuminurie in de hete-
rologe fase. Morfologisch was er een onmiddellijke lineaire afzetting van 
geite IgG in de GBM, die gepaard ging met diffuse, fijn-granulaire neer-
slagen van muize C3. Neutrofiele granulocyten waren na één uur aanwezig. 
Deze influx werd gevolgd door thrombose en necrose, waarvan de uitge-
breidheid bepalend was voor het beloop van de glomerulonefntis. Dit 
reproduceerbare model is erg geschikt voor het bestuderen van de relatie 
tussen de aktivenng van mediatorensystemen, histologische afwijkingen, 
en proteinune. 
De glomerulonefntis bij de mens kan zich presenteren met een brede 
scala van klinische symptomen. De ziekte kan zich openbaren als een 
nefntisch of een nefrotisch syndroom; niennsufficientie kan akuut ont-
staan of het beloop kan geprotraheerd zijn en histologische afwijkingen 
kunnen zeer uitgebreid of nagenoeg afwezig zijn. Alhoewel cellulaire 
immuunmechamsmen waarschijnlijk belangrijk zijn bij sommige vormen van 
glomerulonefntis, speelt de humorale immuniteit in de meeste gevallen 
een belangrijke rol. De grote variabiliteit in de presentatie van deze 
ziekte is waarschijnlijk gekoppeld aan verschillen in bindingskinetiek 
van de betrokken antilichamen, in de lokalisatie en de aard van de anti-
genen, en in de bijdrage van secundaire mediatorsystemen. De reproduceer-
bare modellen, die in dit proefschrift zijn beschreven, maken meer gede-
tailleerde studies naar de doelwit-antigenen en naar de rol van secundai-
re mediatoren in deze ziekte mogelijk. 
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Bij de membraneuze glomerulonefritis in de muis is niet het Heymann anti-
geen (gp 330) betrokken, maar een kleiner antigeen (gp 90) met een volle-
dige andere lokalisatie en distributie 
II 
Het is niet uitgesloten dat heterologe antistoffen tegen gp 90 ook bij de 
rat een membraneuze glomerulonefritis kunnen veroorzaken, aangezien de 
distributie van dit antigeen bij de rat sterk lijkt op die bij de muis. 
III 
Dat gp 90 mogelijk een enzym is, wordt gesuggereerd door het feit dat 
zijn orgaanlokalisatie dezelfde is als die van sommige proteasen van de 
renale, tubulaire borstel zoom. 
IV 
De zogenaamde Heymann nefritis kan alleen bij de rat opgewekt worden, 
omdat het betrokken antigeen (gp 330) alleen bij deze diersoort in de 
glomerulaire capillairwand voorkomt 
V 
IgA nefropathie gaat, in tegenstelling tot de Henoch-Schönlein nefritis, 
niet gepaard met neerslagen van IgA in de dermale vaten. 
VI 
In een groot aantal nierbiopten van kinderen met hématurie worden afwij-
kingen aan de glomerulaire besaalmembraan gevonden. 
VII 
De aanwezigheid van een of enkele banden in het gammagebied van het serum 
eiwitspectrum van patiënten met een "graft versus host disease" wijst 
niet op een maligne lymfoproliferatief proces maar op een stoornis in de 
immuunregulatie. 
Vili 
Verminderde doorbloeding van een niertransplantaat beschermt dit orgaan 
tegen destructie door antistoffen. Dit wordt mogelijk veroorzaakt door 
verminderde expressie van transplantatie-antigenen op het vasculaire 
endotheel van het transplantaat. 
K.J.M. Assmann en R.A.P. Koene. Protection against rejection by impaired 
blood flow in a renal allograft, transplantation 1981; .52: 256-258. 
IX 
Bij onverklaard rectaal bloedverlies dient niet volstaan te worden met 
een rectoscopie, maar is onderzoek van het gehele colon geïndiceerd. 
X 
De voor de mens onaangename geurstoffen in muize-urine blijken een in de 
H-2 regio gecodeerd polymorfisme te tonen, dat belangrijk is voor de 
bevordering van het sociaal en sexueel kontakt tussen dieren die ver-
schillen voor deze genetische regio. 
XI 
Dat een financiële versterking van de eerste lijn in de gezondheidszorg 
zich uiteindelijk zelf laat betalen is een illusie. 
XII 
De vrij algemene overtuiging dat psychische en sociale faktoren een 
direkte rol spelen bij het ontstaan van organische aandoeningen zoals 
maagzweer, hartinfarct of kanker berust op folklore en magisch denken. 
M. Angeli. Disease as a reflection of the psyche. New Engl J Med 1985; 
313: 1570-1572. 
XIII 
De hoge eisen geformuleerd in de funktieomschrijving van Universitair 
Hoofd Docenten wekken de verwachting dat binnenkort een nieuwe omschrij-
ving van de funktie van Hoogleraar zal volgen. 
nijmegen, 17 december 1985 K.J.M. Assmann 






